
<html lang="en"     class="pb-page"  data-request-id="48f4611f-4935-423c-8f6e-cf9aeca3dbe5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2021.64.issue-10;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.0c01971;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Adamantyl Isothiocyanates as Mutant p53 Rescuing Agents and Their Structure–Activity Relationships" /></meta><meta name="dc.Creator" content="Vladimir  Burmistrov" /></meta><meta name="dc.Creator" content="Rahul  Saxena" /></meta><meta name="dc.Creator" content="Dmitry  Pitushkin" /></meta><meta name="dc.Creator" content="Gennady M.  Butov" /></meta><meta name="dc.Creator" content="Fung-Lung  Chung" /></meta><meta name="dc.Creator" content="Monika  Aggarwal" /></meta><meta name="dc.Description" content="Mutant p53 rescue by small molecules is a promising therapeutic strategy. In this structure–activity relationship study, we examined a series of adamantyl isothiocyanates (Ad-ITCs) to discover nove..." /></meta><meta name="Description" content="Mutant p53 rescue by small molecules is a promising therapeutic strategy. In this structure–activity relationship study, we examined a series of adamantyl isothiocyanates (Ad-ITCs) to discover nove..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 7, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01971" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01971" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01971" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01971" /></link>
        
    
    

<title>Adamantyl Isothiocyanates as Mutant p53 Rescuing Agents and Their Structure–Activity Relationships | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01971" /></meta><meta property="og:title" content="Adamantyl Isothiocyanates as Mutant p53 Rescuing Agents and Their Structure–Activity Relationships" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0008.jpeg" /></meta><meta property="og:description" content="Mutant p53 rescue by small molecules is a promising therapeutic strategy. In this structure–activity relationship study, we examined a series of adamantyl isothiocyanates (Ad-ITCs) to discover novel agents as therapeutics by targeting mutant p53. We demonstrated that the alkyl chain connecting adamantane and ITC is a crucial determinant for Ad-ITC inhibitory potency. Ad-ITC 6 with the longest chain between ITC and adamantane displayed the maximum growth inhibition in p53R280K, p53R273H, or p53R306Stop mutant cells. Ad-ITC 6 acted in a mutant p53-dependent manner. It rescued p53R280K and p53R273H mutants, thereby resulting in upregulating canonical wild-type (WT) p53 targets and phosphorylating ATM. Ad-ISeC 14 with selenium showed a significantly enhanced inhibitory potency, without affecting its ability to rescue mutant p53. Ad-ITCs selectively depleted mutant p53, but not the WT, and this activity correlates with their inhibitory potencies. These data suggest that Ad-ITCs may serve as novel promising leads for the p53-targeted drug development." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01971"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01971">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01971&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01971&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01971&amp;href=/doi/10.1021/acs.jmedchem.0c01971" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 6621-6633</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01926" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c02001" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Adamantyl Isothiocyanates as Mutant p53 Rescuing Agents and Their Structure–Activity Relationships</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Vladimir Burmistrov</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vladimir Burmistrov</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Volgograd State Technical University, Volgograd 400005, Russia</div><div class="loa-info-affiliations-info">Department of Chemistry, Technology and Equipment of Chemical Industry, Volzhsky Polytechnic Institute (branch) Volgograd State Technical University, Volzhsky 404121, Russia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vladimir++Burmistrov">Vladimir Burmistrov</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8547-9166" title="Orcid link">http://orcid.org/0000-0002-8547-9166</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rahul Saxena</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rahul Saxena</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Molecular and Cellular Biology, Georgetown University, Washington, D.C. 20007, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rahul++Saxena">Rahul Saxena</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dmitry Pitushkin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dmitry Pitushkin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Volgograd State Technical University, Volgograd 400005, Russia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dmitry++Pitushkin">Dmitry Pitushkin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gennady M. Butov</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gennady M. Butov</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Volgograd State Technical University, Volgograd 400005, Russia</div><div class="loa-info-affiliations-info">Department of Chemistry, Technology and Equipment of Chemical Industry, Volzhsky Polytechnic Institute (branch) Volgograd State Technical University, Volzhsky 404121, Russia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gennady+M.++Butov">Gennady M. Butov</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fung-Lung Chung</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fung-Lung Chung</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, D.C. 20007, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fung-Lung++Chung">Fung-Lung Chung</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8028-6448" title="Orcid link">http://orcid.org/0000-0001-8028-6448</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Monika Aggarwal</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Monika Aggarwal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, D.C. 20007, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#335e52020104077354565c415456475c445d1d565746"><span class="__cf_email__" data-cfemail="d8b5b9e9eaefec98bfbdb7aabfbdacb7afb6f6bdbcad">[email protected]</span></a>. Phone: 202-687-3648. Fax: 202-687-1068.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Monika++Aggarwal">Monika Aggarwal</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0400-5824" title="Orcid link">http://orcid.org/0000-0002-0400-5824</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01971&amp;href=/doi/10.1021%2Facs.jmedchem.0c01971" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 6621–6633</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 7, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 November 2020</li><li><span class="item_label"><b>Published</b> online</span>7 May 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 May 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01971" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01971</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6621%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DVladimir%2BBurmistrov%252C%2BRahul%2BSaxena%252C%2BDmitry%2BPitushkin%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D10%26contentID%3Dacs.jmedchem.0c01971%26title%3DAdamantyl%2BIsothiocyanates%2Bas%2BMutant%2Bp53%2BRescuing%2BAgents%2Band%2BTheir%2BStructure%25E2%2580%2593Activity%2BRelationships%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6633%26publicationDate%3DMay%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01971"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">605</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01971" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Adamantyl Isothiocyanates as Mutant p53 Rescuing Agents and Their Structure–Activity Relationships&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Vladimir&quot;,&quot;last_name&quot;:&quot;Burmistrov&quot;},{&quot;first_name&quot;:&quot;Rahul&quot;,&quot;last_name&quot;:&quot;Saxena&quot;},{&quot;first_name&quot;:&quot;Dmitry&quot;,&quot;last_name&quot;:&quot;Pitushkin&quot;},{&quot;first_name&quot;:&quot;Gennady&quot;,&quot;last_name&quot;:&quot;M. Butov&quot;},{&quot;first_name&quot;:&quot;Fung-Lung&quot;,&quot;last_name&quot;:&quot;Chung&quot;},{&quot;first_name&quot;:&quot;Monika&quot;,&quot;last_name&quot;:&quot;Aggarwal&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;6621-6633&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01971&quot;},&quot;abstract&quot;:&quot;Mutant p53 rescue by small molecules is a promising therapeutic strategy. In this structure–activity relationship study, we examined a series of adamantyl isothiocyanates (Ad-ITCs) to discover novel agents as therapeutics by targeting mutant p53. We demonstrated that the alkyl chain connecting adamantane and ITC is a crucial determinant for Ad-ITC inhibitory potency. Ad-ITC 6 with the longest chain between ITC and adamantane displayed the maximum growth inhibition in p53R280K, p53R273H, or p53R306Stop mutant cells. Ad-ITC 6 acted in a mutant p53-dependent manner. It rescued p53R280K and p53R273H mutants, thereby resulting in upregulating canonical wild-type (WT) p53 targets and phosphorylating ATM. Ad-ISeC 14 with selenium showed a significantly enhanced inhibitory potency, without affecting its ability to rescue mutant p53. Ad-ITCs selectively depleted mutant p53, but not the WT, and this activity correlates with their inhibitory potencies. These data suggest that Ad-ITCs may serve as novel promising leads f&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01971&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01971" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01971&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01971" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01971&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01971" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01971&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01971&amp;href=/doi/10.1021/acs.jmedchem.0c01971" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01971" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01971" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01971%26sid%3Dliteratum%253Aachs%26pmid%3D33961435%26genre%3Darticle%26aulast%3DBurmistrov%26date%3D2021%26atitle%3DAdamantyl%2BIsothiocyanates%2Bas%2BMutant%2Bp53%2BRescuing%2BAgents%2Band%2BTheir%2BStructure%25E2%2580%2593Activity%2BRelationships%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D10%26spage%3D6621%26epage%3D6633%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292349" title="Alkyls">Alkyls</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a>,</li><li><a href="/action/doSearch?ConceptID=291305" title="Cell physiology">Cell physiology</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/jmcmar.2021.64.issue-10/20210527/jmcmar.2021.64.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/medium/jm0c01971_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01971&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Mutant p53 rescue by small molecules is a promising therapeutic strategy. In this structure–activity relationship study, we examined a series of adamantyl isothiocyanates (Ad-ITCs) to discover novel agents as therapeutics by targeting mutant p53. We demonstrated that the alkyl chain connecting adamantane and ITC is a crucial determinant for Ad-ITC inhibitory potency. Ad-ITC <b>6</b> with the longest chain between ITC and adamantane displayed the maximum growth inhibition in p53<sup>R280K</sup>, p53<sup>R273H</sup>, or p53<sup>R306Stop</sup> mutant cells. Ad-ITC <b>6</b> acted in a mutant p53-dependent manner. It rescued p53<sup>R280K</sup> and p53<sup>R273H</sup> mutants, thereby resulting in upregulating canonical wild-type (WT) p53 targets and phosphorylating ATM. Ad-ISeC <b>14</b> with selenium showed a significantly enhanced inhibitory potency, without affecting its ability to rescue mutant p53. Ad-ITCs selectively depleted mutant p53, but not the WT, and this activity correlates with their inhibitory potencies. These data suggest that Ad-ITCs may serve as novel promising leads for the p53-targeted drug development.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72580" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72580" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Adamantane, a polycyclic cage compound with high symmetry, was originally discovered to display potent antiviral activities. Drugs incorporating adamantane (amantadine, rimantadine, tromantadine, memantine) used for the treatment of viral diseases (Influenza A, herpes) and neurological disorders (Parkinson’s, Alzheimer’s) were the first to be introduced to clinics. Adamantane derivatives are used in medicinal chemistry and drug development because of their lipophilic nature that allows modifying various pharmacophores to enhance drug lipophilicity and metabolic stability, thereby improving their pharmacokinetics.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1−4)</a> Adamantane also leads to a better understanding of underlying molecular mechanisms, for example, the interactions of aminoadamantane anti-Influenza A agents with the M<sub>2</sub> ion channel.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">Adamantane derivatives have been studied as promising anticancer agents. The cisplatin analog LA-12 that contains the hydrophobic 1-adamantylamine showed cytotoxicity against cisplatin-resistant cancers.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6−8)</a> Increased activity of this compound can be attributed to its enhanced ability to penetrate the cell membrane.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Thus, adamantane scaffolds enhance the metabolic stability, pharmacokinetics, and membrane transfer of the modified drugs.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10−12)</a> Studies of how adamantane scaffolds affect the anticancer activities of dietary-related natural compounds, such as isothiocyanates (ITCs), however, are scarce.</div><div class="NLM_p">ITCs, compounds derived from cruciferous vegetables, inhibit tumorigenesis in animal models.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> Epidemiological studies also support their role in protection against human cancers.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Phenethyl isothiocyanate (PEITC), an arylalkyl ITC abundant in watercress, has been investigated under clinical phase 1 and phase 2 trials (<a href="http://www.clinicaltrials.gov/ct2/results?term=PEITC" class="extLink">http://www.clinicaltrials.gov/ct2/results?term=PEITC</a>). Several activities have been proposed for PEITC, including modulation of phase I and phase II enzymes, oxidative stress, binding to target proteins, cell cycle arrest, and apoptosis.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20">(13−20)</a> We reported that PEITC selectively depletes p53 mutant protein, but not the wild-type (WT), in human cancer cells.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> These observations led to our recent discovery of a novel mechanism for PEITC in which it reactivates a structural mutant p53<sup>R175H</sup>, <i>in vitro</i> and in a breast xenograft mouse model, resulting in tumor growth inhibition.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> We further demonstrated that PEITC inhibits the growth of prostate cancer cells expressing p53 structural (p53<sup>R175H</sup>, p53<sup>P223L</sup>) and contact (p53<sup>R248W</sup>) mutants <i>in vitro</i> and <i>in vivo</i> via mutant p53 rescue.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> These studies showed for the first time that the anticancer activity of PEITC is cancer type-independent but mutant p53-dependent, suggesting its potential as a “basket trial” agent for cancers harboring mutant p53.</div><div class="NLM_p last">The structure−activity relationships (SARs) of arylalkyl ITCs to deplete mutant p53 and to induce apoptosis<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> were previously studied in human cancer cells. These studies revealed that increased lipophilicity by incorporating aromatic rings is one of the key structural features important for their increased potency.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Here, we describe a study in which the effects of combining an ITC group with a highly lipophilic and metabolically inert cycloalkane adamantane, adamantyl-ITCs (Ad-ITCs), on its anticancer activities are investigated. We evaluated the activities of Ad-ITCs as potential novel cancer therapeutics by targeting mutant p53 in triple negative breast cancer (TNBC) cells and examined their SARs. TNBC is an aggressive subset of breast cancer that is not amenable to endocrine therapy due to the lack of estrogen receptor (ER)/progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), and they often show resistance to current chemotherapeutic agents. TNBC displays the highest frequency of p53 gene mutation (∼80%) among the different subtypes of breast cancers.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> In fact, p53 is the most frequently mutated gene in TNBC, suggesting its crucial role in this disease.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Despite this, therapeutic options targeting mutant p53 in TNBC patients are lacking.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66320" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66320" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Effects of Ad-ITCs on p53<sup>R280K</sup> MDA-MB-231 Cell Proliferation</h3><div class="NLM_p">We examined a series of ITCs containing an adamantyl moiety, Ad-ITCs <b>1</b>–<b>12</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figures S1–S4</a>), that were synthesized as described previously,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> except compounds <b>6</b> and <b>8</b> that were synthesized in this study. Ad-ITCs <b>1</b> and <b>2</b> are structures with a −N=C=S in the nodal and bridge positions of adamantane. Ad-ITCs <b>3</b>, <b>5</b>, and <b>6</b> have an aliphatic bridge of 1–3 carbon atoms, and Ad-ITC <b>7</b> has an aromatic bridge between −N=C=S and adamantane. These compounds should determine how the bridge length connecting adamantane and ITC and the substituents on it influences their activities. Ad-ITCs <b>4</b> and <b>10</b> have branched aliphatic chains between −N=C=S and adamantane. They should reveal how steric hindrance affects the activities. Ad-ITCs <b>8</b>, <b>9</b>, and <b>12</b> containing an oxygen atom in the alkyl chain allow evaluating the effects of electron withdrawal by the oxygen atom near the ITC group. Finally, Ad-ITC <b>11</b> with two methyl groups on the adamantane is expected to further enhance lipophilicity resulting in even better absorption by tissues, such as the blood–brain barrier.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/medium/jm0c01971_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of Ad-ITCs and Ad-compound <b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01971&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Ad-ITCs <b>1</b>–<b>11</b> were synthesized from the corresponding amines by a two-step reaction (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S1A,B</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The amines were first reacted with CS<sub>2</sub> in ethanol in the presence of Et<sub>3</sub>N. The formation of Et<sub>3</sub>N salt of corresponding carbamodithioic acid occurred at room temperature (RT) within 30 min. Next, Boc<sub>2</sub>O and a catalytic amount of DMAP were added at 0 °C. Desulfurization led to formation of compounds <b>1</b>–<b>11</b>. Ad-ITC <b>12</b> was synthesized by treating adamantyl acetic acid chloride with sodium thiocyanate (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S1C</a>).</div><div class="NLM_p">To study whether the −N=C=S group is essential for its activity, Ad-compound <b>13</b> was used.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Ad-compound <b>13</b> is a 2-thioxoimidazolidin-4-one derivative prepared from Ad-ITC <b>5</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S1D</a>). It retains the structure of Ad-ITC <b>5</b> except that the ITC group is replaced by a thiooxoimidazole ring. Octanol/water partition coefficients were also measured for compounds <b>1</b>–<b>13</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Table S1</a>). Log <i>P</i> values for Ad-ITC <b>1</b>–<b>12</b> were within the range of 3.73–6.77. Except for the two most lipophilic compounds, Ad-ITC <b>7</b> (log <i>P</i> 6.34) and Ad-ITC <b>10</b> (log <i>P</i> 6.77), and the least lipophilic Ad-ITC <b>12</b> (log <i>P</i> 3.73), the lipophilicity of Ad-ITCs was relatively consistent (log <i>P</i> 5.0 ± 0.5). These values satisfy Lipinski’s rule of five.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Such lipophilicity is favorable for the transport of molecules through the cell membrane and for protein binding as observed previously for adamantane-containing drugs.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a></div><div class="NLM_p">To determine the biological activity and the structural features important for the activity, we divided Ad-ITCs into four categories: (1) Ad-ITCs with different alkyl chain lengths connecting the adamantane to ITC (<b>1</b>, <b>2</b>, <b>3</b>, <b>5</b>, <b>6</b>), (2) Ad-ITCs with electron-releasing substituents, electron-withdrawing substituents, branched chains, double bonds, or heteroatoms in the alkyl chain (<b>4</b>, <b>8</b>, <b>9</b>, <b>10</b>, <b>12</b>), (3) the Ad-ITC with a benzene ring between adamantane and ITC (<b>7</b>), and (4) Ad-ITC <b>11</b> with electron-releasing alkyl substituents on adamantane. The proliferation of p53<sup>R280K</sup> MDA-MB-231 TNBC cells treated with various concentrations of Ad-ITCs <b>1</b>–<b>12</b> or Ad-compound <b>13</b> for 24 or 72 h was compared with dimethyl sulfoxide (DMSO)-treated cells (as a control). Of all the 13 compounds tested, only <b>3</b>, <b>5</b>, <b>6</b>, and <b>7</b> displayed dose-dependent activities (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/medium/jm0c01971_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effects of Ad-ITCs on the proliferation of breast cancer cell lines expressing mutant p53 or WT p53. (A–C) The mutant p53 (p53<sup>R280K</sup> MDA-MB-231 and p53<sup>R273H</sup> MDA-MB-468) and WT p53 (MCF-7) cells, respectively, were treated with DMSO (as a control) or different Ad-ITCs or Ad-compound <b>13</b> at the indicated concentrations for 24 h. Percent cell proliferation determined by WST-1 was calculated as the ratio of OD<sub>450</sub> values obtained for cells grown in the presence of the respective Ad-ITC or Ad-compound <b>13</b> compared with that of DMSO. Experiments were performed in triplicate. Error bars represent the standard deviation (SD).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01971&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Ad-ITC <b>6</b> with the three-carbon alkyl chain connecting the ITC to adamantane showed the greatest inhibition against MDA-MB-231 cell proliferation (IC<sub>50</sub> 12–24 μM) followed by Ad-ITCs <b>5</b> and <b>3</b> (two- and one-carbon alkyl chain, respectively) (IC<sub>50</sub> 24–48 μM) after 24 h (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). After 72 h, both Ad-ITCs <b>5</b> and <b>6</b> displayed IC<sub>50</sub> values of 12–24 μM, whereas for Ad-ITC <b>3</b>, ∼50% inhibition of cell proliferation remained at 24–48 μM (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S5A</a>). Consistent with this finding, the Ad-ITCs containing a bulky adamantane adjacent to ITC (<b>1</b>, <b>2</b>, and <b>11)</b> that is likely to cause steric hindrance, therefore blocking their binding to the target proteins, failed to show any significant inhibition of cell proliferation (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S5A</a>). Ad-ITC <b>7</b> showed enhanced potency when compared with Ad-ITCs <b>1</b> and <b>2</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S5A</a>); however, this compound was significantly less potent than Ad-ITCs <b>3</b>, <b>5</b>, and <b>6</b>. The lower potency of Ad-ITC <b>7</b> could be due to an aromatic ring adjacent to the −N=C=S leading to low mobility and the inability to adjust to the active site.</div><div class="NLM_p last">The Ad-ITCs <b>4</b> and <b>10</b> with branched alkyl chains did not show any significant inhibition of MDA-MB-231 cell proliferation (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S5A</a>). These data could reflect a weaker binding to the target protein due to steric hindrance created by the alkyl substitution adjacent to the ITC. Ad-ITC <b>12</b> with a double bond failed to inhibit the cell proliferation (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S5A</a>). Similarly, Ad-ITCs <b>8</b> and <b>9</b> with an oxygen atom replacing gamma-carbon were not active <i>in vitro</i> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S5A</a>), suggesting that the addition of a heteroatom could lead to the loss of activity. Importantly, Ad-compound <b>13</b> that lacked the ITC group did not inhibit the proliferation of MDA-MB-231 cells, suggesting that the ITC group is essential for the biological activities of Ad-ITCs (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S5A</a>). We also examined the effects of pure adamantane on MDA-MB-231 cell proliferation. Our results showed that adamantane did not inhibit MDA-MB-231 cell proliferation (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S6</a>), thus confirming that the −N=C=S functional group is required for the activity of Ad-ITCs. Previously, we showed that PEITC inhibits the growth of cancer cells expressing mutant p53.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> As a positive control, we also examined the effects of PEITC on the proliferation of MDA-MB-231 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S6</a>). Collectively, these results demonstrated that the potency of Ad-ITC to inhibit MDA-MB-231 cell proliferation enhances with increasing length of the aliphatic alkyl chain connecting ITC to adamantane and decreases with the introduction of substituents, possibly due to steric hindrance at the α-position to the ITC.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Effects of Ad-ITCs on Proliferation of p53<sup>R273H</sup> MDA-MB-468 and WT p53 MCF-7 Cells</h3><div class="NLM_p">To validate that the increase in the length of the aliphatic alkyl chain connecting adamantane to ITC enhances the potency of Ad-ITCs to inhibit cell proliferation, we evaluated the effects of Ad-ITCs <b>3</b>, <b>5</b>, and <b>6</b> on a different p53 mutant TNBC cell line MDA-MB-468 (p53<sup>R273H</sup>). Consistent with our findings with MDA-MB-231 cells, Ad-ITC <b>6</b> showed the greatest inhibition of p53<sup>R273H</sup> MDA-MB-468 cell proliferation at 24 and 72 h (IC<sub>50</sub> 12–24 μM) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S5B</a>). As expected, Ad-compound <b>13</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S5B</a>) and adamantane (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S6</a>) did not inhibit MDA-MB-468 cell proliferation. As a positive control, we also examined the effects of PEITC on the proliferation of MDA-MB-468 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S6</a>). Thus, the length of the aliphatic alkyl chain is a crucial determinant of Ad-ITC potential to inhibit cell proliferation. These results agree with our previous observations that the potency of aromatic ITC enhanced with the increase in alkyl chain length.<a onclick="showRef(event, 'ref21 ref32'); return false;" href="javascript:void(0);" class="ref ref21 ref32">(21,32)</a></div><div class="NLM_p last">We evaluated the effects of Ad-ITCs <b>3</b>, <b>5</b>, and <b>6</b> on proliferation of WT p53 MCF-7 cells. MCF-7 cells were remarkably less sensitive to Ad-ITCs <b>3</b> and <b>6</b> than p53<sup>R280K</sup> MDA-MB-231 and p53<sup>R273H</sup> MDA-MB-468 cells (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S5C</a>). Consistent with this, MCF-7 cells were also considerably less sensitive to PEITC that was used as a positive control in these experiments (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S6</a>). Ad-ITC <b>5</b> and Ad-compound <b>13</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S5C</a>) and adamantane (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S6</a>) did not inhibit MCF-7 cell proliferation. These results demonstrated that p53<sup>R280K</sup> MDA-MB-231 and p53<sup>R273H</sup> MDA-MB-468 are significantly more sensitive to Ad-ITCs <b>3</b> and <b>6</b> than the WT p53 MCF-7 cells.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Colony Formation Assays to Determine the Effects of Ad-ITCs on Proliferation of p53<sup>R280K</sup> MDA-MB-231 and WT p53 MCF-7 Cells</h3><div class="NLM_p last">We performed a colony formation assay (CFA) with selected compounds with differential abilities to inhibit cell proliferation, <b>1</b> (mild inhibition), <b>6</b> (maximum inhibition), and <b>13</b> (as a negative control). Similar differences in the sensitivities of p53<sup>R280K</sup> MDA-MB-231 and WT p53 MCF-7 cells to Ad-ITC <b>6</b> were observed in the CFA (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S7</a>). These data reinforce the findings that mutant p53 cells are more sensitive to growth inhibition by Ad-ITC <b>6</b> than the WT p53 cells.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Ad-ITCs Induce Apoptosis in Mutant p53 TNBC Cells</h3><div class="NLM_p">The inhibitory effects of Ad-ITCs <b>3</b>, <b>5</b>, and <b>6</b> on cell proliferation suggested that these compounds might also possess apoptotic potential. The p53<sup>R280K</sup> MDA-MB-231 and p53<sup>R273H</sup> MDA-MB-468 cells treated with 6 or 12 μM Ad-ITCs <b>3</b>, <b>5</b>, or <b>6</b> showed a significant (∼2.0–5.1-fold) increase in the Annexin-V-stained cells as compared to the DMSO-treated cells (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A,B and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S8A</a>). Ad-ITC <b>1</b> and Ad-compound <b>13</b> (6 or 12 μM), used as negative controls, did not induce a significant increase in apoptosis of MDA-MB-231 and MDA-MB-468 cells (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A,B). WT p53 MCF-7 cells treated with Ad-ITCs <b>1</b>, <b>3</b>, <b>5</b>, <b>6</b>, or Ad-compound <b>13</b> did not display any significant increase in Annexin-V-stained cells (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S8A</a>). As a positive control, we also examined the effects of PEITC on induction of apoptosis in p53<sup>R280K</sup> MDA-MB-231, p53<sup>R273H</sup> MDA-MB-468, and WT p53 MCF-7 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S9A,B</a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/medium/jm0c01971_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of Ad-ITCs on apoptosis induction and p53 levels in breast cancer cell lines with mutant p53 or WT p53. (A–C) The mutant p53 (p53<sup>R280K</sup> MDA-MB-231 and p53<sup>R273H</sup> MDA-MB-468) and WT p53 (MCF-7) cells, respectively, were treated with DMSO (as a control) or different Ad-ITCs or Ad-compound <b>13</b> at the indicated concentrations for 24 h. Apoptosis was measured by Annexin-V staining by flow cytometry using a BD LSRFORTESSA instrument. Percent values of Annexin-V positive stained cells were calculated as the ratio of stained cells obtained for cells grown in the presence of the respective Ad-ITC or Ad-compound <b>13</b> compared with the presence of DMSO. (D) SARs for the depletion of mutant p53 levels by Ad-ITCs. The mutant p53 (p53<sup>R280K</sup> MDA-MB-231 and p53 <sup>R273H</sup> MDA-MB-468) and WT p53 (MCF-7) cells, respectively, were treated with DMSO (as a control) or 6 or 12 μM of different Ad-ITCs or Ad-compound <b>13</b> for 24 h. Cells were harvested, and lysates were prepared. 20 or 50 μg of the mutant p53 or WT p53 cell lysate fractions, respectively, was resolved by SDS-PAGE and probed with the p53 DO-1 antibody. Blots were stripped and reprobed with anti-GAPDH as a loading control. Experiments were performed in triplicate. Error bars represent the SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01971&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Cleavage of poly(ADP-ribose) polymerase-1 (PARP1) by caspase 3 is considered to be the hallmark of apoptosis.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Therefore, to further confirm the apoptotic potential of Ad-ITCs, we examined the effects of most potent compound Ad-ITC <b>6</b> on caspase 3 and PARP1 levels in p53<sup>R280K</sup> MDA-MB-231, p53<sup>R273H</sup> MDA-MB-468, and WT p53 MCF-7 cells. Western blot analysis showed a significant decrease in the levels of uncleaved caspase 3 and PARP1 in p53<sup>R280K</sup> MDA-MB-231 and p53<sup>R273H</sup> MDA-MB-468 cells treated with 6 or 12 μM Ad-ITC <b>6</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S8B</a>). We also detected a concomitant increase in the levels of cleaved-PARP1 in these cells (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S8B</a>). Consistent with the Annexin V results (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C), we did not detect any significant decrease in the levels of uncleaved PARP1 or accumulation of cleaved-PARP1 fragments in WT p53 MCF-7 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S8B</a>). MCF-7 cells are deficient in caspase 3.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Therefore, we did not detect any caspase 3 expression in WT p53 MCF-7 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S8B</a>). PEITC-treated p53<sup>R280K</sup> MDA-MB-231 and p53<sup>R273H</sup> MDA-MB-468 cells, used as a positive control, also displayed a significant decrease in the levels of uncleaved caspase 3 and accumulation of cleaved-PARP1 fragments (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S9C</a>). However, we observed a significant decrease in the levels of uncleaved PARP1 and accumulation of cleaved-PARP1 in PEITC-treated caspase 3-deficient MCF-7 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S9C</a>). These results are consistent with previous reports<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> that suggested a possible involvement of other caspases in the cleavage of PARP1 in the absence of caspase 3. These results further support that mutant p53 cells were more sensitive to Ad-ITCs with specific structural features.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Effects of Ad-ITCs on the Expression of p53 Protein</h3><div class="NLM_p last">Since aromatic ITCs can selectively deplete mutant p53 protein,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> we examined the effects of Ad-ITCs <b>3</b>, <b>5</b>, and <b>6</b> on p53 expression in mutant p53 cells. Treatment with Ad-ITCs (6 or 12 μM) for 24 h led to a differential decrease in the expression of mutant p53 in MDA-MB-231 and MDA-MB-468 cells (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D). As expected, no depletion was observed with Ad-ITC <b>1</b> in both the cell lines (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D). These results demonstrated that the ability of Ad-ITCs to reduce mutant p53 expression seems to correlate with their growth inhibitory potencies. Concurrently, the alkyl chain length seems to influence their potency in reducing the expression of mutant p53. Furthermore, the ITC group is essential for this activity as Ad-compound <b>13</b> failed to affect mutant p53 expression. On the contrary, Ad-ITCs <b>1</b>, <b>3</b>, <b>5</b>, <b>6</b>, and Ad-compound <b>13</b> did not decrease WT p53 expression in MCF-7 cells (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D). As a positive control, we also examined the effects of PEITC on p53 expression levels in MDA-MB-231, MDA-MB-468, and MCF-7 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S9C</a>). We observed a significant decrease in the expressions of p53<sup>R280K</sup> and p53<sup>R273H</sup> mutants in PEITC (6 or 12 μM)-treated MDA-MB-231 and MDA-MB-468 cells, respectively. Consistent with our previous study,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> we also detected an increase in p53 levels in MCF-7 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S9C</a>). These results suggest that mutant p53 is an important target for these novel Ad-ITCs.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Ad-ITC 6 Rescues p53 Mutants and Activates Ataxia-Telangiectasia Mutated (ATM)</h3><div class="NLM_p">Since Ad-ITC <b>6</b> induced apoptosis in mutant p53 cells, we reasoned that it may do so by restoring WT functions. Therefore, we determined its effects on the canonical p53 targets in these cells. Treatment with 6 μM Ad-ITC <b>6</b> enhanced the expression of the canonical p53 targets p21 and NOXA in both MDA-MB-231 and MDA-MB-468 cells (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). These results suggested that Ad-ITC <b>6</b> restores transactivation functions to p53<sup>R280K</sup> and p53<sup>R273H</sup> mutants in MDA-MB-231 and MDA-MB-468 cells, respectively. Ad-ITC <b>6</b> also upregulated the expressions of p21 and NOXA in WT p53 MCF-7 cells (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). The WT p53 is regulated by MDM2 by an autoregulatory feedback loop.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Consistent with this idea, 6 μM Ad-ITC <b>6</b> enhanced the expression of MDM2 in both p53<sup>R273H</sup> MDA-MB-468 and WT p53 MCF-7 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S10A</a>). These results demonstrated that Ad-ITC <b>6</b> can not only rescue mutant p53 but also activate WT p53.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/medium/jm0c01971_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of Ad-ITC <b>6</b> on canonical p53 targets, cell cycle progression, and activation of ATM. (A) qRT-PCR of p53 regulated downstream target genes p21 and NOXA in mutant p53 (p53<sup>R280K</sup> MDA-MB-231, p53<sup>R273H</sup> MDA-MB-468) and WT p53 (MCF-7) cell treated with DMSO or 6 μM Ad-ITC <b>6</b> for 4 h. (***<i>p</i> ≤ 0.0005 and *<i>p</i> ≤ 0.05). (B<b>)</b> Cells were treated with DMSO or 6 μM Ad-ITC <b>6</b> for 24 h and analyzed by flow cytometry. (C) Cells were treated with DMSO or 6 μM Ad-ITC <b>6</b> for 24 h. Blots were probed using the anti-pATM S1981 antibody and reprobed with the GAPDH antibody. Experiments were performed in triplicate. Error bars represent the SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01971&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To determine whether depletion of mutant p53 in cells occurs at the transcriptional or post-transcriptional level, we compared the mRNA levels of p53 in DMSO- and Ad-ITC <b>6</b>-treated MDA-MB-231 and MDA-MB-468 cells. As a control, we also evaluated mRNA levels of p53 in WT p53 MCF-7 cells. As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S10B</a>, 4 h after Ad-ITC <b>6</b> treatment, the mutant p53 mRNA levels remained unchanged in MDA-MB-231 and MDA-MB-468 cells. Therefore, Ad-ITC <b>6</b> depleted mutant p53 without causing changes in the p53 mRNA expression levels. These results strongly suggest that Ad-ITC <b>6</b> depletes mutant p53 at the post-transcriptional level. These findings are consistent with our previous study where we have shown that PEITC depletes mutant p53 at the post-transcriptional level.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> We also detected an increase in the p53 mRNA level in MCF-7 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S10B</a>); however, we did not observe any significant increase in the WT p53 protein (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D).</div><div class="NLM_p">WT p53 plays a crucial role in cell cycle progression and genome stability maintenance by inducing the DNA damage response (DDR) pathway. We examined if the reactivated p53<sup>R280K</sup> and p53<sup>R273H</sup> mutants could modulate cell cycle progression. p53<sup>R280K</sup> MDA-MB-231 and p53<sup>R273H</sup> MDA-MB-468 cells treated with Ad-ITC <b>6</b> (6 μM) displayed a significant delay in the G1 phase compared to DMSO-treated cells at 24 h (48.2 and 53.23% vs 42.9 and 30.6%, respectively) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). WT p53 MCF-7 cells treated with Ad-ITC <b>6</b> (6 μM) displayed a small increase in the G2/M phase compared with DMSO-treated cells (24.3% vs 21.3%) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). These results confirmed that Ad-ITC <b>6</b> restores “WT-like” functions to p53<sup>R280K</sup> and p53<sup>R273H</sup> mutants in TNBC cells.</div><div class="NLM_p last">We examined if the delay in cell cycle progression was due to activation of the DDR pathway. As a gain of function (GOF) activity, mutant p53 inhibits activation of ATM by impairing its recruitment to the site of DNA damage and induces genetic instability.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Previously, we showed that PEITC-induced rescue of mutant p53 abolished this GOF activity.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> Here, we showed that treatment with 6 μM Ad-ITC <b>6</b> resulted in phosphorylation of ATM at S1981 in MDA-MB-231 and MDA-MB-468 cells (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C), suggesting that restoration of WT p53 functions to p53<sup>R280K</sup> and p53<sup>R273H</sup> mutants abolishes their ability to inhibit the activation of ATM. Consistent with the WT p53 expression level (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D) and cell cycle data (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B), pATM-S1981 was absent in WT p53 MCF-7 cells (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). Taken together, these results suggest that Ad-ITC <b>6</b> rescues p53<sup>R280K</sup> and p53<sup>R273H</sup> and reactivates DDR.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Ad-ITC 6 Inhibits Cell Proliferation via Mutant p53</h3><div class="NLM_p">To determine if the antiproliferative effects of Ad-ITC <b>6</b> were mediated through mutant p53, we examined its effects on the proliferation of p53 null MDA-MB-436 cells. MDA-MB-436 cells treated with Ad-ITC <b>6</b> showed significantly reduced sensitivity at 24 and 72 h (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A,B) compared to the p53<sup>R280K</sup> MDA-MB-231 or p53<sup>R273H</sup> MDA-MB-468 cells (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A,B and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S5A,B</a>). To further confirm the mutant p53-mediated inhibition of cell proliferation, we compared Ad-ITC <b>6</b> effects on MDA-MB-468 cells that were transfected either with p53 siRNA or nonspecific (NS) siRNA. The p53 knockdown MDA-MB-468 cells showed markedly reduced sensitivity to Ad-ITC <b>6</b>, whereas NS siRNA MDA-MB-468 cells remained highly sensitive (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S11</a>). These results showed that Ad-ITC <b>6</b>-induced inhibition of cell proliferation is, at least partially, dependent on mutant p53.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/medium/jm0c01971_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of Ad-ITC <b>6</b> on the proliferation of MDA-MB-436 (p53 null) and HCC1937 (truncated mutant p53) cells. Cells were treated with DMSO (as a control) or Ad-ITC <b>6</b> at the indicated concentrations for 24 (A) or 72 h (B). Percent cell proliferation determined by WST-1 was calculated as the ratio of OD<sub>450</sub> values obtained for cells grown in the presence of the Ad-ITC <b>6</b> compared with the presence of DMSO. Experiments were performed in triplicate. Error bars represent the SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01971&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We also examined the antiproliferative effects of Ad-ITC <b>6</b> on the TNBC cell line HCC1937 that expresses a truncated p53<sup>R306Stop</sup> mutant. HCC1937 cells displayed a remarkable sensitivity to Ad-ITC <b>6</b> (IC<sub>50</sub> = 12 μM) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A,B). These results strongly demonstrated the functional involvement of the mutational status of p53 in cell response to Ad-ITC <b>6</b>.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Ad-ISeC 14 Displayed Enhanced Potency Compared to Ad-ITCs</h3><div class="NLM_p">Since the −N=C=S group is essential for the activity of Ad-ITCs, we determined if replacing the sulfur (S) in the ITC with selenium (Se) will influence their activities. The Se atom was selected as it exhibits cancer chemopreventive activities and is an integral part of many mammalian selenoproteins that may influence various pathways of cancer development.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> We used an analog of Ad-ITC <b>5</b> where S in the ITC has been substituted with a Se, 1-isoselenocyanato-2-(adamantan-1-yl)ethane (Ad-ISeC <b>14</b>) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S12A,B</a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Octanol/water partition coefficients were measured for Ad-ISeC <b>14</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Table S1</a>). Most of the known methods of Ad-ISeC synthesis use potassium selenocyanate that spontaneously converts to potassium cyanate even at 4 °C. Isocyanates have high reactivity, water sensibility, and toxicity. We adapted a relatively easy and safe method for the synthesis of isoselenocyanates, including 1-isoselenocyanatoadamantane.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p">Ad-ISeC <b>14</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A) displayed the maximum potency to inhibit proliferation of p53<sup>R280K</sup> MDA-MB-231 or p53<sup>R273H</sup> MDA-MB-468 cells at 24 and 72 h (IC<sub>50</sub> between 6 and 12 μM, respectively) (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S12C</a>) when compared to all S-containing Ad-ITCs, including Ad-ITC <b>5</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A,B and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S5A,B</a>). These results demonstrated that the substitution of S with Se in Ad-ITC <b>5</b> enhanced its potency, presumably because of its electron-withdrawing property rendering it more electrophilic. Such substitution also enhances water solubility (log <i>P</i> of Ad-ISeC <b>14</b> is 4.05, which is 0.71 points lower than that of Ad-ITC <b>5</b>). Ad-ISeC <b>14</b> also inhibited MCF-7 cell proliferation; however, these cells were considerably less sensitive than mutant p53 cells (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S12C</a>). Similar differences in the sensitivities of MDA-MB-231 and MCF-7 cells to Ad-ISeC <b>14</b> were also observed in CFA (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S12D</a>). These results demonstrated that the p53 mutation status in TNBC cells plays an important role in sensitizing cells to Ad-ISeC <b>14</b>.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/medium/jm0c01971_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Ad-ISeC <b>14</b> showed an enhanced potency to inhibit the growth of TNBC with mutant p53. (A) Structure of Ad-ISeC <b>14</b>. (B) The mutant p53 (p53<sup>R280K</sup> MDA-MB-231 and p53<sup>R273H</sup> MDA-MB-468) and WT p53 (MCF-7) cells, respectively, were treated with DMSO or Ad-ISeC <b>14</b> for 24 h. Percent cell proliferation determined by WST-1 was calculated as the ratio of OD<sub>450</sub> obtained for cells grown in the presence of Ad-ISeC <b>14</b> compared with the presence of DMSO. (C) The mutant p53 and WT p53 cells were treated with DMSO or Ad-ISeC <b>14</b> for 24 h. Apoptosis was measured by Annexin-V staining. Percent values of Annexin-V positive stained cells were calculated as the ratio of stained cells obtained for cells grown in the presence of the Ad-ISeC <b>14</b> compared with the presence of DMSO. (D) The mutant p53 and WT p53 cells were treated with DMSO or Ad-ISeC <b>14</b> (6 or 12 μM) for 24 h, and mutant p53 expression was analyzed. 20 or 50 μg of the mutant or WT p53 cell lysate fractions, respectively, was resolved by SDS-PAGE and probed with the p53 DO-1 antibody. Blots were reprobed with anti-GAPDH as a loading control. (E) Effects of Ad-ISeC <b>14</b> on canonical p53 targets. qRT-PCR of p53 regulated downstream target genes p21 and NOXA in mutant p53 and WT p53 cell treated with DMSO or 6 μM Ad-ISeC <b>14</b> for 4 h. (***<i>p</i> ≤ 0.0005, **<i>p</i> ≤ 0.005, and *<i>p</i> ≤ 0.05). Experiments were performed in triplicate. Error bars represent the SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01971&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Treatment with Ad-ISeC <b>14</b> (6 or 12 μM) enhanced the apoptotic potential of MDA-MB-231 and MDA-MB-468 cells but not in MCF-7 cells (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S13A</a>). In fact, Ad-ISeC <b>14</b> (6 or 12 μM) induced a significantly greater (>2-fold) level of apoptosis in p53<sup>R273H</sup> MDA-MB-468 cells than Ad-ITC <b>5</b> (6 or 12 μM) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). To further confirm the apoptotic potential of Ad-ISeC <b>14</b>, we demonstrated a decrease in the levels of uncleaved caspase 3 and PARP-1 and an increase in the levels of the cleaved-PARP1 fragment in Ad-ISeC <b>14</b>-treated MDA-MB-231 and MDA-MB-468 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S13B</a>). We did not detect any significant change in the level of uncleaved PARP1, uncleaved caspase 3, or accumulation of cleaved-PARP1 in MCF-7 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S13B</a>). MDA-MB-231 and MDA-MB-468 cells treated with Ad-ISeC <b>14 (</b>6 or 12 μM) showed a significant reduction in mutant p53 expression when compared to the DMSO control (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D). Ad-ISeC <b>14</b> (6 or 12 μM) induced a significantly greater decrease in the p53<sup>R280K</sup> and p53<sup>R273H</sup> expression levels in MDA-MB-231 and MDA-MB-468 cells, respectively, than Ad-ITC <b>5</b> (6 or 12 μM) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). Together, like its sulfur counterpart, these results showed a correlation between the growth inhibitory potency and the ability to destabilize mutant p53 in TNBC cells, suggesting that Se does not influence Ad-ISeC <b>14</b> interactions with the target proteins. Contrary to mutant p53, WT p53 expression appeared to be marginally elevated after treatment with 12 μM Ad-ISeC <b>14</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D), suggesting that Ad-ISeC <b>14</b> might activate WT p53. Ad-ISeC <b>14</b> (6 μM) significantly enhanced the levels of p21 and NOXA in MDA-MB-231 and MDA-MB-468 cells (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>E), demonstrating that it restored the transactivational functions to p53<sup>R280K</sup> and p53<sup>R273H</sup> mutants. A significant increase in the expression levels was also observed in the MCF-7 treated with 6 μM Ad-ISeC <b>14</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>E), suggesting that Ad-ISeC <b>14</b> also activated WT p53. We also detected a statistically significant elevation of MDM2 in both p53<sup>R273H</sup> MDA-MB-468 and WT p53 MCF-7 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S14A</a>). Taken together, these data strongly suggest that Ad-ISeC <b>14</b> can not only reactivate mutant p53 but also activate WT p53.</div><div class="NLM_p last">To determine whether Ad-ISeC <b>14</b> also depletes mutant p53 at the post-transcriptional level, we examined the mRNA levels of p53 in DMSO- and Ad-ISeC <b>14</b>-treated MDA-MB-231 and MDA-MB-468 cells. As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S14B</a>, the mutant p53 mRNA levels remained unchanged in MDA-MB-231 and MDA-MB-468 cells after Ad-ISeC <b>14</b> treatment. These results suggest that Ad-ISeC <b>14</b> depletes mutant p53 at the post-transcriptional level. We also detected an increase in the p53 mRNA level in MCF-7 cells treated with Ad-ISeC <b>14</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S14B</a>). Consistent with this, we detected an elevated level of WT p53 in Ad-ISeC <b>14</b>-treated MCF-7 cells (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D).</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Effects of Ad-ITC 6 and Ad-ISeC 14 on Proliferation of Normal Cells</h3><div class="NLM_p last">To determine if Ad-ITC <b>6</b> and Ad-ISeC <b>14</b> have inhibitory effects on the proliferation of normal cells, we examined their effects on two different normal cell types, mammary epithelial cells (MCF10A) and colon cells (CCD841), expressing WT p53. Our results showed that IC<sub>50</sub> values for Ad-ITC <b>6</b> and Ad-ISeC <b>14</b> were significantly higher than those of the p53<sup>R280K</sup> MDA-MB-231 and p53<sup>R273H</sup> MDA-MB-468 tumor cells (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">Figure S15</a>). These results further support that Ad-ITCs may serve as novel promising leads for p53-targeted drug development.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12840" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12840" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The p53 gene is the most frequently mutated gene in human cancers. These mutations are predominantly missense (∼74%) and are classified as either structural (e.g., R175H) or contact (e.g., R273H). Mutations in p53 impair WT activity; however, the mutants may also gain oncogenic functions.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> Small molecules that can rescue mutant p53 have been identified and are now under clinical investigations.<a onclick="showRef(event, 'ref25 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref25 ref42 ref43">(25,42,43)</a> However, studies to investigate the potential of small molecules toward targeting mutant p53 in TNBC are limited. In this study, we showed that, depending on their structures, the novel Ad-ITCs <b>3</b>, <b>5</b>, <b>6</b>, and Ad-ISeC <b>14</b> exhibited potential anticancer activities against p53<sup>R280K</sup> and p53<sup>R273H</sup> mutant TNBC cells. These compounds also inhibited the proliferation of WT p53 MCF-7 cells, albeit the mutant p53 cells were more sensitive. Ad-ITC <b>6</b> and Ad-ISeC <b>14</b> induced apoptosis selectively in mutant p53 cells, and not in WT p53, as evidenced by Annexin V staining and Western blot analysis of caspase 3 and PARP1 cleavage. Supporting mutant p53 as a target, Ad-ITC <b>6</b> and Ad-ISeC <b>14</b> selectively depleted mutant p53 protein, but not WT, in these cells.</div><div class="NLM_p">The SARs revealed the importance of the alkyl chain length connecting adamantane and −N=C=S in Ad-ITC anticancer activities. Elongation of the alkyl chain from 0 to 3 carbons significantly enhances the antiproliferative potency of Ad-ITCs, following an order of Ad-ITC <b>6</b> > <b>5</b> > <b>3</b> > <b>1</b>. Concurrently, the alkyl chain length markedly affects its mutant p53 depleting activity. The greater potency for longer-alkyl-chain Ad-ITCs may reflect the diminished steric hindrance and an increased lipophilicity as evidenced by their log <i>P</i> values. Both structural features are favorable for interactions with the target proteins. Previously, we showed the enhanced inhibitory potential of aromatic ITCs with an increase in alkyl chain length and lipophilicity of the side chain moiety <i>in vitro</i> and in a mouse model of lung tumorigenesis.<a onclick="showRef(event, 'ref21 ref32'); return false;" href="javascript:void(0);" class="ref ref21 ref32">(21,32)</a></div><div class="NLM_p">The lack of antiproliferative activity for Ad-ITC <b>8</b>, an analog of Ad-ITC <b>6</b>, where the carbon atom of the bridge closest to adamantane was substituted by an oxygen atom, could be attributed to its lower lipophilicity than Ad-ITC <b>6</b> (log <i>P</i> values 4.42 vs 5.17, respectively) and altered electron distribution characteristics. These hypotheses may be further examined by synthesizing Ad-ITCs containing different hydrogen bond acceptors and hydrogen bond donors such as F, Cl, OH, and O–CH<sub>3</sub> in the nodal and bridge positions of adamantyl along with a linker between adamantane and ITC.</div><div class="NLM_p">A comparison of the IC<sub>50</sub> of Ad-ITC <b>5</b> with PEITC demonstrates the differential effects of an aryl vs an adamantyl group on the activities of ITCs. Because Ad-ITC <b>5</b> is more lipophilic than PEITC (log <i>P</i> values 4.76 vs 3.50, respectively), we expected lower IC<sub>50</sub> for Ad-ITC <b>5</b> and its longer-chain analogs than PEITC.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> This suggests that other factors could also affect the potency of Ad-ITCs, including their size, shape, and the resulting rigidity. Thus, it is possible that a longer alkyl chain length in Ad-ITCs may lead to IC<sub>50</sub> comparable to or even better than that of the corresponding aromatic ITCs.</div><div class="NLM_p">Similar to ITCs, the chemopreventive effects of ISeC may be attributed to redox modulation and modification of protein thiols and ISeC can act synergistically with ITCs.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Furthermore, the substitution of S with Se in aromatic ITCs resulted in compounds with lower IC<sub>50</sub>s.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Interestingly, Ad-ISeC <b>14</b> displayed a significantly greater antiproliferative activity than the S-containing analog Ad-ITC <b>5</b>. In fact, the IC<sub>50</sub> for Ad-ISeC <b>14</b> was similar to that of PEITC in p53 contact mutant cells.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> Furthermore, Ad-ISeC <b>14</b> induced a significantly greater level of apoptosis in p53<sup>R273H</sup> MDA-MB-468 cells and a decrease in the levels of p53<sup>R280K</sup> and p53<sup>R273H</sup> mutants compared to Ad-ITC <b>5</b>. Because the same starting amine can be used for the synthesis of Ad-ITC <b>5</b> and Ad-ISeC <b>14</b>, the preparation of ISeCs with a longer bridge (up to (CH<sub>2</sub>)<sub>5</sub>) should be readily attainable.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The Se-containing compounds with the general formula R-Se-R (selenides), R-SeH (selenols), and R-Se-Se-R (diselenides) may be synthesized.</div><div class="NLM_p">Our results showed that Ad-ITC <b>6</b> and Ad-ISeC <b>14</b> cause mutant p53 depletion at the post-transcriptional level since the levels of mutant p53 mRNA remain unchanged in Ad-ITC <b>6</b>- or Ad-ISeC <b>14</b>-treated MDA-MB-231 and MDA-MB-468 cells. Ad-ITC <b>6</b> and Ad-ISeC <b>14</b> rescued p53<sup>R280K</sup> and p53<sup>R273H</sup> mutants. Ad-ITC <b>6</b> caused a G1 phase arrest and pATM-S1981. Consistent with this idea, the reactivation of DDR might be responsible for the activation of rescued p53 mutants and apoptosis. Previously, we showed that PEITC-induced oxidative stress activates DDR in the presence of the restored p53 mutant.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> The activation of ATM in Ad-ITC <b>6</b>-treated cells suggests that these compounds may also exert oxidative stress. The data on Ad-ITCs reinforce a mechanism involving the binding of Ad-ITC to the mutant p53 protein via −N=C=S through hydrophobic interactions. We also detected an upregulation of canonical p53 targets in Ad-ITC <b>6</b>-treated MCF-7 cells, but without a significant change in the cell cycle. Supporting this, we did not detect any phosphorylation of ATM. Collectively, these results suggest that the WT p53 cells may respond to Ad-ITCs via a different mechanism. Further studies are needed to understand the divergent mechanisms in WT p53 cells.</div><div class="NLM_p">The p53 exon-6 truncating nonsense mutations occur at higher than expected frequencies and promote cancer cell proliferation, survival, and metastasis.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> However, the studies exploring the potential of the truncated p53 mutants in targeted therapies are scarce. We showed that Ad-ITC <b>6</b> inhibited the proliferation of HCC1937 cells harboring a truncated p53<sup>R306Stop</sup> mutant. An in-depth mechanistic study of Ad-ITC <b>6</b> on cell lines harboring p53 exon-6 truncating mutations is important to gain insights into the underlying mechanism. These studies may open up avenues to develop strategies to target cancers harboring these prevalent p53 truncating mutations, unlike p53 point mutants that are classified as DNA binding or structural mutants, an area that warrants comprehensive investigation.</div><div class="NLM_p last">The adamantyl moiety is relatively inert to metabolic transformation and highly stable in humans,<a onclick="showRef(event, 'ref4 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref4 ref48 ref49">(4,48,49)</a> and compounds containing adamantane are likely to have a better pharmacokinetic profile <i>in vivo</i>. In support of this notion, previous pharmacokinetics studies of antiviral drugs incorporating adamantane,<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48,49)</a> amantadine, and rimantadine have demonstrated that these drugs are highly stable in humans with an elimination half-life of 24–60 h and a significantly greater steady-state volumes of distribution in human plasma. Previously, we showed in a phase I safety and pharmacokinetic clinical trial (NCT00005883) of PEITC, an aromatic ring containing ITC, that the estimated half-life of PEITC is ∼2.4 h and four daily doses of PEITC are required to maintain steady-state plasma ITC levels throughout the 24 h.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> These studies clearly indicate that an extensive investigation on adamantane derivatives of ITCs, including Ad-ITC <b>6,</b> Ad-ISeC <b>14</b>, and other adamantyl containing ITCs/ ISeCs, <i>in vitro</i> and <i>in vivo</i>, is needed urgently to unravel their mechanisms, pharmacokinetic profiles, and efficacies. Nevertheless, a new insight is afforded by our study that the previously unappreciated adamantyl moiety can be added to ITCs that has potential to enhance the lipophilicity and efficacy of an existing anticancer agents, thus laying a platform for the development of adamantyl compounds as novel p53 targeted therapeutic agents.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00534" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00534" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Synthesis of Ad-ITCs <b>1</b>–<b>11</b></h3><div class="NLM_p">Carbon disulfide (40–80 mmol) and triethylamine (4–8 mmol) were added to a mixture of corresponding adamantyl amine (4–8 mmol) and 6–12 mL of ethanol. The mixture was stirred for 30 min at RT and cooled to 0 °C. Di-<i>tert</i>-butyl dicarbonate (Boc<sub>2</sub>O, 4–8 mmol) and 4-(dimethylamino)pyridine (DMAP, 0.01–0.02 g) were added, and the mixture was stirred for 1 h at RT. The solvent was distilled off, and the residue was purified either by crystallization from EtOH (for solid compounds) or by column chromatography (for liquid compounds). For details, see below and ref <a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>. Purity of synthesized compounds was determined via GC–MS (Agilent GC 5975/MSD 7820) and is >95%.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 1-Isothiocyanatoadamantane (<b>1</b>)</h4><div class="NLM_p last">The general method above was used with 1-aminoadamantane to afford a white solid (1.06 g, 92% yield), mp 167 °C. MS (EI): <i>m</i>/<i>z</i> (%) = 193 (47) [M]<sup>+</sup>, 135 (100) [Ad]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 2.01–1.46 (m, 15H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ = 129.45 (s, 1C, NCS), 58.54 (s, 1C, quaternary C in Ad), 43.83 (s, 3C, Ad), 35.61 (s, 3C, Ad), 29.29 (s, 3C, Ad). Elemental analysis calculated for C<sub>11</sub>H<sub>15</sub>NS: C 68.35, H 7.82, N 7.25, S 16.58; found C 68.33, H 7.83, N 7.24, S 16.60.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 2-Isothiocyanatoadamantane (<b>2</b>)</h4><div class="NLM_p last">The general method above was used with 2-aminomethyladamantane to afford a white solid (1.10 g, 86% yield), mp 140–141 °C. MS (EI): <i>m</i>/<i>z</i> (%) = 193 (100) [M]<sup>+</sup>, 135 (100) [Ad]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ = 3.89 (s, CH-NCS), 2.12–1.64 (m, 14H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ = 129.62 (s, 1C, NCS), 62.17 (s, 1C, <u class="uu">C</u>H-NCS), 38.98 (s, 1C, Ad), 36.15 (s, 2C, Ad), 33.63 (s, 1C, Ad), 31.61 (s, 3C, Ad), 26.92 (s, 1C, Ad), 26.60 (s, 1C, Ad). Elemental analysis: calculated for C<sub>11</sub>H<sub>15</sub>NS: C 68.35, H 7.82, N 7.26, S 16.57; found C 68.36, H 7.81, N 7.25, S 16.60.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 1-Isothiocyanatomethyladamantane (<b>3</b>)</h4><div class="NLM_p last">The general method above was used with 1-aminomethyladamantane to afford a white solid (1.07 g, 85% yield), mp 67–68 °C. MS (EI): <i>m</i>/<i>z</i> (%) = 207 (14) [M]<sup>+</sup>, 135 (100) [Ad]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-d6): δ = 3.29 (s, 2H, CH<sub>2</sub>), 1.95 (s, 3H, Ad), 1.61 (dd, <i>J</i> = 11.7 Hz, <i>J</i> = 39.6 Hz, 6H, Ad), 1.47 (d, <i>J</i> = 2.5 Hz, 6H, Ad). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ = 128.95 (s, 1C, NCS), 56.68 (s, 1C, CH<sub>2</sub>-NCS), 39.55 (s, 1C, Ad), 37.05 (s, 1C, Ad), 36.65 (s, 3C, Ad), 34.86 (s, 1C, Ad), 28.22 (s, 1C, Ad), 28.04 (s, 3C, Ad). Elemental analysis: calculated for C<sub>12</sub>H<sub>17</sub>NS: C 69.52, H 8.26, N 6.76, S 15.46; found C 69.55, H 8.25, N 6.74, S 15.46.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 1-Isothiocyanato-1-(adamantan-1-yl)ethane (<b>4</b>)</h4><div class="NLM_p last">The general method above was used with 1-amino-1-(adamantan-1-yl)ethane to afford a dark brown liquid crystallizing on storage (1.02 g, 82% yield). MS (EI): <i>m</i>/<i>z</i> (%) = 221 (12) [M]<sup>+</sup>, 163 (8) [Ad-CH(CH<sub>3</sub>)]<sup>+</sup>, 135 (100) [Ad]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ = 3.35 (q, <i>J</i> = 6.5 Hz, 1 H, CH), 2.03 (s, 3 H), 1.74–1.46 (m, 12 H), 1.27 (d, <i>J</i> = 6.5 Hz, 3 H, CH<sub>3</sub>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ = 128.50 (s, NCS), 63.68 (s, 1 C, CH), 38.22 (s, 3 C, Ad), 36.90 (s, quaternary C in Ad), 36.72 (s, 3 C, Ad), 28.17 (s, 3 C, Ad), 15.13 (s, 1 C, CH<sub>3</sub>). Elemental analysis calculated for C<sub>13</sub>H<sub>19</sub>NS: C, 70.54; H, 8.65; N, 6.32; S, 14.49; found: C, 70.51; H, 8.66; N, 6.31; S 14.46.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 1-Isothiocyanato-2-(adamantan-1-yl)ethane (<b>5</b>)</h4><div class="NLM_p last">The general method above was used with 1-amino-2-(adamantan-1-yl)ethane to afford a yellow viscous liquid (1.06 g, 86% yield). MS (EI): <i>m</i>/<i>z</i> (%) = 221 (15) [M]<sup>+</sup>, 135 (100) [Ad]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ = 3.51 (t, <i>J</i> = 7.5 Hz, 2 H, CH<sub>2</sub>-NCS), 1.96 (s, 3 H), 1.67 (dd, <i>J</i> = 32.0, 12.0 Hz, 4 H), 1.54–1.49 (m, 10 H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ = 128.99 (s, 1 C, NCS), 43.89 (s, 1 C, <u class="uu">C</u>H<sub>2</sub>-NCS), 41.88 (s, 3 C, Ad), 40.19 (s, 1 C, Ad-CH<sub>2</sub>), 36.79 (s, 3 C, Ad), 28.38 (s, 3 C, Ad), 27.54 (s, 1 C, quaternary C in Ad). Elemental analysis calculated for C<sub>13</sub>H<sub>19</sub>NS: C, 70.54; H, 8.65; N, 6.32; S, 14.49; found: C, 70.50; H, 8.66; N, 6.32; S, 14.46.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 1-Isothiocyanato-3-(adamantan-1-yl)propane (<b>6</b>)</h4><div class="NLM_p last">The general method above was used with 1-amino-3-(adamantan-1-yl)propane to afford a brown oil (0.23 g, 82% yield). MS (EI): <i>m</i>/<i>z</i> (%) = 234 (51) [M]<sup>+</sup>, 202 (26) [M – S]<sup>+</sup>, 175 (1) [M – HNCS]<sup>+</sup>, 135 (100) [Ad]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ = 3.47 (t, <i>J</i> = 6.5 Hz, 2 H, CH<sub>2</sub>-NCS), 1.96 (s, 3 H), 1.72–1.61 (m, 8 H), 1.47 (s, 6 H), 1.13 (t, <i>J</i> = 8.0 Hz, 2 H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>-Ad). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ = 129.50 (s, 1 C, NCS), 45.99 (s, 1 C, <u class="uu">C</u>H<sub>2</sub>-NCS), 42.31 (s, 3 C, Ad), 41.33 (s, 1 C, Ad-CH<sub>2</sub>), 37.09 (s, 3 C, Ad), 28.62 (s, 3 C, Ad), 28.43 (s, 1 C, Ad-CH<sub>2</sub>-<u class="uu">C</u>H<sub>2</sub>-CH<sub>2</sub>-NCS), 23.65 (s, 1 C, quaternary C in Ad). Elemental analysis calculated for C<sub>14</sub>H<sub>21</sub>NS: C, 71.44; H, 8.99; N, 5.95; S, 13.62; found: C, 71.45; H, 9.01; N, 5.93; S, 13.61.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 1-(4-Isothiocyanatophenyl)adamantane (<b>7</b>)</h4><div class="NLM_p last">The general method above was used with 4-(adamantan-1-yl)aniline to afford a light brown solid (1.02 g, 82% yield), mp 120–121 °C. MS (EI): <i>m</i>/<i>z</i> (%) = 269 (100) [M]<sup>+</sup>, 212 (80) [Ad-C<sub>6</sub>H<sub>4</sub>]<sup>+</sup>, 135 (4) [Ad]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ = 7.37 dd (4H, H<sub>arom</sub>, <i>J</i> = 8.5, 36.8 Hz), 2.04 (3H, Ad), 1.82 s (6H, Ad), 1.72 s (6H, Ad). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ = 150.95 (C<sub>arom</sub>), 133.50 (NCS), 126.26 (4C, C<sub>arom</sub>), 125.52 (C<sub>arom</sub>), 42.43 (3C, Ad), 36.14 (4C, Ad), 28.34 (3C, Ad). Elemental analysis calculated for C<sub>17</sub>H<sub>19</sub>NS: C, 75.79; H, 7.11; N, 5.20; S, 11.90; found: C, 75.77; H, 7.12; N, 5.25; S, 11.86.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 1-(2-Isothiocyanatoethoxy)adamantane (<b>8</b>)</h4><div class="NLM_p last">The general method above was used with 1-(2-aminoethoxy)adamantane to afford an orange viscous liquid (0.78 g, 86% yield). MS (EI): <i>m</i>/<i>z</i> (%) = 237 (7) [M]<sup>+</sup>, 151 (16) [Ad-O]<sup>+</sup>, 135 (100) [Ad]<sup>+</sup>. Elemental analysis calculated for C<sub>13</sub>H<sub>19</sub>NOS: C, 65.78; H, 8.07; N, 5.90; S, 13.51; found: C, 65.80; H, 8.04; N, 5.88; S, 13.55.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 1-(2-Isothiocyanato-2-methylpropoxy)adamantane (<b>9</b>)</h4><div class="NLM_p last">The general method above was used with 1-(adamantan-1-yloxy)-2-methylpropan-2-amine to afford an orange viscous liquid (0.95 g, 80% yield). MS (EI): <i>m</i>/<i>z</i> (%) = 265 (10) [M]<sup>+</sup>, 235 (75) [M – 2CH<sub>3</sub>]<sup>+</sup>, 135 (100) [Ad]<sup>+</sup>. Elemental analysis calculated for C<sub>15</sub>H<sub>23</sub>NOS: C, 67.88; H, 8.73; N, 5.28; S, 12.08; found: C, 67.82; H, 8.72; N, 5.31; S, 12.11.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 2-(1-Isothiocyanatopentan-2-yl)adamantane (<b>10</b>)</h4><div class="NLM_p last">The general method above was used with 2-(adamantan-2-yl)pentan-1-amine to afford an orange viscous liquid (1.06 g, 85% yield). MS (EI): <i>m</i>/<i>z</i> (%) = 263 (25) [M]<sup>+</sup>, 262 (100) [M – 1]<sup>+</sup>, 220 (60) [M – CS]<sup>+</sup>, 135 (85) [Ad]<sup>+</sup>. Elemental analysis calculated for C<sub>16</sub>H<sub>25</sub>NS: C, 72.95; H, 9.57; N, 5.32; S, 12.17; found: C, 72.96; H, 9.55; N, 5.31; S, 12.19.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 1-Isothiocyanato-3,5-dimethyladamantane (<b>11</b>)</h4><div class="NLM_p last">The general method above was used with 1-amino-3,5-dimethyladamantane to afford a light orange viscous liquid (1.07 g, 86% yield). MS (EI): <i>m</i>/<i>z</i> (%) = 221 (5) [M]<sup>+</sup>, 163 (100) [Ad]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ = 2.17 (s, 1H), 1.81 (s, 2H), 1.62 (dd, <i>J</i> = 13.0, 12.0 Hz, 4H), 1.32 (dd, <i>J</i> = 16.0, 12.5 Hz, 4H), 1.15 (s, 2H), 0.87 (s, 6H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ = 129.92 (s, 1C, NCS), 59.75 (s, 1C, C-NCS), 49.88 (s, 1C, Ad), 49.61 (s, 2C, Ad), 42.26 (s, 1C, Ad), 41.89 (s, 2C, Ad), 32.58 (s, 1C, Ad), 29.90 (s, 2C, Ad), 29.62 (s, 2C, 2CH<sub>3</sub>). Elemental analysis calculated for C<sub>13</sub>H<sub>19</sub>NS: C, 70.54; H, 8.65; N, 6.30; S, 14.50; found: C, 70.59; H, 8.67; N, 6.27; S, 14.46.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Preparation of 2-(Adamantan-1-yl)acetyl Isothiocyanate (<b>12</b>)</h3><div class="NLM_p last">Ammonium thiocyanate (1.8 g, 23.5 mmol) was added to the solution of (adamantant-1-yl)acetic acid chloride (5 g, 23.5 mmol) in 50 mL of anhydrous acetone. After stirring for 1 h at RT, ammonium chloride was filtered off and solvent was removed <i>in vacuo</i>. The residue was purified by crystallization from ethanol to afford a yellow solid (5.24 g, 95%), mp 38–40°C. MS (EI): <i>m</i>/<i>z</i> (%) = 235 (40) [M]<sup>+</sup>, 135 (100) [Ad]<sup>+</sup>. Elemental analysis calculated for C<sub>13</sub>H<sub>17</sub>NOS: C 66.35; H 7.28; N 5.95; S 13.62; found: C 66.37; H 7.30; N 5.91; S 13.60.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Preparation of 3-(2-(Adamantan-1-yl)ethyl)-2-thioxoimidazolidin-4-one (<b>13</b>)</h3><div class="NLM_p last">To a solution of compound <b>5</b> (1.0 g, 4.52 mmol) in DMF (8 mL), glycine ethyl ester hydrochloride (0.63 g, 4.52 mmol) and Et<sub>3</sub>N (0.92 g, 9.04 mmol) were added. The mixture was stirred for 8 h at RT. Solvent was removed <i>in vacuo</i>, and the crude product was crystallized from ethanol. Yield 0.94 g. (75%), mp 180–181 °C. For details, see ref <a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a>. MS (EI): <i>m</i>/<i>z</i> (%) = 278 (4) [M]<sup>+</sup>, 245 (100) [M – S]<sup>+</sup>, 143 (15%) [M – Ad], 135 (12) [Ad]<sup>+</sup>, 117 (35) [M – AdCH<sub>2</sub>CH<sub>2</sub>]. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ = 10.10 s (1H, NH), 4.09 s (2H, NH-C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 3.69–3.64 m (2H, N-C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.92 s (3H, Ad), 1.68–1.48 m (12H, Ad), 1.31–1.26 m (2H, Ad-C<u class="uu">H</u><sub><u class="uu">2</u></sub>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ = 183.13 (1C, C=S), 172.36 (1C, C=O), 76.55 (1C, NH-<u class="uu">C</u>H<sub>2</sub>-CH<sub>2</sub>), 41.45 (3C, Ad), 40.85 (1C, N-CH<sub>2</sub>), 36.41 (3C, Ad), 35.24 (1C, NH-CH<sub>2</sub>-<u class="uu">C</u>H<sub>2</sub>), 31.35 (1C, Ad quart.), 27.83 (3C, Ad). Elemental analysis calculated for C<sub>15</sub>H<sub>22</sub>N<sub>2</sub>OS: C 64.71; H 7.96; N 10.06; S 11.52; found: C 64.68; H 7.99; N 10.02; S 11.48.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Preparation of 1-Isoselenocyanato-2-(adamantan-1-yl)ethane (<b>14</b>)</h3><div class="NLM_p last">CHCl<sub>3</sub> (1.5 mL), Aliquat 336 (0.15 g), and 50% aqueous NaOH (4 mL) were added to the solution of 2.0 g (11.17 mmol) 2-(adamantan-1-yl)ethylamine in 20 mL of CH<sub>2</sub>Cl<sub>2</sub>. After refluxing for 4 h, selenium (Se) (5.0 g, 63.3 mmol) was added. After refluxing for another 4 h, the mixture was cooled to RT and quenched with 30 mL of CH<sub>2</sub>Cl<sub>2</sub> and 30 mL of water. Excessive Se was filtered off, and the organic layer was separated and dried with Na<sub>2</sub>SO<sub>4</sub>. After filtering the Na<sub>2</sub>SO<sub>4</sub>, solvent was removed <i>in vacuo</i>. The residue was purified by column chromatography (hexanes) to afford a pale yellow solid (1.65 g, 55%), mp 78–79°C. For details, see ref <a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a>. MS (EI): <i>m</i>/<i>z</i> (%) = 269 (40) [M]<sup>+</sup>, 188 (20) [M – Se]<sup>+</sup>, 163 (70%) [Ad-CH<sub>2</sub>-CH<sub>2</sub>]<sup>+</sup>, 149 (3%) [Ad-CH<sub>2</sub>]<sup>+</sup>, 135 (100) [Ad]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ = 3.60 t (2H, <i>J</i> = 8.0 Hz, C<u class="uu">H</u><sub><u class="uu">2</u></sub>-NCSe), 1.98 s (3H, Ad), 1.61–1.73 m (6H, Ad), 1.56 t (2H, <i>J</i> = 8.0 Hz, Ad-C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.49 s (6H, Ad). Elemental analysis calculated for C<sub>13</sub>H<sub>19</sub>NSe: C 58.21; H 7.14; N 5.22; found: C 58.18; H 7.16; N 5.25.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Log <i>P</i> Determination</h3><div class="NLM_p last">Each compound (10 μL of 10 mM solution in DMSO) was added to 0.5 mL of octanol and 0.5 mL of sodium phosphate buffer (pH 7.4) in a 2 mL vial, stirred for 18 h, and centrifuged for 2 h at 3600 rpm as described previously.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> An Agilent LC 1200 MS 6420 triple quadrupole, column Zorbax xdb-c18 (length 50 mm, diameter 2.1 mm, solid phase size 3.5 μm) was used to determine the concentration in each phase.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Cell Lines</h3><div class="NLM_p last">MDA-MB-231, MDA-MB-468, MDA-MB-436, HCC1937, and WT p53 MCF-7 cells were obtained from the Tissue Culture Source Resource, Georgetown University, Washington, DC. MDA-MB-231, MDA-MB-468, and MCF-7 cells were cultured in a Roswell Park Memorial Institute (RPMI) 1640 medium with 10% fetal bovine serum (FBS), 1% penicillin/streptomycin, and 1% <span class="smallcaps smallerCapital">l</span>-glutamine. MDA-MB-436 cells were cultured in Dulbecco’s modified Eagle medium (DMEM) with 10% FBS, 1% penicillin/streptomycin, and 1% <span class="smallcaps smallerCapital">l</span>-glutamine. HCC1937 cells were cultured in an RPMI 1640 medium with 10% FBS, 1% penicillin/streptomycin, 1% <span class="smallcaps smallerCapital">l</span>-glutamine, and 1% sodium pyruvate. All the cell lines were negative for mycoplasma.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Cell Proliferation Assays</h3><div class="NLM_p last">The effect of different Ad-ITCs, PEITC or adamantane on MDA-MB-231 cell proliferation was determined by using the WST-1 assay (Roche) as described previously.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> Briefly, each Ad-ITC was diluted in DMSO so that 10 μL of diluted stock in a 1 mL aliquot of cells (40,000 cells/mL) yielded a desired concentration at 1% DMSO. MDA-MB-231 cell cultures containing Ad-ITC were plated onto a 96-well microtiter plate at 4000 cells per well in duplicate. As a control, 4000 cells per well were seeded in a medium containing 1% DMSO in duplicate. For background subtraction, wells lacking cells but containing the medium were used. Plates were incubated at 37 °C for 24 or 72 h followed by the addition of the WST-1 reagent for 2 h. OD<sub>450</sub> was measured using a microplate reader (Bio-Rad). Percent cell proliferation was calculated as the ratio of OD<sub>450</sub> values obtained for respective cells grown in the presence of Ad-ITC compared with the presence of DMSO. Similar assays were performed to determine the effect of different Ad-ITCs, PEITC, or adamantane on proliferation of other cell lines.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Colony Formation Assays</h3><div class="NLM_p last">To measure colony survival, 500 MDA-MB-231 or MCF-7 cells per well were seeded in a six-well plate 24 h before treatment. Cells then were treated with the indicated concentrations of different Ad-ITCs, Ad-ISeC <b>14</b> or DMSO as a control for 24 h at 37 °C. Following treatment, cells were incubated in a regular medium (RPMI, 10% FBS) at 37 °C for 10 days. Colonies formed were fixed in methanol, stained with methylene blue (Sigma), and counted to determine percentage survival relative to the DMSO control.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Annexin V Staining</h3><div class="NLM_p last">Annexin V staining was done in accordance with the manufacturer’s instructions (Biolegend). In brief, cells were treated with Ad-ITCs <b>1</b>, <b>3</b>, <b>5</b>, <b>6</b>, Ad-compound <b>13</b>, or Ad-ISeC <b>14</b> or PEITC as indicated or DMSO as a control for 24 h. Cells were harvested by scraping, washed once with PBS, and resuspended in 0.5 mL of Annexin V binding buffer. Cells were collected by centrifugation, 5 μL of the fluorochrome conjugated Annexin V was added in the residual buffer, and cells were incubated at RT in the dark for 15 min followed by the addition of 0.5 mL of Annexin V binding buffer and 5 μL of PI staining solution (0.1 μg/mL). Cells were then analyzed by flow cytometry using a BD LSRFORTESSA instrument (BD Biosciences).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Lysate Preparation and Western Blot Analysis</h3><div class="NLM_p">Cells were treated with Ad-ITCs <b>1</b>, <b>3</b>, <b>5</b>, <b>6</b>, Ad-compound <b>13</b>, or Ad-ISeC <b>14</b> or PEITC as indicated or DMSO for 24 h. Cells were then harvested by centrifugation at 1600<i>g</i> for 10 min at 4 °C, washed once with PBS, resuspended in lysis buffer (20 mM Tris-Cl (pH 8.0), 137 mM sodium chloride, 10% glycerol, 1% NP-40, 2 mM EDTA) containing a protease inhibitor cocktail (Roche Molecular Biochemicals), and were then incubated on ice for 30 min. The lysates were centrifuged at 18,500<i>g</i> for 10 min at 4 °C. Then 20 (MDA-MB-231 or MDA-MB-468) or 50 μg (MCF-7) of the lysates was loaded on 4–12% SDS-PAGE. Protein was transferred onto a PVDF membrane, and the blots were developed using the ECL Prime Western Blot Detection Kit according to the manufacturer’s protocol (Amersham). The antibodies for p53 (DO-1) and GAPDH were purchased from Santa Cruz Biotechnology and Novus Biologicals, respectively.</div><div class="NLM_p">Cells were treated with DMSO or 6 μM Ad-ITC <b>6</b> for 24 h. For detecting phosphorylation of ATM, 250 μg of the cell lysate was loaded on 4–12% SDS-PAGE. The proteins were then transferred onto a PVDF membrane, and the blot was probed with the anti-pATM Ser1981 antibody (1:500) (Santa Cruz Biotechnology). For the secondary antibody, peroxidase-labeled anti-mouse IgG (1:1000, GE Healthcare) was used. The blot was developed using the ECL Prime Western Blot Detection Kit following the manufacturer’s protocol (Amersham). As a control, the blot was probed with the anti-GAPDH antibody (1:5000) (Novus Biologicals).</div><div class="NLM_p last">Cells were treated with DMSO or Ad-ITC <b>6</b>, Ad-ISeC <b>14</b>, or PEITC at the indicated concentrations for 24 h. For detecting uncleaved caspase 3, uncleaved PARP1, or cleaved PARP1, 100 μg of the cell lysate was loaded on 4–12% SDS-PAGE. The proteins were then transferred onto a PVDF membrane, and the blot was probed with anti-PARP (1:1000, BioLegend) or anti-caspase 3 (1:1000, Cell Signaling) antibodies. For the secondary antibody, peroxidase-labeled anti-mouse IgG (1:1000, GE Healthcare) or anti-rabbit (1:1000, Santa Cruz) was used. The blot was developed using the ECL Prime Western Blot Detection Kit following the manufacturer’s protocol (Amersham). As a control, the blot was probed with the anti-GAPDH antibody (1:5000, Santa Cruz).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Real-Time Polymerase Chain Reaction (qRT-PCR) Assay</h3><div class="NLM_p last">Cells were treated with DMSO or 6 μM Ad-ITC <b>6</b> or Ad-ISeC <b>14</b> for 4 h. RNA was extracted using a Qiagen RNeasy Kit (Qiagen, Valencia, CA, USA), cDNA was synthesized by using a High Capacity RNA to cDNA kit (Applied Biosystems, Invitrogen, Thermo Fisher Scientific), and the gene expression level was measured by qRT-PCR using TaqMan gene expression assays (Applied Biosystems, Invitrogen). The gene expression level was normalized with GAPDH, and the average is presented with standard deviation from triplicates of repeated experiments.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Flow Cytometric Analysis</h3><div class="NLM_p last">Cells were treated with DMSO or 6 μM Ad-ITC <b>6</b> for 24 h. Cells were then prepared for flow cytometric analysis. Briefly, cells were washed with PBS free of Ca<sup>2+</sup> and Mg<sup>2+</sup>, trypsinized for 5 min, and harvested by centrifugation at 190<i>g</i> for 3 min at 4 °C. Cells were washed once with PBS, and pellets were resuspended in 1 mL of 70% ethanol and stored at −20 °C overnight. Cells were harvested by centrifugation at 420<i>g</i> for 10 min. The cell pellets were washed once with 1 mL of cold PBS and resuspended in 1 mL of freshly prepared PI staining solution (PBS with 0.1% Triton X-100, 0.05 μg/mL propidium iodide, 0.1 mg/mL RNase (Sigma)). The cell suspension was incubated at room temperature for 30 min in the dark followed by incubation for 30 min at 4 °C. The samples were run on a Becton Dickinson FACS sort, and the data was analyzed using the Mod Fit program (Verity Software House).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> siRNA Transfection in Cells</h3><div class="NLM_p last">The p53 siRNA was obtained from SMARTpool (Thermo Scientific/Dharmacon, Lafayette, CO, USA). The siRNA was transfected with Lipofectamine 2000 as described previously.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> Briefly, MDA-MB-468 cells were plated to 50–60% confluence in 10 cm dishes 24 h before transfection. The siRNA (0.430 nmol) was mixed with 43 μL of Lipofectamine 2000 in 1 mL of Opti-MEM (Invitrogen). The mixture was added to the cells that subsequently were incubated for 5 h. After 24 h, a second transfection was performed similarly. Seventy-two hours after the initial transfection, cells were treated with Ad-ITC <b>6</b> or DMSO at the indicated concentrations, and cell proliferation was measured by using the WST-1 reagent (Sigma) as described previously.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Statistical Analysis</h3><div class="NLM_p last">Statistical differences in canonical p53 targets were evaluated with a two-tailed Student’s <i>t</i> test. Differences were considered statistically significant at <i>p</i> values of ≤0.05. All statistical tests were two-sided.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01971" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55241" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55241" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01971?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01971</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Schemes for the synthesis of the title compounds, purity data, effects of the title compounds, adamantane, and PEITC on breast cancer cell lines, colony formation assay, Ad-ITC <b>6</b>- and PEITC-induced apoptosis on breast cancer cell lines, effects of Ad-ITC <b>6</b> on MDM2 and TP53 expression in mutant p53 and WT p53 cells  and siRNA transfected MDA-MB-468 cell proliferation, synthesis of Ad-ISeC <b>14</b> and its effect on breast cancer cell proliferation, apoptosis, and MDM2 and TP53 regulation, effects of Ad-ITC <b>6</b> and Ad-ISeC <b>14</b> on normal mammary epithelial and normal colon cell proliferation, and log <i>P</i> values (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf">jm0c01971_si_001.pdf (1.43 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_002.csv">jm0c01971_si_002.csv (0.7 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01971" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85635" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85635" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Monika Aggarwal</span> - <span class="hlFld-Affiliation affiliation">Department
of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, D.C. 20007, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0400-5824" title="Orcid link">http://orcid.org/0000-0002-0400-5824</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#83eee2b2b1b4b7c3e4e6ecf1e4e6f7ecf4edade6e7f6"><span class="__cf_email__" data-cfemail="187579292a2f2c587f7d776a7f7d6c776f76367d7c6d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vladimir Burmistrov</span> - <span class="hlFld-Affiliation affiliation">Volgograd
State Technical University, Volgograd 400005, Russia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Technology and Equipment of Chemical Industry, Volzhsky Polytechnic Institute (branch) Volgograd
State Technical University, Volzhsky 404121, Russia</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8547-9166" title="Orcid link">http://orcid.org/0000-0002-8547-9166</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rahul Saxena</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular and Cellular Biology, Georgetown University, Washington, D.C. 20007, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dmitry Pitushkin</span> - <span class="hlFld-Affiliation affiliation">Volgograd
State Technical University, Volgograd 400005, Russia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gennady M. Butov</span> - <span class="hlFld-Affiliation affiliation">Volgograd
State Technical University, Volgograd 400005, Russia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Technology and Equipment of Chemical Industry, Volzhsky Polytechnic Institute (branch) Volgograd
State Technical University, Volzhsky 404121, Russia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fung-Lung Chung</span> - <span class="hlFld-Affiliation affiliation">Department
of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, D.C. 20007, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8028-6448" title="Orcid link">http://orcid.org/0000-0001-8028-6448</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>V.B. and M.A. contributed equally to this work. M.A. contributed to the conception and design of the study, acquisition of experimental data, to the analysis and interpretation of results, and to the writing of the manuscript and supervised the study. V.B. contributed to the acquisition of experimental data, to the analysis and interpretation of results, and to the writing of the manuscript. R.S. contributed to the acquisition of experimental data. F.-L.C. provided guidance and encouragement and contributed to the interpretation of results and writing of the manuscript. D.P. contributed to the synthesis of Ad-ITCs. G.M.B. provided guidance for the synthetic part and contributed to the interpretation of spectral data. All authors read and approved the final manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63456" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63456" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Karen Creswell for flow cytometry and the Tissue Culture Shared Resource (TCSR) for the cell lines and the mycoplasma testing of these cell lines at Georgetown University. Synthesis of isothiocyanates <b>1</b>–<b>12</b> is supported by a grant from the Russian Science Foundation (project no. 19-73-10002), and synthesis of isoselenocyanate <b>14</b> is supported by a grant from the Russian Fund for Basic Research (project no. 20-03-00298). Mechanistic studies are supported by a grant from National Cancer Institute of the National Institutes of Health (NIH) CA100853 and Lombardi Cancer Center Support Grant P30 CA51008.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">Ad-ISeC</td><td class="NLM_def"><p class="first last">1-isoselenocyanato-2-(adamantan-1-yl)ethane</p></td></tr><tr><td class="NLM_term">Ad-ITC</td><td class="NLM_def"><p class="first last">adamantyl isothiocyanate</p></td></tr><tr><td class="NLM_term">ATM</td><td class="NLM_def"><p class="first last">Ataxia-Telangiectasia Mutated</p></td></tr><tr><td class="NLM_term">CFA</td><td class="NLM_def"><p class="first last">colony formation assay</p></td></tr><tr><td class="NLM_term">DDR</td><td class="NLM_def"><p class="first last">DNA damage response</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s modified Eagle medium</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">estrogen receptor</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">GOF</td><td class="NLM_def"><p class="first last">gain of function</p></td></tr><tr><td class="NLM_term">HER2</td><td class="NLM_def"><p class="first last">human epidermal growth factor receptor 2</p></td></tr><tr><td class="NLM_term">ITCs</td><td class="NLM_def"><p class="first last">isothiocyanates</p></td></tr><tr><td class="NLM_term">NS</td><td class="NLM_def"><p class="first last">nonspecific</p></td></tr><tr><td class="NLM_term">PEITC</td><td class="NLM_def"><p class="first last">phenethyl isothiocyanate</p></td></tr><tr><td class="NLM_term">PR</td><td class="NLM_def"><p class="first last">progesterone receptor</p></td></tr><tr><td class="NLM_term">RPMI</td><td class="NLM_def"><p class="first last">Roswell Park Memorial Institute</p></td></tr><tr><td class="NLM_term">RT-PCR</td><td class="NLM_def"><p class="first last">real-time polymerase chain reaction</p></td></tr><tr><td class="NLM_term">S</td><td class="NLM_def"><p class="first last">sulfur</p></td></tr><tr><td class="NLM_term">SARs</td><td class="NLM_def"><p class="first last">structure–activity relationships</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">Se</td><td class="NLM_def"><p class="first last">selenium</p></td></tr><tr><td class="NLM_term">TNBC</td><td class="NLM_def"><p class="first last">triple negative breast cancer</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild-type</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83364" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83364" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 51 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerzon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krumkalns, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindle, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, M. A.</span></span> <span> </span><span class="NLM_article-title">The adamantyl group in medicinal agents. I. Hypoglycemic N-Arylsulfonyl-N’-adamantylureas</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1963</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">760</span>– <span class="NLM_lpage">763</span>, <span class="refDoi"> DOI: 10.1021/jm00342a029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00342a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADyaF2cXitlSnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1963&pages=760-763&author=K.+Gerzonauthor=E.+V.+Krumkalnsauthor=R.+L.+Brindleauthor=F.+J.+Marshallauthor=M.+A.+Root&title=The+adamantyl+group+in+medicinal+agents.+I.+Hypoglycemic+N-Arylsulfonyl-N%E2%80%99-adamantylureas&doi=10.1021%2Fjm00342a029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Adamantyl group in medical agents. I. Hypoglycemic N-arylsulfonyl-N'-adamantylureas</span></div><div class="casAuthors">Gerzon, Koert; Krumalns, Eriks V.; Brindle, Richard L.; Marshall, Frederick J.; Root, Mary A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1963</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">760-3</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">To assess the possible pharmacodynamic effects of the sym. lipophilic adamantyl group, a no. of N-arylsulfonyl-N'-adamantylureas, ArSO2NHCONHR (I), were prepd. for evaluation as hypoglycemic agents.  (All m.ps. were taken in sealed, submerged capillary tubes).  Adamantane-1-carboxamide (9 g.) in 200 ml. dry Et2O added to 10 g. LiAlH4 suspended in 500 ml. dry Et2O with stirring, the mixt. refluxed 4 hrs., cooled to -5° with stirring, treated dropwise by 10 ml. H2O, followed by 30 ml. 10% aq. NaOH and 10 ml. H2O, the solids filtered off and washed with 500 ml. Et2O, the combined Et2O solns. dried and evapd. in vacuo, the residue dissolved in 50 ml. Et2O, and the soln. filtered and treated with dry HCl gave 7 g. 1-aminomethyladamantane-HCl, m. 320° (EtOH).  1-Methyladamantane brominated by the procedure reported for 1-bromoadamantane (Stetter, et al., CA 53, 21709f; 54, 1356a) gave 93% 3-methyl-1-bromoadamantane (II), b0.05 65-7°, whose structure was supported by its nuclear magnetic resonance (n.m.r.) spectrum.  From II was prepd. by the MeCN-H2SO4 method (S., et al., CA 54, 9950d) 1-acetamido-3-methyladamantane (III), m. 108-9° (sublimation at 90-100°/0.05 mm.).  Deacetylation of III by KOH in O(CH2CH2OH)2, followed by Et2O extn. gave an Et2O soln. contg. product and ∼5% unchanged III, which was treated with dry HCl to give 87% 1-amino-3-methyladamantane-HCl, m. 295-300°.  1,3-Dimethyladamantane brominated as above gave 77.5 g. 1-bromo-3,5-dimethyladamantane (IV), b0.03 67-9°, n25D 1.5178 (structure supported by n.m.r. spectrum), which was converted into 96% 1-acetamido analog of IV, m. 80-2° (sublimation), and the latter into 87% 1-amino analog of IV HCl salt, m. 290-5°.  Adamantane (V) (100 g.) and 85 g. tert-BuCl in 400 ml. anhyd. cyclohexane treated portionwise during 8 hrs. with 4.6 g. (total) AlCl3 (in 0.5 g. batches AlCl3), when the reaction was complete (as judged from escaping isobutane gas), 100 ml. N HCl added with stirring, followed by 500 ml. Et2O, and the org. layer sepd., washed with 50 ml. cold H2O and 50 ml. 5% aq. NaHCO3, dried, and evapd. in vacuo gave 115 g. crude 1-chloroadamantane (VI), m. 152-6°, contg. (gas chromatography) 90-5% VI and 5-10% V; recrystn. of a sample from EtOH at - 50° gave pure VI, as detd. by mixed m.p. with authentic VI and by x-ray diffraction patterns.  Crude VI was converted by the MeCN-H2SO4 method into 83% crude 1-acetamidoadamantane (VII), m. 144-6°; pure VII m. 147-9° (EtOH).  Crude VII (108 g.) sapond. gave 51 g. pure 1-aminoadamantane (VIII), m. 160-200°.  VIII (302.5 g.) and 535 g. 4-MeC6H4SO2NHCO2Et in 6 l. dry PhMe refluxed 5 hrs., cooled to room temp., the cryst. solid filtered off and dissolved (without application of heat) in ∼2 l. CHCl3 which had previously been shaken with 50 g. Al2O3 to remove traces EtOH, the soln. washed with cold 5% HCl and H2O until neutral, dried (MgSO4), concd. in vacuo to 1/2 its vol., warmed to 50°, dild. with hot petr. ether (b. 60-71°) to start crystn., and chilled overnight gave 400 g. I (Ar = 4-MeC6H4, R = 1-adamantyl) (IX), m. 178-9° (CHCl3-petr. ether).  The following I were prepd. (Ar, R, m.p., relative potency with respect to hypoglycemic activity given): 4-MeC6H4, Bu (Tolbutamide), -, 1; 4-MeC6H4, 1-adamantyl, 178-9°, 15.5; 4-MeC6H4, cyclohexyl (Tolcyclamide), -, 12.8; 4-EtC6H4, 1-adamantyl, 153-5°, 14.8; 4-EtC6H4, cyclohexyl, -, 9.3; 4-MeSC6H4, 1-adamantyl, 155-8°, 8.7; 4-MeSC6H4, cyclohexyl (Thiohexamide), -, 4.1; 4-ClC6H4, 1-adamantyl, 150-1°, 5.1; 4-ClC6H4, cyclohexyl, -, 5.6; 4-ClC6H4, Pr, -, 2.1; 4-iso-PrC6H4, 1-adamantyl, 190-2°, 2.9; 4-AcC6H4, 1-adamantyl, 163-5°, 1.6; 4-AcC6H4, cyclohexyl (Acetohexamide), -, 4.0; 4,3-Me(H2N)C6H3, 1-adamantyl, 175° (decompn.), 0; 4,3-Me(H2N)C6H3, cyclohexyl (Metahexamide), -, 5.0; 4-MeC6H4, 2-adamantyl, 206-8°, 4.0; 4-MeC6H4, 3-methyl-l-adamantyl, 184-6°, 2.8; 4-MeC6H4, 3,5-dimethyl-1-adamantyl, 166-8°, 0; 4-EtC6H4, 1-adamantylmethyl, 203-5°, 0.2; 4-AcC6H4, 1-adamantylmethyl, 204-6°, 0.  The pharmacol. evaluation of the compds. is discussed; particularly with respect to IX.  Preliminary clinical data thus far indicate IX to be a most satisfactory, potent oral hypoglycemic agent with an effective av. dose, single or divided, of 400 reg./day.  IX is equal to Chlorpropamide on a wt. basis and possesses about 5 times the potency of Tolbutamide.  The activity of IX is rapid in onset with tentative duration of 4-6 hrs., indicating that IX is rapidly absorbed and utilized by the body.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv8XqLXlCyArVg90H21EOLACvtfcHk0lj0JlLdR6sfmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2cXitlSnsQ%253D%253D&md5=3628367dabac00a8be059ae056ebf268</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm00342a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00342a029%26sid%3Dliteratum%253Aachs%26aulast%3DGerzon%26aufirst%3DK.%26aulast%3DKrumkalns%26aufirst%3DE.%2BV.%26aulast%3DBrindle%26aufirst%3DR.%2BL.%26aulast%3DMarshall%26aufirst%3DF.%2BJ.%26aulast%3DRoot%26aufirst%3DM.%2BA.%26atitle%3DThe%2520adamantyl%2520group%2520in%2520medicinal%2520agents.%2520I.%2520Hypoglycemic%2520N-Arylsulfonyl-N%25E2%2580%2599-adamantylureas%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1963%26volume%3D6%26spage%3D760%26epage%3D763%26doi%3D10.1021%2Fjm00342a029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rapala, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraay, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerzon, K.</span></span> <span> </span><span class="NLM_article-title">The adamantyl group in medicinal agents. II. Anabolic steroid 17β-adamantoates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1965</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">580</span>– <span class="NLM_lpage">583</span>, <span class="refDoi"> DOI: 10.1021/jm00329a007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00329a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADyaF2MXks1egtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1965&pages=580-583&author=R.+T.+Rapalaauthor=R.+J.+Kraayauthor=K.+Gerzon&title=The+adamantyl+group+in+medicinal+agents.+II.+Anabolic+steroid+17%CE%B2-adamantoates&doi=10.1021%2Fjm00329a007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The adamantyl group in medicinal agents. II. Anabolic steroid 17β-adamantoates</span></div><div class="casAuthors">Rapala, Richard T.; Kraay, Russell J.; Gerzon, Koert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">580-3</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The synthesis of several steroidal 17β-adamantoate esters is described.  The adamantoic ester of 19-nortestosterone produces a profound and unique effect on anabolic potency as compared with other esters.  The long duration of high myotropic activity with diminished androgenicity may be an indication that the ester is acting in toto as opposed to prior hydrolysis to the parent compound.  The action of this anabolic ester over a period of several weeks after a single injection is confirmed by the radioactive aminoisobutyric acid (AIB)14C uptake data.  Cf. CA 60, 4022f.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYaAvLSr6ziLVg90H21EOLACvtfcHk0lioNek4yynoKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXks1egtLg%253D&md5=b6ffd526ca97131eebb2c3303d585db7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm00329a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00329a007%26sid%3Dliteratum%253Aachs%26aulast%3DRapala%26aufirst%3DR.%2BT.%26aulast%3DKraay%26aufirst%3DR.%2BJ.%26aulast%3DGerzon%26aufirst%3DK.%26atitle%3DThe%2520adamantyl%2520group%2520in%2520medicinal%2520agents.%2520II.%2520Anabolic%2520steroid%252017%25CE%25B2-adamantoates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1965%26volume%3D8%26spage%3D580%26epage%3D583%26doi%3D10.1021%2Fjm00329a007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerzon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kau, D.</span></span> <span> </span><span class="NLM_article-title">The adamantyl group in medicinal agents. III. Nucleoside 5′-adamantoates. The adamantoyl function as a protecting group</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1021/jm00314a014</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00314a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADyaF2sXnsVyrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1967&pages=189-199&author=K.+Gerzonauthor=D.+Kau&title=The+adamantyl+group+in+medicinal+agents.+III.+Nucleoside+5%E2%80%B2-adamantoates.+The+adamantoyl+function+as+a+protecting+group&doi=10.1021%2Fjm00314a014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The adamantyl group in medicinal agents.  III.  Nucleoside 5'-adamantoates.  The adamantoyl function as a protecting group</span></div><div class="casAuthors">Gerzon, Koert; Kau, Don</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">189-99</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The prepn. and biol. evaluation are described for the 5'-adamantoates of the deoxyribonucleosides, thymidine, 2'-deoxy-5-fluorouridine, and deoxyadenosine, and of the ribonucleosides, adenosine, inosine, 6-thioinosine, and 6-azauridine.  The adamantoylation of the deoxyribonucleosides proceeds preferentially to give the 5'-esters in which the adamantoyl function can serve as a base-sensitive protecting group in nucleoside synthesis.  The adamantoate of 6-thioinosine suppresses antibody formation in the mouse following challenge by sheep erythrocytes.  The adamantoate of adenosine inhibits ADP-induced platelet aggregation in vitro.  The antitumor activity of the adamantoates of several nucleoside analogs is recorded.  The possible mode of action of adamantane-contg. agents is described in terms of a precise binding of the adamantane moiety to complementary, hydrophobic regions in the receptor site protein mol.  48 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowa4XCHx8yKbVg90H21EOLACvtfcHk0lgzWIKpvTpkDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXnsVyrsw%253D%253D&md5=4490b497819a795404b06c7fcbc70b06</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm00314a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00314a014%26sid%3Dliteratum%253Aachs%26aulast%3DGerzon%26aufirst%3DK.%26aulast%3DKau%26aufirst%3DD.%26atitle%3DThe%2520adamantyl%2520group%2520in%2520medicinal%2520agents.%2520III.%2520Nucleoside%25205%25E2%2580%25B2-adamantoates.%2520The%2520adamantoyl%2520function%2520as%2520a%2520protecting%2520group%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1967%26volume%3D10%26spage%3D189%26epage%3D199%26doi%3D10.1021%2Fjm00314a014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wanka, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiner, P. R.</span></span> <span> </span><span class="NLM_article-title">The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">3516</span>– <span class="NLM_lpage">3604</span>, <span class="refDoi"> DOI: 10.1021/cr100264t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr100264t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVajs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2013&pages=3516-3604&author=L.+Wankaauthor=K.+Iqbalauthor=P.+R.+Schreiner&title=The+lipophilic+bullet+hits+the+targets%3A+medicinal+chemistry+of+adamantane+derivatives&doi=10.1021%2Fcr100264t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The Lipophilic Bullet Hits the Targets: Medicinal Chemistry of Adamantane Derivatives</span></div><div class="casAuthors">Wanka, Lukas; Iqbal, Khalid; Schreiner, Peter R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">3516-3604</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This review focuses on the medicinal chem. of the parent hydrocarbon, adamantane, and its derivs.  We will describe the development of adamantane-based chemotherapeutics for viral infections including Influenza A, Herpes simplex, Hepatitis C, and HIV.  Adamantane derivs. to be used as antimalarials will also be covered there.  Emerging adamantane resistant strains of Influenza A may lead to an end of the use of aminoadamantanes against these infections, whereas the utilization of the pronounced lipophilic properties of adamantane derivs. in pharmaceuticals for neurol. disorders still prospers.  This latest review article gives clogP data on adamantyl derivs. comparing them with nonadamantyl-analogs.  Adamantane is not a magic bullet, but it certainly is more than just a lipophilic add-on, as we have tried to show in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEwNNxUUkDQ7Vg90H21EOLACvtfcHk0lgzWIKpvTpkDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVajs70%253D&md5=19e864e9e5dc1bfdb5d2db3f08f81671</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fcr100264t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr100264t%26sid%3Dliteratum%253Aachs%26aulast%3DWanka%26aufirst%3DL.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DSchreiner%26aufirst%3DP.%2BR.%26atitle%3DThe%2520lipophilic%2520bullet%2520hits%2520the%2520targets%253A%2520medicinal%2520chemistry%2520of%2520adamantane%2520derivatives%26jtitle%3DChem.%2520Rev.%26date%3D2013%26volume%3D113%26spage%3D3516%26epage%3D3604%26doi%3D10.1021%2Fcr100264t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cady, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt-Rohr, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soto, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degrado, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, M.</span></span> <span> </span><span class="NLM_article-title">Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>463</i></span>,  <span class="NLM_fpage">689</span>– <span class="NLM_lpage">692</span>, <span class="refDoi"> DOI: 10.1038/nature08722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1038%2Fnature08722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=20130653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVygu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=463&publication_year=2010&pages=689-692&author=S.+D.+Cadyauthor=K.+Schmidt-Rohrauthor=J.+Wangauthor=C.+S.+Sotoauthor=W.+F.+Degradoauthor=M.+Hong&title=Structure+of+the+amantadine+binding+site+of+influenza+M2+proton+channels+in+lipid+bilayers&doi=10.1038%2Fnature08722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers</span></div><div class="casAuthors">Cady, Sarah D.; Schmidt-Rohr, Klaus; Wang, Jun; Soto, Cinque S.; De Grado, William F.; Hong, Mei</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">463</span>
        (<span class="NLM_cas:issue">7281</span>),
    <span class="NLM_cas:pages">689-692</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The M2 protein of influenza A virus is a membrane-spanning tetrameric proton channel targeted by the antiviral drugs amantadine and rimantadine.  Resistance to these drugs has compromised their effectiveness against many influenza strains, including pandemic H1N1.  A recent crystal structure of M2(22-46) showed electron densities attributed to a single amantadine in the amino-terminal half of the pore, indicating a phys. occlusion mechanism for inhibition.  However, a soln. NMR structure of M2(18-60) showed four rimantadines bound to the carboxy-terminal lipid-facing surface of the helixes, suggesting an allosteric mechanism.  Here we show by solid-state NMR spectroscopy that two amantadine-binding sites exist in M2 in phospholipid bilayers.  The high-affinity site, occupied by a single amantadine, is located in the N-terminal channel lumen, surrounded by residues mutated in amantadine-resistant viruses.  Quantification of the protein-amantadine distances resulted in a 0.3 Å-resoln. structure of the high-affinity binding site.  The second, low-affinity, site was obsd. on the C-terminal protein surface, but only when the drug reaches high concns. in the bilayer.  The orientation and dynamics of the drug are distinct in the two sites, as shown by 2H NMR.  These results indicate that amantadine phys. occludes the M2 channel, thus paving the way for developing new antiviral drugs against influenza viruses.  The study demonstrates the ability of solid-state NMR to elucidate small-mol. interactions with membrane proteins and det. high-resoln. structures of their complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3_-eACNO4ZbVg90H21EOLACvtfcHk0ljk8q-AfGiKgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVygu70%253D&md5=9db7a0cb6fe8eb60124cb620ead6aa45</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnature08722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08722%26sid%3Dliteratum%253Aachs%26aulast%3DCady%26aufirst%3DS.%2BD.%26aulast%3DSchmidt-Rohr%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSoto%26aufirst%3DC.%2BS.%26aulast%3DDegrado%26aufirst%3DW.%2BF.%26aulast%3DHong%26aufirst%3DM.%26atitle%3DStructure%2520of%2520the%2520amantadine%2520binding%2520site%2520of%2520influenza%2520M2%2520proton%2520channels%2520in%2520lipid%2520bilayers%26jtitle%3DNature%26date%3D2010%26volume%3D463%26spage%3D689%26epage%3D692%26doi%3D10.1038%2Fnature08722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kozubík, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horváth, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Švihálková-Šindlerová, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souček, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmanová, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sova, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroutil, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Žák, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistr, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turánek, J.</span></span> <span> </span><span class="NLM_article-title">High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2004.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1016%2Fj.bcp.2004.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=15652229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVSgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2005&pages=373-383&author=A.+Kozub%C3%ADkauthor=V.+Horv%C3%A1thauthor=L.+%C5%A0vih%C3%A1lkov%C3%A1-%C5%A0indlerov%C3%A1author=K.+Sou%C4%8Dekauthor=J.+Hofmanov%C3%A1author=P.+Sovaauthor=A.+Kroutilauthor=F.+%C5%BD%C3%A1kauthor=A.+Mistrauthor=J.+Tur%C3%A1nek&title=High+effectiveness+of+platinum%28IV%29+complex+with+adamantylamine+in+overcoming+resistance+to+cisplatin+and+suppressing+proliferation+of+ovarian+cancer+cells+in+vitro&doi=10.1016%2Fj.bcp.2004.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro</span></div><div class="casAuthors">Kozubik, Alois; Horvath, Viktor; Svihalkova-Sindlerova, Lenka; Soucek, Karel; Hofmanova, Jirina; Sova, Petr; Kroutil, Ales; Zak, Frantisek; Mistr, Adolf; Turanek, Jaroslav</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">373-383</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">[(OC-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV)], coded as LA-12, is an octahedral platinum(IV) complex contg. a bulky hydrophobic ligand - adamantylamine.  The use of bulky hydrophobic amines as non-leaving ligands, may increase uptake of the compd. by the cancer cells.  Therefore, the effects of LA-12 on sensitive (A2780) and cisplatin resistant (A2780cis) ovarian cancer cell lines were investigated and compared to those of cisplatin.  IC50 and IC90 concns. of LA-12 were 6- (A2780) or 18-fold (A2780cis) lower than those for cisplatin (MTT assay).  Equitoxic concns. (IC50 or IC90) of both compds. caused a significant and similar time- and dose-dependent inhibition of cell proliferation and an increase in the no. of floating cells which corresponded to the decrease of total cell viability.  A different type and dynamics of cell cycle perturbation after cisplatin and LA-12 treatment were detected.  Exposure to LA-12 resulted in transient accumulation of A2780 and A2780cis cells in S phase, while cisplatin caused G2/M arrest in sensitive and S phase arrest in resistant cells.  A relatively low rate of apoptosis after exposure to IC50 or IC90 of both complexes was obsd., markedly higher in resistant A2780cis cells.  Western blot anal. indicated a concn.-dependent p53 level increase in both lines (higher after cisplatin treatment).  PARP cleavage was obsd. only in A2780cis cells.  In conclusion, LA-12 was found to be significantly more efficient than cisplatin, and it was able to overcome the acquired cisplatin resistance (showing resistance factor 2.84-fold lower than those for cisplatin).  In spite of the low rate of apoptosis, LA-12 caused increase of p53 level and cell cycle perturbations in the ovarian cancer cell lines studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFHh3HYlDbu7Vg90H21EOLACvtfcHk0lhz8uP_qQWJbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVSgsw%253D%253D&md5=a72e3252412e5973a04c0c58314e37d9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2004.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2004.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DKozub%25C3%25ADk%26aufirst%3DA.%26aulast%3DHorv%25C3%25A1th%26aufirst%3DV.%26aulast%3D%25C5%25A0vih%25C3%25A1lkov%25C3%25A1-%25C5%25A0indlerov%25C3%25A1%26aufirst%3DL.%26aulast%3DSou%25C4%258Dek%26aufirst%3DK.%26aulast%3DHofmanov%25C3%25A1%26aufirst%3DJ.%26aulast%3DSova%26aufirst%3DP.%26aulast%3DKroutil%26aufirst%3DA.%26aulast%3D%25C5%25BD%25C3%25A1k%26aufirst%3DF.%26aulast%3DMistr%26aufirst%3DA.%26aulast%3DTur%25C3%25A1nek%26aufirst%3DJ.%26atitle%3DHigh%2520effectiveness%2520of%2520platinum%2528IV%2529%2520complex%2520with%2520adamantylamine%2520in%2520overcoming%2520resistance%2520to%2520cisplatin%2520and%2520suppressing%2520proliferation%2520of%2520ovarian%2520cancer%2520cells%2520in%2520vitro%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2005%26volume%3D69%26spage%3D373%26epage%3D383%26doi%3D10.1016%2Fj.bcp.2004.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vondálová
Blanářová, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šafaříková, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herůdková, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krkoška, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tománková, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahounová, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andřra, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouchal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharaishvili, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Král, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sova, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozub́k, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyršlová Vaculová, A.</span></span> <span> </span><span class="NLM_article-title">Cisplatin or LA-12 enhance killing effects of TRAIL in prostate cancer cells through Bid-dependent stimulation of mitochondrial apoptotic pathway but not caspase-10</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>, <span class="NLM_elocation-id">e0188584</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0188584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1371%2Fjournal.pone.0188584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=29182622" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&author=O.+Vond%C3%A1lov%C3%A1%0ABlan%C3%A1%C5%99ov%C3%A1author=B.+%C5%A0afa%C5%99%C3%ADkov%C3%A1author=J.+Her%C5%AFdkov%C3%A1author=M.+Krko%C5%A1kaauthor=S.+Tom%C3%A1nkov%C3%A1author=Z.+Kahounov%C3%A1author=L.+And%C5%99raauthor=J.+Bouchalauthor=G.+Kharaishviliauthor=M.+Kr%C3%A1lauthor=P.+Sovaauthor=A.+Kozub%CC%81kauthor=A.+Hyr%C5%A1lov%C3%A1+Vaculov%C3%A1&title=Cisplatin+or+LA-12+enhance+killing+effects+of+TRAIL+in+prostate+cancer+cells+through+Bid-dependent+stimulation+of+mitochondrial+apoptotic+pathway+but+not+caspase-10&doi=10.1371%2Fjournal.pone.0188584"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0188584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0188584%26sid%3Dliteratum%253Aachs%26aulast%3DVond%25C3%25A1lov%25C3%25A1%2BBlan%25C3%25A1%25C5%2599ov%25C3%25A1%26aufirst%3DO.%26aulast%3D%25C5%25A0afa%25C5%2599%25C3%25ADkov%25C3%25A1%26aufirst%3DB.%26aulast%3DHer%25C5%25AFdkov%25C3%25A1%26aufirst%3DJ.%26aulast%3DKrko%25C5%25A1ka%26aufirst%3DM.%26aulast%3DTom%25C3%25A1nkov%25C3%25A1%26aufirst%3DS.%26aulast%3DKahounov%25C3%25A1%26aufirst%3DZ.%26aulast%3DAnd%25C5%2599ra%26aufirst%3DL.%26aulast%3DBouchal%26aufirst%3DJ.%26aulast%3DKharaishvili%26aufirst%3DG.%26aulast%3DKr%25C3%25A1l%26aufirst%3DM.%26aulast%3DSova%26aufirst%3DP.%26aulast%3DKozub%25CC%2581k%26aufirst%3DA.%26aulast%3DHyr%25C5%25A1lov%25C3%25A1%2BVaculov%25C3%25A1%26aufirst%3DA.%26atitle%3DCisplatin%2520or%2520LA-12%2520enhance%2520killing%2520effects%2520of%2520TRAIL%2520in%2520prostate%2520cancer%2520cells%2520through%2520Bid-dependent%2520stimulation%2520of%2520mitochondrial%2520apoptotic%2520pathway%2520but%2520not%2520caspase-10%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26doi%3D10.1371%2Fjournal.pone.0188584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herůdkov́, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paruch, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khirsariya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souček, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krkoška, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanářová, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sova, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozubík, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaculová, A. H.</span></span> <span> </span><span class="NLM_article-title">CHK1 inhibitor SCH900776 effectively potentiates the cytotoxic effects of platinum-based chemotherapeutic drugs in human colon cancer cells</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">830</span>– <span class="NLM_lpage">841</span>, <span class="refDoi"> DOI: 10.1016/j.neo.2017.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1016%2Fj.neo.2017.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=28888100" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=830-841&author=J.+Her%C5%AFdkov%CC%81author=K.+Paruchauthor=P.+Khirsariyaauthor=K.+Sou%C4%8Dekauthor=M.+Krko%C5%A1kaauthor=O.+V.+Blan%C3%A1%C5%99ov%C3%A1author=P.+Sovaauthor=A.+Kozub%C3%ADkauthor=A.+H.+Vaculov%C3%A1&title=CHK1+inhibitor+SCH900776+effectively+potentiates+the+cytotoxic+effects+of+platinum-based+chemotherapeutic+drugs+in+human+colon+cancer+cells&doi=10.1016%2Fj.neo.2017.08.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.neo.2017.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neo.2017.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DHer%25C5%25AFdkov%25CC%2581%26aufirst%3DJ.%26aulast%3DParuch%26aufirst%3DK.%26aulast%3DKhirsariya%26aufirst%3DP.%26aulast%3DSou%25C4%258Dek%26aufirst%3DK.%26aulast%3DKrko%25C5%25A1ka%26aufirst%3DM.%26aulast%3DBlan%25C3%25A1%25C5%2599ov%25C3%25A1%26aufirst%3DO.%2BV.%26aulast%3DSova%26aufirst%3DP.%26aulast%3DKozub%25C3%25ADk%26aufirst%3DA.%26aulast%3DVaculov%25C3%25A1%26aufirst%3DA.%2BH.%26atitle%3DCHK1%2520inhibitor%2520SCH900776%2520effectively%2520potentiates%2520the%2520cytotoxic%2520effects%2520of%2520platinum-based%2520chemotherapeutic%2520drugs%2520in%2520human%2520colon%2520cancer%2520cells%26jtitle%3DNeoplasia%26date%3D2017%26volume%3D19%26spage%3D830%26epage%3D841%26doi%3D10.1016%2Fj.neo.2017.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Procházka, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turánek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesařík, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knotigová, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polášková, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrysík, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozubík, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Žák, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sova, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuzil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machala, M.</span></span> <span> </span><span class="NLM_article-title">Apoptosis and inhibition of gap-junctional intercellular communication induced by LA-12, a novel hydrophobic platinum(IV) complex</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>462</i></span>,  <span class="NLM_fpage">54</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2007.03.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1016%2Fj.abb.2007.03.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=17466256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsF2msbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2007&pages=54-61&author=L.+Proch%C3%A1zkaauthor=J.+Tur%C3%A1nekauthor=R.+Tesa%C5%99%C3%ADkauthor=P.+Knotigov%C3%A1author=P.+Pol%C3%A1%C5%A1kov%C3%A1author=Z.+Andrys%C3%ADkauthor=A.+Kozub%C3%ADkauthor=F.+%C5%BD%C3%A1kauthor=P.+Sovaauthor=J.+Neuzilauthor=M.+Machala&title=Apoptosis+and+inhibition+of+gap-junctional+intercellular+communication+induced+by+LA-12%2C+a+novel+hydrophobic+platinum%28IV%29+complex&doi=10.1016%2Fj.abb.2007.03.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis and inhibition of gap-junctional intercellular communication induced by LA-12, a novel hydrophobic platinum(IV) complex</span></div><div class="casAuthors">Prochazka, Lubomir; Turanek, Jaroslav; Tesarik, Radek; Knotigova, Pavlina; Polaskova, Pavlina; Andrysik, Zdenek; Kozubik, Alois; Zak, Frantisek; Sova, Petr; Neuzil, Jiri; Machala, Miroslav</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-61</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A new hydrophobic platinum(IV) complex, LA-12, a very efficient anticancer drug lacking cross-resistance with cisplatin (CDDP), is now being tested in clin. trials.  Here we investigated the apoptogenic activity of LA-12 and its effect on gap-junctional intercellular communication (GJIC) in the rat liver epithelial cell line WB-F344.  LA-12 induced apoptosis much more efficiently than did CDDP due to a combination of rapid penetration into the cell and attack on DNA, leading to fast activation of p53 and caspase-3.  Exposure of WB-F344 cells to LA-12 led to rapid induction of the time- and dose-dependent decrease in GJIC.  On the mol. level, loss of GJIC induced by LA-12 was mediated by activation of extracellular signal-regulated kinase (ERK)-1 and ERK-2, as demonstrated by the use of inhibitors of ERK activation.  Inhibition of GJIC was linked to rapid hyperphosphorylation of connexin-43 and disappearance of connexon clusters from membranes, which was not obsd. in the case of CDDP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5ne7yLiSpkbVg90H21EOLACvtfcHk0liWDeI8ok1QrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsF2msbY%253D&md5=7970846f6ce5c2a8a781282ede0a92af</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2007.03.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2007.03.021%26sid%3Dliteratum%253Aachs%26aulast%3DProch%25C3%25A1zka%26aufirst%3DL.%26aulast%3DTur%25C3%25A1nek%26aufirst%3DJ.%26aulast%3DTesa%25C5%2599%25C3%25ADk%26aufirst%3DR.%26aulast%3DKnotigov%25C3%25A1%26aufirst%3DP.%26aulast%3DPol%25C3%25A1%25C5%25A1kov%25C3%25A1%26aufirst%3DP.%26aulast%3DAndrys%25C3%25ADk%26aufirst%3DZ.%26aulast%3DKozub%25C3%25ADk%26aufirst%3DA.%26aulast%3D%25C5%25BD%25C3%25A1k%26aufirst%3DF.%26aulast%3DSova%26aufirst%3DP.%26aulast%3DNeuzil%26aufirst%3DJ.%26aulast%3DMachala%26aufirst%3DM.%26atitle%3DApoptosis%2520and%2520inhibition%2520of%2520gap-junctional%2520intercellular%2520communication%2520induced%2520by%2520LA-12%252C%2520a%2520novel%2520hydrophobic%2520platinum%2528IV%2529%2520complex%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2007%26volume%3D462%26spage%3D54%26epage%3D61%26doi%3D10.1016%2Fj.abb.2007.03.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zefirov, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoppe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuznetsova, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chernyshov, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grishin, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloshitskaya, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuznetsov, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zefirova, O. N.</span></span> <span> </span><span class="NLM_article-title">Homologous series of novel adamantane–colchicine conjugates: synthesis and cytotoxic effect on human cancer cells</span>. <i>Mendeleev Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.1016/j.mencom.2018.05.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1016%2Fj.mencom.2018.05.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVCku7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=308-310&author=N.+A.+Zefirovauthor=M.+Hoppeauthor=I.+V.+Kuznetsovaauthor=N.+A.+Chernyshovauthor=Y.+K.+Grishinauthor=O.+A.+Maloshitskayaauthor=S.+A.+Kuznetsovauthor=O.+N.+Zefirova&title=Homologous+series+of+novel+adamantane%E2%80%93colchicine+conjugates%3A+synthesis+and+cytotoxic+effect+on+human+cancer+cells&doi=10.1016%2Fj.mencom.2018.05.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Homologous series of novel adamantane-colchicine conjugates: Synthesis and cytotoxic effect on human cancer cells</span></div><div class="casAuthors">Zefirov, Nikolay A.; Hoppe, Marius; Kuznetsova, Irina V.; Chernyshov, Nikita A.; Grishin, Yuri K.; Maloshitskaya, Olga A.; Kuznetsov, Sergei A.; Zefirova, Olga N.</div><div class="citationInfo"><span class="NLM_cas:title">Mendeleev Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">308-310</span>CODEN:
                <span class="NLM_cas:coden">MENCEX</span>;
        ISSN:<span class="NLM_cas:issn">0959-9436</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Homologues of N-[7-(adamantan-1-yloxy)-7-oxoheptanoyl]-N-deacetylcolchicine with sequential shift of the ester group in the chain connecting colchicine and adamantane moieties were synthesized to find an optimal position of this group.  All homologues possessed very high cytotoxicity to human lung carcinoma cell line A549 demonstrating a weak dependence of toxic activity on the ester group position.  The cytotoxicity (EC50 = 5.9 nm) of the most active compd., I, was close to that of clin. used anti-tubulin anticancer drug taxol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM3WAZoNHwOLVg90H21EOLACvtfcHk0lgYmS0LYEu6Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVCku7bM&md5=b16ac9b8412bd681cbf012b02a7f6b8d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.mencom.2018.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mencom.2018.05.027%26sid%3Dliteratum%253Aachs%26aulast%3DZefirov%26aufirst%3DN.%2BA.%26aulast%3DHoppe%26aufirst%3DM.%26aulast%3DKuznetsova%26aufirst%3DI.%2BV.%26aulast%3DChernyshov%26aufirst%3DN.%2BA.%26aulast%3DGrishin%26aufirst%3DY.%2BK.%26aulast%3DMaloshitskaya%26aufirst%3DO.%2BA.%26aulast%3DKuznetsov%26aufirst%3DS.%2BA.%26aulast%3DZefirova%26aufirst%3DO.%2BN.%26atitle%3DHomologous%2520series%2520of%2520novel%2520adamantane%25E2%2580%2593colchicine%2520conjugates%253A%2520synthesis%2520and%2520cytotoxic%2520effect%2520on%2520human%2520cancer%2520cells%26jtitle%3DMendeleev%2520Commun.%26date%3D2018%26volume%3D28%26spage%3D308%26epage%3D310%26doi%3D10.1016%2Fj.mencom.2018.05.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vasilenko, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dueva, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlovskaya, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zefirov, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grishin, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butov, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palyulin, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuznetsova, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karganova, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zefirova, O. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osolodkin, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Averina, E. B.</span></span> <span> </span><span class="NLM_article-title">Tick-borne flavivirus reproduction inhibitors based on isoxazole core linked with adamantane</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">637</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2019.03.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1016%2Fj.bioorg.2019.03.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=30947098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmsVWktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2019&pages=629-637&author=D.+A.+Vasilenkoauthor=E.+V.+Duevaauthor=L.+I.+Kozlovskayaauthor=N.+A.+Zefirovauthor=Y.+K.+Grishinauthor=G.+M.+Butovauthor=V.+A.+Palyulinauthor=T.+S.+Kuznetsovaauthor=G.+G.+Karganovaauthor=O.+N.+Zefirovaauthor=D.+I.+Osolodkinauthor=E.+B.+Averina&title=Tick-borne+flavivirus+reproduction+inhibitors+based+on+isoxazole+core+linked+with+adamantane&doi=10.1016%2Fj.bioorg.2019.03.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Tick-borne flavivirus reproduction inhibitors based on isoxazole core linked with adamantane</span></div><div class="casAuthors">Vasilenko, Dmitry A.; Dueva, Evgenia V.; Kozlovskaya, Liubov I.; Zefirov, Nikolay A.; Grishin, Yuri K.; Butov, Gennady M.; Palyulin, Vladimir A.; Kuznetsova, Tamara S.; Karganova, Galina G.; Zefirova, Olga N.; Osolodkin, Dmitry I.; Averina, Elena B.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">629-637</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Infections caused by flaviviruses pose a huge threat for public health all over the world.  The search for therapeutically relevant compds. targeting tick-borne flaviviruses requires the exploration of novel chemotypes.  In the present work a large series of novel polyfunctionalized isoxazole derivs. bearing substituents with various steric and electronic effects was obtained by our unique versatile synthetic procedure and their antiviral activity against tick-borne encephalitis, Omsk hemorrhagic fever, and Powassan viruses was studied in vitro.  The majority of studied isoxazoles showed activity in low micromolar range.  No appreciable cytotoxicity was obsd. for tested compds.  The lead compds., 5-aminoisoxazole derivs. contg. adamantyl moiety, exhibited strong antiviral activity and excellent therapeutic index.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7Y0wrHHE5RLVg90H21EOLACvtfcHk0liSoIcwJjPDig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmsVWktLo%253D&md5=264567cd6427bf27dacd6a98ec5ea77e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2019.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2019.03.028%26sid%3Dliteratum%253Aachs%26aulast%3DVasilenko%26aufirst%3DD.%2BA.%26aulast%3DDueva%26aufirst%3DE.%2BV.%26aulast%3DKozlovskaya%26aufirst%3DL.%2BI.%26aulast%3DZefirov%26aufirst%3DN.%2BA.%26aulast%3DGrishin%26aufirst%3DY.%2BK.%26aulast%3DButov%26aufirst%3DG.%2BM.%26aulast%3DPalyulin%26aufirst%3DV.%2BA.%26aulast%3DKuznetsova%26aufirst%3DT.%2BS.%26aulast%3DKarganova%26aufirst%3DG.%2BG.%26aulast%3DZefirova%26aufirst%3DO.%2BN.%26aulast%3DOsolodkin%26aufirst%3DD.%2BI.%26aulast%3DAverina%26aufirst%3DE.%2BB.%26atitle%3DTick-borne%2520flavivirus%2520reproduction%2520inhibitors%2520based%2520on%2520isoxazole%2520core%2520linked%2520with%2520adamantane%26jtitle%3DBioorg.%2520Chem.%26date%3D2019%26volume%3D87%26spage%3D629%26epage%3D637%26doi%3D10.1016%2Fj.bioorg.2019.03.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Svingen, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tefferi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kottke, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sausville, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, S. H.</span></span> <span> </span><span class="NLM_article-title">Effects of the Bcr/Abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">249</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10656455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtVCjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=237-249&author=P.+A.+Svingenauthor=A.+Tefferiauthor=T.+J.+Kottkeauthor=G.+Kaurauthor=V.+L.+Narayananauthor=E.+A.+Sausvilleauthor=S.+H.+Kaufmann&title=Effects+of+the+Bcr%2FAbl+kinase+inhibitors+AG957+and+NSC+680410+on+chronic+myelogenous+leukemia+cells+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the bcr/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro</span></div><div class="casAuthors">Svingen, Phyllis A.; Tefferi, Ayalew; Kottke, Timothy J.; Kaur, Gurmeet; Narayanan, Ven L.; Sausville, Edward A.; Kaufmann, Scott H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">237-249</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The tyrphostin AG957 (NSC 654705) inhibits p210bcr/abl, the transforming kinase responsible for most cases of chronic myelogenous leukemia (CML).  The present studies were performed to det. the fate of AG957-treated cells and assess the selectivity of AG957 for CML myeloid progenitors.  When K562 cells (derived from a patient with blast crisis CML) were treated with AG957, dose-and time-dependent p210bcr/abl down-regulation was followed by mitochondrial release of cytochrome c, activation of caspase-9 and caspase-3, and apoptotic morphol. changes.  These apoptotic changes were inhibited by transfection with cDNA encoding dominant neg. caspase-9 but not dominant-neg. FADD or blocking anti-Fas antibodies.  In addnl. expts., a 24-h AG957 exposure caused dose-dependent inhibition of K562 colony formation in soft agar.  To extend these studies to clin. samples of CML, peripheral blood mononuclear cells from 10 chronic phase CML patients and normal controls were assayed for the growth of hematopoietic colonies in vitro in the presence of increasing concns. of AG957.  These assays demonstrated selectivity of AG957 for CML progenitors, with median IC50s (CML vs. normal) of 7.3 vs. >20 μM AG957 in granulocyte colony-forming cells (P < 0.001), 5.3 vs. >20 μM in granulocyte/macrophage colony-forming cells (P < 0.05), and 15.5 vs. > 20 μM in erythroid colony-forming cells (P > 0.05).  The adamantyl ester of AG957 (NSC 680410) down-regulated p210bcr/abl in K562 cells and inhibited granulocyte colony formation in CML specimens at lower concns. without enhanced toxicity in normal progenitors.  These observations not only demonstrate that AG957-induced p210bcr/abl down-regulation is followed by activation of the cytochrome c/Apaf-1/caspase-9 pathway but also indicate that this class of kinase inhibitor exhibits selectivity worthy of further evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBU5e7XVihMbVg90H21EOLACvtfcHk0ljiDuxDDSginQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtVCjs78%253D&md5=377b9d70f9d6dbf4666b9aaf634b3c71</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSvingen%26aufirst%3DP.%2BA.%26aulast%3DTefferi%26aufirst%3DA.%26aulast%3DKottke%26aufirst%3DT.%2BJ.%26aulast%3DKaur%26aufirst%3DG.%26aulast%3DNarayanan%26aufirst%3DV.%2BL.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DKaufmann%26aufirst%3DS.%2BH.%26atitle%3DEffects%2520of%2520the%2520Bcr%252FAbl%2520kinase%2520inhibitors%2520AG957%2520and%2520NSC%2520680410%2520on%2520chronic%2520myelogenous%2520leukemia%2520cells%2520in%2520vitro%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2000%26volume%3D6%26spage%3D237%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, F.-L.</span></span> <span> </span><span class="NLM_article-title">Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.2174/1389200023337496</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.2174%2F1389200023337496" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=12083319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD38XkslyrsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=233-255&author=C.+Conawayauthor=Y.-M.+Yangauthor=F.-L.+Chung&title=Isothiocyanates+as+cancer+chemopreventive+agents%3A+their+biological+activities+and+metabolism+in+rodents+and+humans&doi=10.2174%2F1389200023337496"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans</span></div><div class="casAuthors">Conaway, C. Clifford; Yang, Yang-Ming; Chung, Fung-Lung</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">233-255</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Isothiocyanates (ITCs) are a group of naturally occurring compds. that occur as thioglucoside conjugates, termed glucosinolates, in plants and cruciferous vegetables such as watercress, Brussels sprouts, broccoli, cabbage, kai choi, kale, horseradish, radish and turnip.  ITCs inhibit the development of tumors in many of the exptl. models investigated, and are being investigated as possible chemopreventive agents for specific human cancers.  The goal of this review is to provide a mechanistic understanding for the biol. activities of ITCs and to relate the metab. of ITCs to their action as chemopreventive agents.  In vivo animal studies have been conducted to address issues of tissue disposition, pharmacokinetics, and metab. of ITCs.  Methods for anal. of ITCs and their metabolites in urine and plasma have been developed.  The metab. of several naturally occurring ITCs as constituents of foodstuffs or as drugs has also been investigated in human studies.  Finally, based on recent epidemiol. studies, the role of dietary consumption of vegetables contg. ITCs in prevention of human cancers and human cancer susceptibility is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpzGn2a4nB0rVg90H21EOLACvtfcHk0ljiDuxDDSginQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkslyrsrY%253D&md5=2fc1107e0b6a547ff6e79bbef6402b39</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F1389200023337496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200023337496%26sid%3Dliteratum%253Aachs%26aulast%3DConaway%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DY.-M.%26aulast%3DChung%26aufirst%3DF.-L.%26atitle%3DIsothiocyanates%2520as%2520cancer%2520chemopreventive%2520agents%253A%2520their%2520biological%2520activities%2520and%2520metabolism%2520in%2520rodents%2520and%2520humans%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2002%26volume%3D3%26spage%3D233%26epage%3D255%26doi%3D10.2174%2F1389200023337496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahey, J. W.</span></span> <span> </span><span class="NLM_article-title">Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism</span>. <i>J. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">3027S</span>– <span class="NLM_lpage">3033S</span>, <span class="refDoi"> DOI: 10.1093/jn/131.11.3027S</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1093%2Fjn%2F131.11.3027S" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=11694642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosVGit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2001&pages=3027S-3033S&author=P.+Talalayauthor=J.+W.+Fahey&title=Phytochemicals+from+cruciferous+plants+protect+against+cancer+by+modulating+carcinogen+metabolism&doi=10.1093%2Fjn%2F131.11.3027S"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism</span></div><div class="casAuthors">Talalay, Paul; Fahey, Jed W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nutrition</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">11S</span>),
    <span class="NLM_cas:pages">3027S-3033S</span>CODEN:
                <span class="NLM_cas:coden">JONUAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-3166</span>.
    
            (<span class="NLM_cas:orgname">American Society for Nutritional Sciences</span>)
        </div><div class="casAbstract">A review on the role of cruciferous vegetables in the protective effects of vegetables against the risk of cancer and on the role of phase 2 enzymes in detg. susceptibility to carcinogens and in redn. of this susceptibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBLSyOd4Dqy7Vg90H21EOLACvtfcHk0lghJqrPjQRmqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosVGit7g%253D&md5=2857f6075d29b5951964b389fdc5138c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fjn%2F131.11.3027S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjn%252F131.11.3027S%26sid%3Dliteratum%253Aachs%26aulast%3DTalalay%26aufirst%3DP.%26aulast%3DFahey%26aufirst%3DJ.%2BW.%26atitle%3DPhytochemicals%2520from%2520cruciferous%2520plants%2520protect%2520against%2520cancer%2520by%2520modulating%2520carcinogen%2520metabolism%26jtitle%3DJ.%2520Nutr.%26date%3D2001%26volume%3D131%26spage%3D3027S%26epage%3D3033S%26doi%3D10.1093%2Fjn%2F131.11.3027S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">WHOIARC</span> <i>handbook on cancer prevention. Cruciferous
vegetables, isothiocyanates
and indoles</i>, vol.  <span class="NLM_volume">9</span>. <span class="NLM_publisher-loc">Lyon</span>: <span class="NLM_publisher-name">IARC Press</span>, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=WHOIARC&title=handbook+on+cancer+prevention.+Cruciferous%0Avegetables%2C+isothiocyanates%0Aand+indoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3Dhandbook%2520on%2520cancer%2520prevention.%2520Cruciferous%250Avegetables%252C%2520isothiocyanates%250Aand%2520indoles%26volume%3D9%26pub%3DIARC%2520Press%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecht, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Z.</span></span> <span> </span><span class="NLM_article-title">Essential role of p53 in phenethyl isothiocyanate-induced apoptosis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4102</span>– <span class="NLM_lpage">4106</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=9751619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADyaK1cXmtlCks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=4102-4106&author=C.+Huangauthor=W.-Y.+Maauthor=J.+Liauthor=S.+S.+Hechtauthor=Z.+Dong&title=Essential+role+of+p53+in+phenethyl+isothiocyanate-induced+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Essential role of p53 in phenethyl isothiocyanate-induced apoptosis</span></div><div class="casAuthors">Huang, Chuanshu; Ma, Wei-Ya; Li, Jingxia; Hecht, Stephen S.; Dong, Zigang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4102-4106</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Phenethyl isothiocyanate (PEITC) is a natural product that is among the most effective cancer chemopreventive agents known.  Mechanistic studies indicate that the chemopreventive activity of PEITC is assocd. with its favorable modification of carcinogen metab. and its induction of apoptosis.  Here, the authors found that PEITC blocks tumor promoter (12-O-tetradecanoylphorbol-13-acetate or epidermal growth factor)-induced cell transformation in mouse epidermal JB6 cells, and this inhibitory activity on cell transformation is correlated with induction of apoptosis.  Most importantly, apoptosis induction by PEITC occurs through a p53-dependent pathway.  This was demonstrated not only by results that PEITC induction of p53 protein expression and p53-dependent transactivation but also by PEITC-induced apoptosis in p53 +/+ cells but not in p53 -/- cells.  In contrast, PEITC induced apoptosis in cells with both normal or deficient sphingomyelinase activity.  The results demonstrate for the first time that p53 elevation is required for PEITC-induced apoptosis, which may be involved in its cancer chemopreventive activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprtsEny5gd8LVg90H21EOLACvtfcHk0lghJqrPjQRmqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtlCks7w%253D&md5=69a814f87715b54f9c66e739be57ccf3</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DW.-Y.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHecht%26aufirst%3DS.%2BS.%26aulast%3DDong%26aufirst%3DZ.%26atitle%3DEssential%2520role%2520of%2520p53%2520in%2520phenethyl%2520isothiocyanate-induced%2520apoptosis%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D4102%26epage%3D4106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egner, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agyeman, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visvanathan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groopman, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahey, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span> <span> </span><span class="NLM_article-title">Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane</span>. <i>Top. Curr. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>329</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1007/128_2012_339</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1007%2F128_2012_339" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2012&pages=163-177&author=T.+W.+Kenslerauthor=P.+A.+Egnerauthor=A.+S.+Agyemanauthor=K.+Visvanathanauthor=J.+D.+Groopmanauthor=J.+G.+Chenauthor=T.+Y.+Chenauthor=J.+W.+Faheyauthor=P.+Talalay&title=Keap1-nrf2+signaling%3A+a+target+for+cancer+prevention+by+sulforaphane&doi=10.1007%2F128_2012_339"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2F128_2012_339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F128_2012_339%26sid%3Dliteratum%253Aachs%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DEgner%26aufirst%3DP.%2BA.%26aulast%3DAgyeman%26aufirst%3DA.%2BS.%26aulast%3DVisvanathan%26aufirst%3DK.%26aulast%3DGroopman%26aufirst%3DJ.%2BD.%26aulast%3DChen%26aufirst%3DJ.%2BG.%26aulast%3DChen%26aufirst%3DT.%2BY.%26aulast%3DFahey%26aufirst%3DJ.%2BW.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DKeap1-nrf2%2520signaling%253A%2520a%2520target%2520for%2520cancer%2520prevention%2520by%2520sulforaphane%26jtitle%3DTop.%2520Curr.%2520Chem.%26date%3D2012%26volume%3D329%26spage%3D163%26epage%3D177%26doi%3D10.1007%2F128_2012_339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A.-N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owuor, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebbar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandlekar, S.</span></span> <span> </span><span class="NLM_article-title">Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE)</span>. <i>Drug Metab. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">271</span>, <span class="refDoi"> DOI: 10.1081/DMR-120000652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1081%2FDMR-120000652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=11768769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvVGrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2001&pages=255-271&author=A.-N.+T.+Kongauthor=E.+Owuorauthor=R.+Yuauthor=V.+Hebbarauthor=C.+Chenauthor=R.+Huauthor=S.+Mandlekar&title=Induction+of+xenobiotic+enzymes+by+the+MAP+kinase+pathway+and+the+antioxidant+or+electrophile+response+element+%28ARE%2FEpRE%29&doi=10.1081%2FDMR-120000652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE)</span></div><div class="casAuthors">Kong, A.-N. Tony; Owuor, Edward; Yu, Rong; Hebbar, Vidya; Chen, Chi; Hu, Rong; Mandlekar, Sandhya</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3 & 4</span>),
    <span class="NLM_cas:pages">255-271</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review.  Cellular responses to xenobiotic-induced stress can signal proliferation, differentiation, homeostasis, apoptosis, or necrosis.  To better understand the underlying mol. mechanisms after exposure to xenobiotics or drugs, the authors studied the signal transduction pathways, the mitogen-activated protein kinase (MAPK), and the basic Leu zipper transcription factor Nrf2, activated by different agents in the induction of Phase II drug metabolizing enzymes (DMEs).  The MAPKs, characterized as Pro-directed Ser/Thr kinases, are essential components of signaling pathways that convert various extracellular signals into intracellular responses through serial phosphorylation cascades.  Once activated, MAPKs can phosphorylate many transcription factors, such as c-Jun, ATF-2, and ultimately lead to changes in gene expression.  Two classes of Phase II gene inducers, which are also cancer chemopreventive agents, were studied: (1) the phenolic antioxidants, namely butylated hydroxyanisole (BHA) and its active de-methylated metabolite t-butylhydroquinone (tBHQ), and phenolic flavonoids such as green tea polyphenols (GTP) and (-)-epigallocatechin-3-gallate (EGCG); and (2) the naturally occurring isothiocyanates, namely phenethyl isothiocyanate (PEITC), and sulforaphane.  BHA and tBHQ are both well-known phenolic antioxidants used as food preservatives, and strongly activate c-Jun N-terminal kinase 1 (JNK1), extracellular signal-regulated protein kinase 2 (ERK2), or p38, in a time- and dose-dependent fashion.  Free radical scavengers N-acetyl-L-cysteine (NAC), or glutathione (GSH), inhibited ERK2 activation and, to a much lesser extent, JNK1 activation by BHA/tBHQ, implicating the role of oxidative stress.  Under conditions where MAPKs were activated, BHA or GTP also activated ARE/EpRE (antioxidant/electrophile response element), with the induction of Phase II genes such as NQO.  Transfection studies with various cDNAs encoding wild-type or dominant-neg. mutants of MAPKs and/or transcription factor Nrf2, substantially modulated ARE-mediated luciferase reporter activity in the presence or absence of phenolic compds.  Other phyto-chems. including PEITC, and sulforaphane, also differentially regulated the activities of MAPKs, Nrf2, and ARE-mediated luciferase reporter gene activity and Phase II enzyme induction.  A model is proposed where these xenobiotics (BHA, tBHQ, GTP, EGCG, PEITC, sulforaphane) activate the MAPK pathway via an electrophilic-mediated stress response, leading to the transcription activation of Nrf2/Maf heterodimers on ARE/EpRE enhancers, with the subsequent induction of cellular defense/detoxifying genes including Phase II DMEs, which may protect the cells against toxic environmental insults and thereby enhance cell survival.  The studies of these signaling pathways may yield insights into the fate of cells upon exposure to xenobiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1E2JZvCBt_LVg90H21EOLACvtfcHk0lg3f-K2RbHGtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvVGrug%253D%253D&md5=286ab0d39c981d58df9922b6ac205b69</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1081%2FDMR-120000652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FDMR-120000652%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DA.-N.%2BT.%26aulast%3DOwuor%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DR.%26aulast%3DHebbar%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DR.%26aulast%3DMandlekar%26aufirst%3DS.%26atitle%3DInduction%2520of%2520xenobiotic%2520enzymes%2520by%2520the%2520MAP%2520kinase%2520pathway%2520and%2520the%2520antioxidant%2520or%2520electrophile%2520response%2520element%2520%2528ARE%252FEpRE%2529%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2001%26volume%3D33%26spage%3D255%26epage%3D271%26doi%3D10.1081%2FDMR-120000652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lew, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marynowski, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhir, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. V.</span></span> <span> </span><span class="NLM_article-title">Phenethyl isothiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2223</span>– <span class="NLM_lpage">2234</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgl087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1093%2Fcarcin%2Fbgl087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=16774948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKltrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=2223-2234&author=D.+Xiaoauthor=K.+L.+Lewauthor=Y.+Zengauthor=H.+Xiaoauthor=S.+W.+Marynowskiauthor=R.+Dhirauthor=S.+V.+Singh&title=Phenethyl+isothiocyanate-induced+apoptosis+in+PC-3+human+prostate+cancer+cells+is+mediated+by+reactive+oxygen+species-dependent+disruption+of+the+mitochondrial+membrane+potential&doi=10.1093%2Fcarcin%2Fbgl087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Phenethyl isothiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential</span></div><div class="casAuthors">Xiao, Dong; Lew, Karen L.; Zeng, Yan; Xiao, Hui; Marynowski, Stanley W.; Dhir, Rajiv; Singh, Shivendra V.</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2223-2234</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The present study was undertaken to gain insights into the mol. mechanism of apoptosis induction by phenethyl isothiocyanate (PEITC), which is a cancer chemopreventive constituent of cruciferous vegetables, using PC-3 human prostate cancer cells as a model.  The PEITC-induced cell death in PC-3 cells was assocd. with disruption of the mitochondrial membrane potential, release of apoptogenic mols. (cytochrome c and Smac/DIABLO) from mitochondria to the cytosol and generation of reactive oxygen species (ROS), which were blocked in the presence of a combined mimetic of superoxide dismutase and catalase (Euk134).  Ectopic expression of Bcl-xL, whose protein level is reduced markedly on treatment of PC-3 cells with PEITC, conferred partial protection against PEITC-induced apoptosis only at higher drug concns. (>10 μM).  Administration of 12 μmol PEITC/day (Monday through Friday) by oral gavage significantly retarded growth of PC-3 xenografts in athymic mice.  For instance, 31 days after the initiation of PEITC administration, the av. tumor vol. in control mice (721 ± 153 mm3) was ∼2-fold higher compared with mice receiving 12 μmol PEITC/day.  The PEITC-mediated inhibition of PC-3 xenograft growth was assocd. with induction of Bax and Bid proteins.  In conclusion, the present study indicates that the PEITC-induced apoptosis in PC-3 cells is mediated by ROS-dependent disruption of the mitochondrial membrane potential and regulated by Bax and Bid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8l37CPKtL67Vg90H21EOLACvtfcHk0lisBkVbe1KJsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKltrvF&md5=f07fbc7212da95ec54960c6c558aa979</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgl087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgl087%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DD.%26aulast%3DLew%26aufirst%3DK.%2BL.%26aulast%3DZeng%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DH.%26aulast%3DMarynowski%26aufirst%3DS.%2BW.%26aulast%3DDhir%26aufirst%3DR.%26aulast%3DSingh%26aufirst%3DS.%2BV.%26atitle%3DPhenethyl%2520isothiocyanate-induced%2520apoptosis%2520in%2520PC-3%2520human%2520prostate%2520cancer%2520cells%2520is%2520mediated%2520by%2520reactive%2520oxygen%2520species-dependent%2520disruption%2520of%2520the%2520mitochondrial%2520membrane%2520potential%26jtitle%3DCarcinogenesis%26date%3D2006%26volume%3D27%26spage%3D2223%26epage%3D2234%26doi%3D10.1093%2Fcarcin%2Fbgl087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trachootham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelicano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiao, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Achanta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arlinghaus, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span> <span> </span><span class="NLM_article-title">Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">241</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2006.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1016%2Fj.ccr.2006.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=16959615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVSlu73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=241-252&author=D.+Trachoothamauthor=Y.+Zhouauthor=H.+Zhangauthor=Y.+Demizuauthor=Z.+Chenauthor=H.+Pelicanoauthor=P.+J.+Chiaoauthor=G.+Achantaauthor=R.+B.+Arlinghausauthor=J.+Liuauthor=P.+Huang&title=Selective+killing+of+oncogenically+transformed+cells+through+a+ROS-mediated+mechanism+by+beta-phenylethyl+isothiocyanate&doi=10.1016%2Fj.ccr.2006.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate</span></div><div class="casAuthors">Trachootham, Dunyaporn; Zhou, Yan; Zhang, Hui; Demizu, Yusuke; Chen, Zhao; Pelicano, Helene; Chiao, Paul J.; Achanta, Geetha; Arlinghaus, Ralph B.; Liu, Jinsong; Huang, Peng</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">241-252</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) stimulate cell proliferation and induce genetic instability, and their increase in cancer cells is often viewed as an adverse event.  Here, we show that such abnormal increases in ROS can be exploited to selectively kill cancer cells using β-phenylethyl isothiocyanate (PEITC).  Oncogenic transformation of ovarian epithelial cells with H-RasV12 or expression of Bcr-Abl in hematopoietic cells causes elevated ROS generation and renders the malignant cells highly sensitive to PEITC, which effectively disables the glutathione antioxidant system and causes severe ROS accumulation preferentially in the transformed cells due to their active ROS output.  Excessive ROS causes oxidative mitochondrial damage, inactivation of redox-sensitive mols., and massive cell death.  In vivo, PEITC exhibits therapeutic activity and prolongs animal survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobBpNa5uKXTrVg90H21EOLACvtfcHk0liCg8pS9h2xvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVSlu73L&md5=ad819c3ac413b9b8c121a966172bb847</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DTrachootham%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DDemizu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPelicano%26aufirst%3DH.%26aulast%3DChiao%26aufirst%3DP.%2BJ.%26aulast%3DAchanta%26aufirst%3DG.%26aulast%3DArlinghaus%26aufirst%3DR.%2BB.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DP.%26atitle%3DSelective%2520killing%2520of%2520oncogenically%2520transformed%2520cells%2520through%2520a%2520ROS-mediated%2520mechanism%2520by%2520beta-phenylethyl%2520isothiocyanate%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D10%26spage%3D241%26epage%3D252%26doi%3D10.1016%2Fj.ccr.2006.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pasqua, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govind, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCracken, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodrick, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fine, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, F.-L.</span></span> <span> </span><span class="NLM_article-title">Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">816</span>, <span class="refDoi"> DOI: 10.1021/jm101199t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101199t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFOhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=809-816&author=X.+Wangauthor=A.+J.+Di+Pasquaauthor=S.+Govindauthor=E.+McCrackenauthor=C.+Hongauthor=L.+Miauthor=Y.+Maoauthor=J.+Y.+C.+Wuauthor=Y.+Tomitaauthor=J.+C.+Woodrickauthor=R.+L.+Fineauthor=F.-L.+Chung&title=Selective+depletion+of+mutant+p53+by+cancer+chemopreventive+isothiocyanates+and+their+structure-activity+relationships&doi=10.1021%2Fjm101199t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Depletion of Mutant p53 by Cancer Chemopreventive Isothiocyanates and Their Structure-Activity Relationships</span></div><div class="casAuthors">Wang, Xiantao; Di Pasqua, Anthony J.; Govind, Sudha; McCracken, Erin; Hong, Charles; Mi, Lixin; Mao, Yuehua; Wu, Jessie Yu-Chieh; Tomita, York; Woodrick, Jordan C.; Fine, Robert L.; Chung, Fung-Lung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">809-816</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Isothiocyanates (ITCs) derived from cruciferous vegetables induce apoptosis in cancer cells.  We demonstrate that certain naturally occurring ITCs selectively deplete mutant p53 but not the wild-type and do so via a transcription-independent mechanism.  Direct p53 binding followed by conformational changes appears to be a mechanism by which mutant p53 is depleted.  Structure-activity relationship studies (SARs) using naturally occurring and synthetic ITCs show that depletion is influenced by the ITC side-chain moiety.  Furthermore, we show that cells with p53 mutations are more sensitive to cytotoxicity induced by phenethyl isothiocyanate (PEITC) than those with the wild-type protein. 2,2-Diphenylethyl ITC, a synthetic ITC, is one of the most potent depletors of mutant p53 studies and induces apoptosis to the greatest extent in mutant p53 breast cancer cells.  Collectively, this study shows that mutant p53 depletion may be an important novel target for cancer chemoprevention and therapy by natural and synthetic ITCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ3clkiGruC7Vg90H21EOLACvtfcHk0lhs1GuaziyErA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFOhtw%253D%253D&md5=9ac787929f66c785e4868a47cf1e448a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm101199t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101199t%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DDi%2BPasqua%26aufirst%3DA.%2BJ.%26aulast%3DGovind%26aufirst%3DS.%26aulast%3DMcCracken%26aufirst%3DE.%26aulast%3DHong%26aufirst%3DC.%26aulast%3DMi%26aufirst%3DL.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DJ.%2BY.%2BC.%26aulast%3DTomita%26aufirst%3DY.%26aulast%3DWoodrick%26aufirst%3DJ.%2BC.%26aulast%3DFine%26aufirst%3DR.%2BL.%26aulast%3DChung%26aufirst%3DF.-L.%26atitle%3DSelective%2520depletion%2520of%2520mutant%2520p53%2520by%2520cancer%2520chemopreventive%2520isothiocyanates%2520and%2520their%2520structure-activity%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D809%26epage%3D816%26doi%3D10.1021%2Fjm101199t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinclair, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruz, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallakury, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agostino, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blandino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avantaggiati, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, F.-L.</span></span> <span> </span><span class="NLM_article-title">Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1615</span>– <span class="NLM_lpage">1627</span>, <span class="refDoi"> DOI: 10.1038/cdd.2016.48</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1038%2Fcdd.2016.48" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=27258787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsF2ktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=1615-1627&author=M.+Aggarwalauthor=R.+Saxenaauthor=E.+Sinclairauthor=Y.+Fuauthor=A.+Jacobsauthor=M.+Dybaauthor=X.+Wangauthor=I.+Cruzauthor=D.+Berryauthor=B.+Kallakuryauthor=S.+C.+Muellerauthor=S.+D.+Agostinoauthor=G.+Blandinoauthor=M.+L.+Avantaggiatiauthor=F.-L.+Chung&title=Reactivation+of+mutant+p53+by+a+dietary-related+compound+phenethyl+isothiocyanate+inhibits+tumor+growth&doi=10.1038%2Fcdd.2016.48"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth</span></div><div class="casAuthors">Aggarwal, M.; Saxena, R.; Sinclair, E.; Fu, Y.; Jacobs, A.; Dyba, M.; Wang, X.; Cruz, I.; Berry, D.; Kallakury, B.; Mueller, S. C.; Agostino, S. D.; Blandino, G.; Avantaggiati, M. L.; Chung, F-L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1615-1627</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in the p53 tumor-suppressor gene are prevalent in human cancers.  The majority of p53 mutations are missense, which can be classified into contact mutations (that directly disrupts the DNA-binding activity of p53) and structural mutations (that disrupts the conformation of p53).  Both of the mutations can disable the normal wild-type (WT) p53 activities.  Nevertheless, it has been amply documented that small mols. can rescue activity from mutant p53 by restoring WT tumor-suppressive functions.  These compds. hold promise for cancer therapy and have now entered clin. trials.  In this study, we show that cruciferous-vegetable-derived phenethyl isothiocyanate (PEITC) can reactivate p53 mutant under in vitro and in vivo conditions, revealing a new mechanism of action for a dietary-related compd.  PEITC exhibits growth-inhibitory activity in cells expressing p53 mutants with preferential activity toward p53R175, one of the most frequent 'hotspot' mutations within the p53 sequence.  Mechanistic studies revealed that PEITC induces apoptosis in a p53R175 mutant-dependent manner by restoring p53 WT conformation and transactivation functions.  Accordingly, in PEITC-treated cells the reactivated p53R175 mutant induces apoptosis by activating canonical WT p53 targets, inducing a delay in S and G2/M phase, and by phosphorylating ATM/CHK2.  Interestingly, the growth-inhibitory effects of PEITC depend on the redox state of the cell.  Further, PEITC treatments render the p53R175 mutant sensitive to degrdn. by the proteasome and autophagy in a concn.-dependent manner.  PEITC-induced reactivation of p53R175 and its subsequent sensitivity to the degrdn. pathways likely contribute to its anticancer activities.  We further show that dietary supplementation of PEITC is able to reactivate WT activity in vivo as well, inhibiting tumor growth in xenograft mouse model.  These findings provide the first example of mutant p53 reactivation by a dietary compd. and have important implications for cancer prevention and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE57uMyty4PbVg90H21EOLACvtfcHk0lgKalNIY1--Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsF2ktbc%253D&md5=7145bbe706d3d73def415ebc31bc9dc9</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2016.48&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2016.48%26sid%3Dliteratum%253Aachs%26aulast%3DAggarwal%26aufirst%3DM.%26aulast%3DSaxena%26aufirst%3DR.%26aulast%3DSinclair%26aufirst%3DE.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DJacobs%26aufirst%3DA.%26aulast%3DDyba%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DCruz%26aufirst%3DI.%26aulast%3DBerry%26aufirst%3DD.%26aulast%3DKallakury%26aufirst%3DB.%26aulast%3DMueller%26aufirst%3DS.%2BC.%26aulast%3DAgostino%26aufirst%3DS.%2BD.%26aulast%3DBlandino%26aufirst%3DG.%26aulast%3DAvantaggiati%26aufirst%3DM.%2BL.%26aulast%3DChung%26aufirst%3DF.-L.%26atitle%3DReactivation%2520of%2520mutant%2520p53%2520by%2520a%2520dietary-related%2520compound%2520phenethyl%2520isothiocyanate%2520inhibits%2520tumor%2520growth%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2016%26volume%3D23%26spage%3D1615%26epage%3D1627%26doi%3D10.1038%2Fcdd.2016.48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asif, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinclair, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruz, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallakury, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, F.-L.</span></span> <span> </span><span class="NLM_article-title">p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1186/s13046-019-1267-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1186%2Fs13046-019-1267-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=31307507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A280%3ADC%252BB3MznsFCruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2019&pages=307-323&author=M.+Aggarwalauthor=R.+Saxenaauthor=N.+Asifauthor=E.+Sinclairauthor=J.+Tanauthor=I.+Cruzauthor=D.+Berryauthor=B.+Kallakuryauthor=Q.+Phamauthor=T.+T.+Y.+Wangauthor=F.-L.+Chung&title=p53+mutant-type+in+human+prostate+cancer+cells+determines+the+sensitivity+to+phenethyl+isothiocyanate+induced+growth+inhibition&doi=10.1186%2Fs13046-019-1267-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition</span></div><div class="casAuthors">Aggarwal Monika; Asif Nasir; Sinclair Elizabeth; Cruz Idalia; Berry Deborah; Kallakury Bhaskar; Chung Fung-Lung; Saxena Rahul; Tan Judy; Chung Fung-Lung; Pham Quynhchi; Wang Thomas T Y</div><div class="citationInfo"><span class="NLM_cas:title">Journal of experimental & clinical cancer research : CR</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">307</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  We reported previously that phenethyl isothiocyanate (PEITC), a dietary compound, can reactivate p53(R175H) mutant in vitro and in SK-BR-3 (p53(R175H)) breast xenograft model resulting in tumor inhibition.  Because of the diversity of human cancers with p53 mutations, these findings raise important questions whether this mechanism operates in different cancer types with same or different p53 mutations.  In this study, we investigated whether PEITC recuses mutant p53 in prostate cancer cells harboring different types of p53 mutants, structural and contact, in vitro and in vivo.  METHODS:  Cell proliferation, cell apoptosis and cell cycle arrest assays were performed to examine the effects of PEITC on prostate cancer cell lines with p53 mutation(s), wild-type p53, p53 null or normal prostate cells in vitro.  Western blot analysis was used to monitor the expression levels of p53 protein, activation of ATM and upregulation of canonical p53 targets.  Immunoprecipitation, subcellular protein fraction and qRT-PCR was performed to determine change in conformation and restoration of transactivation functions/ inhibition of gain-of-function (GOF) activities to p53 mutant(s).  Mice xenograft models were established to evaluate the antitumor efficacy of PEITC and PEITC-induced reactivation of p53 mutant(s) in vivo.  Immunohistochemistry of xenograft tumor tissues was performed to determine effects of PEITC on expression of Ki67 and mutant p53 in vivo.  RESULTS:  We demonstrated that PEITC inhibits the growth of prostate cancer cells with different "hotspot" p53 mutations (structural and contact), however, preferentially towards structural mutants.  PEITC inhibits proliferation and induces apoptosis by rescuing mutant p53 in p53(R248W) contact (VCaP) and p53(R175H) structural (LAPC-4) mutant cells with differential potency.  We further showed that PEITC inhibits the growth of DU145 cells that co-express p53(P223L) (structural) and p53(V274F) (contact) mutants by targeting p53(P223L) mutant selectively, but not p53(V274F).  The mutant p53 restored by PEITC induces apoptosis in DU145 cells by activating canonical p53 targets, delaying cells in G1 phase and phosphorylating ATM.  Importantly, PEITC reactivated p53(R175H) and p53(P223L/V274F) mutants in LAPC-4 and DU145 prostate xenograft models, respectively, resulting in significant tumor inhibition.  CONCLUSION:  Our studies provide the first evidence that PEITC's anti-cancer activity is cancer cell type-independent, but p53 mutant-type dependent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSGSMQLZZqLiIIRAdBLKY41fW6udTcc2eYP0ItVjzaSZbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MznsFCruw%253D%253D&md5=210330f314ce7c6dde69001c129bfb04</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1186%2Fs13046-019-1267-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-019-1267-z%26sid%3Dliteratum%253Aachs%26aulast%3DAggarwal%26aufirst%3DM.%26aulast%3DSaxena%26aufirst%3DR.%26aulast%3DAsif%26aufirst%3DN.%26aulast%3DSinclair%26aufirst%3DE.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DCruz%26aufirst%3DI.%26aulast%3DBerry%26aufirst%3DD.%26aulast%3DKallakury%26aufirst%3DB.%26aulast%3DPham%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DT.%2BT.%2BY.%26aulast%3DChung%26aufirst%3DF.-L.%26atitle%3Dp53%2520mutant-type%2520in%2520human%2520prostate%2520cancer%2520cells%2520determines%2520the%2520sensitivity%2520to%2520phenethyl%2520isothiocyanate%2520induced%2520growth%2520inhibition%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2019%26volume%3D38%26spage%3D307%26epage%3D323%26doi%3D10.1186%2Fs13046-019-1267-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walerych, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Napoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collavin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Sal, G.</span></span> <span> </span><span class="NLM_article-title">The rebel angel: mutant p53 as the driving oncogene in breast cancer</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">2007</span>– <span class="NLM_lpage">2017</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgs232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1093%2Fcarcin%2Fbgs232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=22822097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1WqsLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=2007-2017&author=D.+Walerychauthor=M.+Napoliauthor=L.+Collavinauthor=G.+Del+Sal&title=The+rebel+angel%3A+mutant+p53+as+the+driving+oncogene+in+breast+cancer&doi=10.1093%2Fcarcin%2Fbgs232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The rebel angel: mutant p53 as the driving oncogene in breast cancer</span></div><div class="casAuthors">Walerych, Dawid; Napoli, Marco; Collavin, Licio; Del Sal, Giannino</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2007-2017</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Breast cancer is the most frequent invasive tumor diagnosed in women, causing over 400 000 deaths yearly worldwide.  Like other tumors, it is a disease with a complex, heterogeneous genetic and biochem. background.  No single genomic or metabolic condition can be regarded as decisive for its formation and progression.  However, a few key players can be pointed out and among them is the TP53 tumor suppressor gene, commonly mutated in breast cancer.  In particular, TP53 mutations are exceptionally frequent and apparently among the key driving factors in triple neg. breast cancer -the most aggressive breast cancer subgroup-whose management still represents a clin. challenge.  The majority of TP53 mutations result in the substitution of single aminoacids in the central region of the p53 protein, generating a spectrum of variants ('mutant p53s', for short).  These mutants lose the normal p53 oncosuppressive functions to various extents but can also acquire oncogenic properties by gain-of-function mechanisms.  This review discusses the mol. processes translating gene mutations to the pathol. consequences of mutant p53 tumorigenic activity, reconciling cell and animal models with clin. outcomes in breast cancer.  Existing and speculative therapeutic methods targeting mutant p53 are also discussed, taking into account the overlap of mutant and wild-type p53 regulatory mechanisms and the crosstalk between mutant p53 and other oncogenic pathways in breast cancer.  The studies described here concern breast cancer models and patients-unless it is indicated otherwise and justified by the importance of data obtained in other models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG-g77bT9kA7Vg90H21EOLACvtfcHk0lg-SOPmxgbx_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1WqsLfE&md5=e5a7d27e2aeaeb4ea58b7c5e68e80fd2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgs232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgs232%26sid%3Dliteratum%253Aachs%26aulast%3DWalerych%26aufirst%3DD.%26aulast%3DNapoli%26aufirst%3DM.%26aulast%3DCollavin%26aufirst%3DL.%26aulast%3DDel%2BSal%26aufirst%3DG.%26atitle%3DThe%2520rebel%2520angel%253A%2520mutant%2520p53%2520as%2520the%2520driving%2520oncogene%2520in%2520breast%2520cancer%26jtitle%3DCarcinogenesis%26date%3D2012%26volume%3D33%26spage%3D2007%26epage%3D2017%26doi%3D10.1093%2Fcarcin%2Fbgs232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blandino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Agostino, S.</span></span> <span> </span><span class="NLM_article-title">New therapeutic strategies to treat human cancers expressing mutant p53 proteins</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1186/s13046-018-0705-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1186%2Fs13046-018-0705-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=29448954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFOqur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&pages=30-42&author=G.+Blandinoauthor=S.+Di+Agostino&title=New+therapeutic+strategies+to+treat+human+cancers+expressing+mutant+p53+proteins&doi=10.1186%2Fs13046-018-0705-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">New therapeutic strategies to treat human cancers expressing mutant p53 proteins</span></div><div class="casAuthors">Blandino, Giovanni; Di Agostino, Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">30/1-30/13</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">The tumor suppressor p53 plays a crit. role to preserve DNA fidelity from diverse insults through the regulation of cell-cycle checkpoints, DNA repair, senescence and apoptosis.  The TP53 is the most frequently inactivated gene in human cancers.  This leads to the prodn. of mutant p53 proteins that loose wild-type p53 tumor suppression functions and concomitantly acquire new oncogenic properties among which deregulated cell proliferation, increased chemoresistance, disruption of tissue architecture, promotion of migration, invasion and metastasis and several other pro-oncogenic activities.  Mouse models show that the genetic reconstitution of the wild type p53 tumor suppression functions rescues tumor growth.  This strongly supports the notion that either restoring wt-p53 activity or inhibiting mutant p53 oncogenic activity could provide an efficient strategy to treat human cancers.  In this review we briefly summarize recent advances in the study of small mols. and compds. that subvert oncogenic activities of mutant p53 protein into wt-p53 tumor suppressor functions.  We highlight inhibitors of signaling pathways aberrantly modulated by oncogenic mutant p53 proteins as promising therapeutic strategies.  Finally, we consider the clin. applications of compds. targeting mutant p53 and the use of currently available drugs in the treatment of tumors expressing mutant p53 proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz6Z-uSiorsbVg90H21EOLACvtfcHk0lg-SOPmxgbx_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFOqur%252FL&md5=fcd91dd6662faba2aa60c7c104f20001</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1186%2Fs13046-018-0705-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-018-0705-7%26sid%3Dliteratum%253Aachs%26aulast%3DBlandino%26aufirst%3DG.%26aulast%3DDi%2BAgostino%26aufirst%3DS.%26atitle%3DNew%2520therapeutic%2520strategies%2520to%2520treat%2520human%2520cancers%2520expressing%2520mutant%2520p53%2520proteins%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2018%26volume%3D37%26spage%3D30%26epage%3D42%26doi%3D10.1186%2Fs13046-018-0705-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shah, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oloumi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turashvili, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haffari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bashashati, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prentice, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khattra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burleigh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yap, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shumansky, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crisan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuliany, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heravi-Moussavi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birol, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varhol, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhalla, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moradian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, S.-W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelmon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, S.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueda, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pharoah, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damaraju, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harkins, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadigotla, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigaroudinia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gascard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tlsty, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costello, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaves, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasserman, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huntsman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirst, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marra, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aparicio, S.</span></span> <span> </span><span class="NLM_article-title">The clonal and mutational evolution spectrum of primary triple-negative breast cancers</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>486</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1038/nature10933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1038%2Fnature10933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=22495314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtVersL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=486&publication_year=2012&pages=395-399&author=S.+P.+Shahauthor=A.+Rothauthor=R.+Goyaauthor=A.+Oloumiauthor=G.+Haauthor=Y.+Zhaoauthor=G.+Turashviliauthor=J.+Dingauthor=K.+Tseauthor=G.+Haffariauthor=A.+Bashashatiauthor=L.+M.+Prenticeauthor=J.+Khattraauthor=A.+Burleighauthor=D.+Yapauthor=V.+Bernardauthor=A.+McPhersonauthor=K.+Shumanskyauthor=A.+Crisanauthor=R.+Giulianyauthor=A.+Heravi-Moussaviauthor=J.+Rosnerauthor=D.+Laiauthor=I.+Birolauthor=R.+Varholauthor=A.+Tamauthor=N.+Dhallaauthor=T.+Zengauthor=K.+Maauthor=S.+K.+Chanauthor=M.+Griffithauthor=A.+Moradianauthor=S.-W.+G.+Chengauthor=G.+B.+Morinauthor=P.+Watsonauthor=K.+Gelmonauthor=S.+Chiaauthor=S.-F.+Chinauthor=C.+Curtisauthor=O.+M.+Ruedaauthor=P.+D.+Pharoahauthor=S.+Damarajuauthor=J.+Mackeyauthor=K.+Hoonauthor=T.+Harkinsauthor=V.+Tadigotlaauthor=M.+Sigaroudiniaauthor=P.+Gascardauthor=T.+Tlstyauthor=J.+F.+Costelloauthor=I.+M.+Meyerauthor=C.+J.+Eavesauthor=W.+W.+Wassermanauthor=S.+Jonesauthor=D.+Huntsmanauthor=M.+Hirstauthor=C.+Caldasauthor=M.+A.+Marraauthor=S.+Aparicio&title=The+clonal+and+mutational+evolution+spectrum+of+primary+triple-negative+breast+cancers&doi=10.1038%2Fnature10933"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The clonal and mutational evolution spectrum of primary triple-negative breast cancers</span></div><div class="casAuthors">Shah, Sohrab P.; Roth, Andrew; Goya, Rodrigo; Oloumi, Arusha; Ha, Gavin; Zhao, Yongjun; Turashvili, Gulisa; Ding, Jiarui; Tse, Kane; Haffari, Gholamreza; Bashashati, Ali; Prentice, Leah M.; Khattra, Jaswinder; Burleigh, Angela; Yap, Damian; Bernard, Virginie; McPherson, Andrew; Shumansky, Karey; Crisan, Anamaria; Giuliany, Ryan; Heravi-Moussavi, Alireza; Rosner, Jamie; Lai, Daniel; Birol, Inanc; Varhol, Richard; Tam, Angela; Dhalla, Noreen; Zeng, Thomas; Ma, Kevin; Chan, Simon K.; Griffith, Malachi; Moradian, Annie; Cheng, S.-W. Grace; Morin, Gregg B.; Watson, Peter; Gelmon, Karen; Chia, Stephen; Chin, Suet-Feung; Curtis, Christina; Rueda, Oscar M.; Pharoah, Paul D.; Damaraju, Sambasivarao; Mackey, John; Hoon, Kelly; Harkins, Timothy; Tadigotla, Vasisht; Sigaroudinia, Mahvash; Gascard, Philippe; Tlsty, Thea; Costello, Joseph F.; Meyer, Irmtraud M.; Eaves, Connie J.; Wasserman, Wyeth W.; Jones, Steven; Huntsman, David; Hirst, Martin; Caldas, Carlos; Marra, Marco A.; Aparicio, Samuel</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">486</span>
        (<span class="NLM_cas:issue">7403</span>),
    <span class="NLM_cas:pages">395-399</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Primary triple-neg. breast cancers (TNBCs), a tumor type defined by lack of estrogen receptor, progesterone receptor and ERBB2 gene amplification, represent approx. 16% of all breast cancers.  Here we show in 104 TNBC cases that at the time of diagnosis these cancers exhibit a wide and continuous spectrum of genomic evolution, with some having only a handful of coding somatic aberrations in a few pathways, whereas others contain hundreds of coding somatic mutations.  High-throughput RNA sequencing (RNA-seq) revealed that only approx. 36% of mutations are expressed.  Using deep re-sequencing measurements of allelic abundance for 2414 somatic mutations, we det. for the first time-to our knowledge-in an epithelial tumor subtype, the relative abundance of clonal frequencies among cases representative of the population.  We show that TNBCs vary widely in their clonal frequencies at the time of diagnosis, with the basal subtype of TNBC showing more variation than non-basal TNBC.  Although p53 (also known as TP53), PIK3CA and PTEN somatic mutations seem to be clonally dominant compared to other genes, in some tumors their clonal frequencies are incompatible with founder status.  Mutations in cytoskeletal, cell shape and motility proteins occurred at lower clonal frequencies, suggesting that they occurred later during tumor progression.  Taken together, our results show that understanding the biol. and therapeutic responses of patients with TNBC will require the detn. of individual tumor clonal genotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3aaF8K7Y8W7Vg90H21EOLACvtfcHk0lgly6HYu8vCbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtVersL4%253D&md5=862d24438c9062123d9b0826cf86da2c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnature10933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10933%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DS.%2BP.%26aulast%3DRoth%26aufirst%3DA.%26aulast%3DGoya%26aufirst%3DR.%26aulast%3DOloumi%26aufirst%3DA.%26aulast%3DHa%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DTurashvili%26aufirst%3DG.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DTse%26aufirst%3DK.%26aulast%3DHaffari%26aufirst%3DG.%26aulast%3DBashashati%26aufirst%3DA.%26aulast%3DPrentice%26aufirst%3DL.%2BM.%26aulast%3DKhattra%26aufirst%3DJ.%26aulast%3DBurleigh%26aufirst%3DA.%26aulast%3DYap%26aufirst%3DD.%26aulast%3DBernard%26aufirst%3DV.%26aulast%3DMcPherson%26aufirst%3DA.%26aulast%3DShumansky%26aufirst%3DK.%26aulast%3DCrisan%26aufirst%3DA.%26aulast%3DGiuliany%26aufirst%3DR.%26aulast%3DHeravi-Moussavi%26aufirst%3DA.%26aulast%3DRosner%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DD.%26aulast%3DBirol%26aufirst%3DI.%26aulast%3DVarhol%26aufirst%3DR.%26aulast%3DTam%26aufirst%3DA.%26aulast%3DDhalla%26aufirst%3DN.%26aulast%3DZeng%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DK.%26aulast%3DChan%26aufirst%3DS.%2BK.%26aulast%3DGriffith%26aufirst%3DM.%26aulast%3DMoradian%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DS.-W.%2BG.%26aulast%3DMorin%26aufirst%3DG.%2BB.%26aulast%3DWatson%26aufirst%3DP.%26aulast%3DGelmon%26aufirst%3DK.%26aulast%3DChia%26aufirst%3DS.%26aulast%3DChin%26aufirst%3DS.-F.%26aulast%3DCurtis%26aufirst%3DC.%26aulast%3DRueda%26aufirst%3DO.%2BM.%26aulast%3DPharoah%26aufirst%3DP.%2BD.%26aulast%3DDamaraju%26aufirst%3DS.%26aulast%3DMackey%26aufirst%3DJ.%26aulast%3DHoon%26aufirst%3DK.%26aulast%3DHarkins%26aufirst%3DT.%26aulast%3DTadigotla%26aufirst%3DV.%26aulast%3DSigaroudinia%26aufirst%3DM.%26aulast%3DGascard%26aufirst%3DP.%26aulast%3DTlsty%26aufirst%3DT.%26aulast%3DCostello%26aufirst%3DJ.%2BF.%26aulast%3DMeyer%26aufirst%3DI.%2BM.%26aulast%3DEaves%26aufirst%3DC.%2BJ.%26aulast%3DWasserman%26aufirst%3DW.%2BW.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DHuntsman%26aufirst%3DD.%26aulast%3DHirst%26aufirst%3DM.%26aulast%3DCaldas%26aufirst%3DC.%26aulast%3DMarra%26aufirst%3DM.%2BA.%26aulast%3DAparicio%26aufirst%3DS.%26atitle%3DThe%2520clonal%2520and%2520mutational%2520evolution%2520spectrum%2520of%2520primary%2520triple-negative%2520breast%2520cancers%26jtitle%3DNature%26date%3D2012%26volume%3D486%26spage%3D395%26epage%3D399%26doi%3D10.1038%2Fnature10933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pitushkin, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burmistrov, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butov, G. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of homologs of 1-isothiocyanatoadamantane</span>. <i>Russ. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1475</span>– <span class="NLM_lpage">1479</span>, <span class="refDoi"> DOI: 10.1134/S1070428018100068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1134%2FS1070428018100068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFejsrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2018&pages=1475-1479&author=D.+A.+Pitushkinauthor=V.+V.+Burmistrovauthor=G.+M.+Butov&title=Synthesis+of+homologs+of+1-isothiocyanatoadamantane&doi=10.1134%2FS1070428018100068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Homologs of 1-Isothiocyanatoadamantane</span></div><div class="casAuthors">Pitushkin, D. A.; Burmistrov, V. V.; Butov, G. M.</div><div class="citationInfo"><span class="NLM_cas:title">Russian Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1475-1479</span>CODEN:
                <span class="NLM_cas:coden">RJOCEQ</span>;
        ISSN:<span class="NLM_cas:issn">1070-4280</span>.
    
            (<span class="NLM_cas:orgname">Pleiades Publishing, Ltd.</span>)
        </div><div class="casAbstract">Amines of the adamantane series reacted with carbon disulfide and di-tert-Bu dicarbonate in the presence of triethylamine and a catalytic amt. of 4-(dimethylamino)pyridine to give homologs of 1-isothiocyanatoadamantane in 80-86% yields.  Adamantan-2-amine, 1-(adamantan-1-yl)ethanamine, and adamantan-1-ylmethanamine turned out to be more reactive than adamantan-1-amine; in the latter case, the reaction time was twice as long.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCaq69-0R2cLVg90H21EOLACvtfcHk0liR-c4iWDo7xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFejsrbJ&md5=281e07379c9bb2e0e1716abdd85959dc</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1134%2FS1070428018100068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1134%252FS1070428018100068%26sid%3Dliteratum%253Aachs%26aulast%3DPitushkin%26aufirst%3DD.%2BA.%26aulast%3DBurmistrov%26aufirst%3DV.%2BV.%26aulast%3DButov%26aufirst%3DG.%2BM.%26atitle%3DSynthesis%2520of%2520homologs%2520of%25201-isothiocyanatoadamantane%26jtitle%3DRuss.%2520J.%2520Org.%2520Chem.%26date%3D2018%26volume%3D54%26spage%3D1475%26epage%3D1479%26doi%3D10.1134%2FS1070428018100068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bumistrov, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitushkin, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasipov, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’yachenko, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butov, G. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 3-adamantylated hydantoins and their 2-thio(seleno) analogs</span>. <i>Chem. Heterocycl. Compd.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">619</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.1007/s10593-019-02507-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1007%2Fs10593-019-02507-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2019&pages=619-622&author=V.+V.+Bumistrovauthor=D.+A.+Pitushkinauthor=V.+V.+Vasipovauthor=V.+S.+D%E2%80%99yachenkoauthor=G.+M.+Butov&title=Synthesis+of+3-adamantylated+hydantoins+and+their+2-thio%28seleno%29+analogs&doi=10.1007%2Fs10593-019-02507-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs10593-019-02507-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10593-019-02507-4%26sid%3Dliteratum%253Aachs%26aulast%3DBumistrov%26aufirst%3DV.%2BV.%26aulast%3DPitushkin%26aufirst%3DD.%2BA.%26aulast%3DVasipov%26aufirst%3DV.%2BV.%26aulast%3DD%25E2%2580%2599yachenko%26aufirst%3DV.%2BS.%26aulast%3DButov%26aufirst%3DG.%2BM.%26atitle%3DSynthesis%2520of%25203-adamantylated%2520hydantoins%2520and%2520their%25202-thio%2528seleno%2529%2520analogs%26jtitle%3DChem.%2520Heterocycl.%2520Compd.%26date%3D2019%26volume%3D55%26spage%3D619%26epage%3D622%26doi%3D10.1007%2Fs10593-019-02507-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominy, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, P. J.</span></span> <span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(00)00129-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2800%2900129-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0lgSmDbs0bQSaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D46%26spage%3D3%26epage%3D26%26doi%3D10.1016%2FS0169-409X%2800%2900129-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cady, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGrado, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, M.</span></span> <span> </span><span class="NLM_article-title">Specific binding of adamantane drugs and direction of their polar amines in the pore of the influenza M2 transmembrane domain in lipid bilayers and dodecylphosphocholine micelles determined by NMR spectroscopy</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">4274</span>– <span class="NLM_lpage">4284</span>, <span class="refDoi"> DOI: 10.1021/ja102581n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja102581n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisl2qtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=4274-4284&author=S.+D.+Cadyauthor=J.+Wangauthor=Y.+Wuauthor=W.+F.+DeGradoauthor=M.+Hong&title=Specific+binding+of+adamantane+drugs+and+direction+of+their+polar+amines+in+the+pore+of+the+influenza+M2+transmembrane+domain+in+lipid+bilayers+and+dodecylphosphocholine+micelles+determined+by+NMR+spectroscopy&doi=10.1021%2Fja102581n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Specific Binding of Adamantane Drugs and Direction of Their Polar Amines in the Pore of the Influenza M2 Transmembrane Domain in Lipid Bilayers and Dodecylphosphocholine Micelles Determined by NMR Spectroscopy</span></div><div class="casAuthors">Cady, Sarah D.; Wang, Jun; Wu, Yibing; DeGrado, William F.; Hong, Mei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4274-4284</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The transmembrane domain of the influenza M2 protein (M2TM) forms a tetrameric proton channel important for the virus life-cycle.  The proton-channel activity is inhibited by amine-contg. adamantyl drugs amantadine and rimantadine, which have been shown to bind specifically to the pore of M2TM near Ser31.  However, whether the polar amine points to the N- or C-terminus of the channel has not yet been detd.  Elucidating the polar group direction will shed light on the mechanism by which drug binding inhibits this proton channel and will facilitate rational design of new inhibitors.  In this study, we det. the polar amine direction using M2TM reconstituted in lipid bilayers as well as dodecylphosphocholine (DPC) micelles. 13C-2H rotational-echo double-resonance NMR expts. of 13C-labeled M2TM and methyl-deuterated rimantadine in lipid bilayers showed that the polar amine pointed to the C-terminus of the channel, with the Me group close to Gly34.  Soln. NMR expts. of M2TM in DPC micelles indicate that drug binding causes significant chem. shift perturbations of the protein that are very similar to those seen for M2TM and M2(18-60) bound to lipid bilayers.  Specific 2H-labeling of the drugs permitted the assignment of drug-protein cross peaks, which indicate that amantadine and rimantadine bind to the pore in the same fashion as for bilayer-bound M2TM.  These results strongly suggest that adamantyl inhibition of M2TM is achieved not only by direct phys. occlusion of the channel, but also by perturbing the equil. const. of the proton-sensing residue His37.  The reprodn. of the pharmacol. relevant specific pore-binding site in DPC micelles, which was not obsd. with a different detergent, DHPC, underscores the significant influence of the detergent environment on the functional structure of this membrane protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHrFx8uRujFLVg90H21EOLACvtfcHk0ljGHAMVu8cY3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisl2qtbs%253D&md5=d2e9d577835a89045092bc2c0b87a24b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fja102581n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja102581n%26sid%3Dliteratum%253Aachs%26aulast%3DCady%26aufirst%3DS.%2BD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DDeGrado%26aufirst%3DW.%2BF.%26aulast%3DHong%26aufirst%3DM.%26atitle%3DSpecific%2520binding%2520of%2520adamantane%2520drugs%2520and%2520direction%2520of%2520their%2520polar%2520amines%2520in%2520the%2520pore%2520of%2520the%2520influenza%2520M2%2520transmembrane%2520domain%2520in%2520lipid%2520bilayers%2520and%2520dodecylphosphocholine%2520micelles%2520determined%2520by%2520NMR%2520spectroscopy%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D4274%26epage%3D4284%26doi%3D10.1021%2Fja102581n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, Q. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R. B.</span></span> <span> </span><span class="NLM_article-title">In depth analysis on the binding sites of adamantane derivatives in HCV (Hepatitis C Virus) p7 channel based on the NMR structure</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e93613</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0093613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1371%2Fjournal.pone.0093613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=24714586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1egsLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=Q.+S.+Duauthor=S.+Q.+Wangauthor=D.+Chenauthor=J.+Z.+Mengauthor=R.+B.+Huang&title=In+depth+analysis+on+the+binding+sites+of+adamantane+derivatives+in+HCV+%28Hepatitis+C+Virus%29+p7+channel+based+on+the+NMR+structure&doi=10.1371%2Fjournal.pone.0093613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">In depth analysis on the binding sites of adamantane derivatives in HCV (hepatitis C virus) p7 channel based on the NMR structure</span></div><div class="casAuthors">Du, Qi-Shi; Wang, Shu-Qing; Chen, Dong; Meng, Jian-Zong; Huang, Ri-Bo</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e93613/1-e93613/7, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: The recently solved soln. structure of HCV (hepatitis C virus) p7 ion channel provides a solid structure basis for drug design against HCV infection.  In the p7 channel the ligand amantadine (or rimantadine) was detd. in a hydrophobic pocket.  However the pharmocophore (-NH2) of the ligand was not assigned a specific binding site.  Results: The possible binding sites for amino group of adamantane derivs. is studied based on the NMR structure of p7 channel using QM calcn. and mol. modeling.  In the hydrophobic cavity and nearby three possible binding sites are proposed: His17, Phe20, and Trp21.  The ligand binding energies at the three binding sites are studied using high level QM method CCSD(T)/6-311+G(d,p) and AutoDock calcns., and the interaction details are analyzed.  The potential application of the binding sites for rational inhibitor design are discussed.  Conclusions: Some useful viewpoints are concluded as follows.  (1) The amino group (-NH2) of adamantane derivs. is protonated (-NH3+), and the pos. charged cation may form cation-π interactions with arom. amino acids.  (2) The arom. amino acids (His17, Phe20, and Trp21) are the possible binding sites for the protonated amino group (-NH3+) of adamantane derivs., and the cation-π bond energies are 3 to 5 times stronger than the energies of common hydrogen bonds.  (3) The higher inhibition potent of rimantadine than amantadine probably because of its higher pKa value (pKa = 10.40) and the higher pos. charge in the amino group.  The potential application of p7 channel structure for inhibitor design is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPPc6YBjnR3LVg90H21EOLACvtfcHk0liBA0A0xJLlnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1egsLfJ&md5=d8eff0c5fa553a703a5e51dd4754ad54</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0093613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0093613%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DQ.%2BS.%26aulast%3DWang%26aufirst%3DS.%2BQ.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DMeng%26aufirst%3DJ.%2BZ.%26aulast%3DHuang%26aufirst%3DR.%2BB.%26atitle%3DIn%2520depth%2520analysis%2520on%2520the%2520binding%2520sites%2520of%2520adamantane%2520derivatives%2520in%2520HCV%2520%2528Hepatitis%2520C%2520Virus%2529%2520p7%2520channel%2520based%2520on%2520the%2520NMR%2520structure%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0093613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morse, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eklind, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecht, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, F.-L.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships for inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone lung tumorigenesis by arylalkyl isothiocyanates in A/J Mice</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1846</span>– <span class="NLM_lpage">1850</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=2004368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADyaK3MXit1Sktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1991&pages=1846-1850&author=M.+A.+Morseauthor=K.+I.+Eklindauthor=S.+S.+Hechtauthor=K.+G.+Jordanauthor=C.+I.+Choiauthor=D.+H.+Desaiauthor=S.+G.+Aminauthor=F.-L.+Chung&title=Structure-activity+relationships+for+inhibition+of+4-%28methylnitrosamino%29-1-%283-pyridyl%29-1-butanone+lung+tumorigenesis+by+arylalkyl+isothiocyanates+in+A%2FJ+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Dietary inhibitors of chemical carcinogenesis. Part 11. Structure-activity relationships for inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone lung tumorigenesis by arylalkyl isothiocyanates in A/J mice</span></div><div class="casAuthors">Morse, Mark A.; Eklind, Karin I.; Hecht, Stephen S.; Jordan, Kevin G.; Choi, Chang In; Desai, Dhimant H.; Amin, Shantu G.; Chung, Fung Lung</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1846-50</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Phenethyl isothiocyanate (PEITC), 3-phenylpropyl isothiocyante (PPITC), 4-phenylbutyl isothiocyanate (PBITC), and the newly synthesized 5-phenylpentyl isothiocyante (PPcITC), 6-phenylhexyl isothiocyanate (PHITC), and 4-(3-pyridyl)butyl isothiocyanate (PyBITC) were tested for their abilities to inhibit tumorigenicity and DNA methylation induced by the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (I) in the lungs of A/J mice.  Mice were administered isothiocyantes by gavage for 4 consecutive days at doses of 5, 1, or 0.2 Mmol/day prior to administration of 10 μmol of I by i.p. injection.  Mice were sacrificed 16 wk after I administration and pulmonary adenomas were quantitated.  PEITC effectively inhibited I-induced lung tumors at a dose of 5 μmol/day but was not inhibitory at doses 1 or 0.2 μmol/day.  PPITC, PBITC, PPeITC, and PHITC were all considerably more potent inhibitors or I lung tumorigenesis than PEITC.  While virtually no differences in inhibitory activity could be ascertained for PPITC, PBITC, and PPeITC, PHITC appeared to be the most potent tumor inhibitor of all of the compds.  At a dose of 0.2 μmol/day, PHITC pretreatment reduced tumor multiplicity by 85%.  PyBITC, an analog on both I and PBITC, was ineffective as an inhibitor.  Using the same protocol, the compds. were found to have qual. similar inhibitory effects on I induced DNA methylation when administered at 1 μmol/day.  These results extend previous findings that increased alkyl chain length enhances the inhibitory activity of an arylalkyl isothiocyanate toward I lung tumorigenesis, and demonstrate the exceptional chemopreventive potentials of 2 new isothiocyantes, PPeITC and PHITC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOc3fsBZbYvrVg90H21EOLACvtfcHk0lj8dRcEaSaiWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXit1Sktb4%253D&md5=1fbdb5f10c997d6bbf5e499b4c02cb2b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorse%26aufirst%3DM.%2BA.%26aulast%3DEklind%26aufirst%3DK.%2BI.%26aulast%3DHecht%26aufirst%3DS.%2BS.%26aulast%3DJordan%26aufirst%3DK.%2BG.%26aulast%3DChoi%26aufirst%3DC.%2BI.%26aulast%3DDesai%26aufirst%3DD.%2BH.%26aulast%3DAmin%26aufirst%3DS.%2BG.%26aulast%3DChung%26aufirst%3DF.-L.%26atitle%3DStructure-activity%2520relationships%2520for%2520inhibition%2520of%25204-%2528methylnitrosamino%2529-1-%25283-pyridyl%2529-1-butanone%2520lung%2520tumorigenesis%2520by%2520arylalkyl%2520isothiocyanates%2520in%2520A%252FJ%2520Mice%26jtitle%3DCancer%2520Res.%26date%3D1991%26volume%3D51%26spage%3D1846%26epage%3D1850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaitanya, G. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, P. P.</span></span> <span> </span><span class="NLM_article-title">PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration</span>. <i>Cell Commun. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.1186/1478-811X-8-31</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1186%2F1478-811X-8-31" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=21176168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtlSmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=31-41&author=G.+V.+Chaitanyaauthor=J.+S.+Alexanderauthor=P.+P.+Babu&title=PARP-1+cleavage+fragments%3A+signatures+of+cell-death+proteases+in+neurodegeneration&doi=10.1186%2F1478-811X-8-31"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration</span></div><div class="casAuthors">Chaitanya, Ganta Vijay; Steve, Alexander J.; Babu, Phanithi Prakash</div><div class="citationInfo"><span class="NLM_cas:title">Cell Communication and Signaling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31</span>CODEN:
                <span class="NLM_cas:coden">CCSEC6</span>;
        ISSN:<span class="NLM_cas:issn">1478-811X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  The normal function of poly (ADP-ribose) polymerase-1 (PARP-1) is the routine repair of DNA damage by adding poly (ADP ribose) polymers in response to a variety of cellular stresses.  Recently, it has become widely appreciated that PARP-1 also participates in diverse physiol. and pathol. functions from cell survival to several forms of cell death and has been implicated in gene transcription, immune responses, inflammation, learning, memory, synaptic functions, angiogenesis and aging.  In the CNS, PARP inhibition attenuates injury in pathologies like cerebral ischemia, trauma and excitotoxicity demonstrating a central role of PARP-1 in these pathologies.  PARP-1 is also a preferred substrate for several 'suicidal' proteases and the proteolytic action of suicidal proteases (caspases, calpains, cathepsins, granzymes and matrix metalloproteinases (MMPs)) on PARP-1 produces several specific proteolytic cleavage fragments with different mol. wts.  These PARP-1 signature fragments are recognized biomarkers for specific patterns of protease activity in unique cell death programs.  This review focuses on specific suicidal proteases active towards PARP-1 to generate signature PARP-1 fragments that can identify key proteases and particular forms of cell death involved in pathophysiol.  The roles played by some of the PARP-1 fragments and their assocd. binding partners in the control of different forms of cell death are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe_v_-uK8kzrVg90H21EOLACvtfcHk0lgCp6jSjfEr0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtlSmtw%253D%253D&md5=0fb5d43adfc5c0607c81fab41f207316</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1186%2F1478-811X-8-31&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1478-811X-8-31%26sid%3Dliteratum%253Aachs%26aulast%3DChaitanya%26aufirst%3DG.%2BV.%26aulast%3DAlexander%26aufirst%3DJ.%2BS.%26aulast%3DBabu%26aufirst%3DP.%2BP.%26atitle%3DPARP-1%2520cleavage%2520fragments%253A%2520signatures%2520of%2520cell-death%2520proteases%2520in%2520neurodegeneration%26jtitle%3DCell%2520Commun.%2520Signaling%26date%3D2010%26volume%3D8%26spage%3D31%26epage%3D41%26doi%3D10.1186%2F1478-811X-8-31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jänicke, R. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprengart, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, A. G.</span></span> <span> </span><span class="NLM_article-title">Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">15540</span>– <span class="NLM_lpage">15545</span>, <span class="refDoi"> DOI: 10.1074/jbc.273.25.15540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1074%2Fjbc.273.25.15540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=9624143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADyaK1cXktVSmtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=15540-15545&author=R.+U.+J%C3%A4nickeauthor=P.+Ngauthor=M.+L.+Sprengartauthor=A.+G.+Porter&title=Caspase-3+is+required+for+alpha-fodrin+cleavage+but+dispensable+for+cleavage+of+other+death+substrates+in+apoptosis&doi=10.1074%2Fjbc.273.25.15540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase-3 is required for α-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis</span></div><div class="casAuthors">Janicke, Reiner U.; Ng, Patrick; Sprengart, Michael L.; Porter, Alan G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">15540-15545</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Although the commonly activated death protease caspase-3 appears not to be essential for apoptosis during development except in the brain, it was not shown whether substrates known to be cleaved by caspase-3 are still proteolyzed in its absence.  We have addressed this question with MCF-7 breast carcinoma cells that we recently showed lack caspase-3 owing to the functional deletion of the CASP-3 gene.  Tumor necrosis factor- or staurosporine-induced apoptosis of caspase-3-deficient MCF-7 cells resulted in cleavage of the death substrates PARP, Rb, PAK2, DNA-PKcs, gelsolin, and DFF-45, but not α-fodrin.  In contrast, all these substrates including α-fodrin were cleaved in apoptotic HeLa cells expressing caspase-3.  Introduction of CASP-3 cDNA, but not CASP-10 cDNA, into MCF-7 cells restored α-fodrin cleavage.  In addn., tumor necrosis factor- or staurosporine-induced apoptosis of MCF-7 cells stably expressing pro-caspase-3 also resulted in α-fodrin cleavage.  Although the specific caspase inhibitory peptides Z-VAD-fmk and Z-DEVD-fmk prevented apoptosis of MCF-7 cells, we were unable to detect activation of caspases 2 and 7, which are known to be inhibited by Z-DEVD-fmk.  Together our results suggest that caspase-3 is essential for cleavage of α-fodrin, but dispensable for the cleavage of PARP, Rb, PAK2, DNA-PKcs, gelsolin, and DFF-45 and imply that one or more caspases other than caspases 2, 3, and 7 is activated and plays a crucial role in the cleavage of these substrates in MCF-7 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-3gj7yUcV5LVg90H21EOLACvtfcHk0lg3hZ6S_nReyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXktVSmtbo%253D&md5=5ba1ea627c2a50289006718edd8185ad</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.25.15540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.25.15540%26sid%3Dliteratum%253Aachs%26aulast%3DJ%25C3%25A4nicke%26aufirst%3DR.%2BU.%26aulast%3DNg%26aufirst%3DP.%26aulast%3DSprengart%26aufirst%3DM.%2BL.%26aulast%3DPorter%26aufirst%3DA.%2BG.%26atitle%3DCaspase-3%2520is%2520required%2520for%2520alpha-fodrin%2520cleavage%2520but%2520dispensable%2520for%2520cleavage%2520of%2520other%2520death%2520substrates%2520in%2520apoptosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D15540%26epage%3D15545%26doi%3D10.1074%2Fjbc.273.25.15540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vousden, K. H.</span></span> <span> </span><span class="NLM_article-title">Regulation and function of the p53 tumor suppressor protein</span>. <i>Curr. Opin. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">337</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1016%2FS0955-0674%2800%2900216-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=332-337&author=K.+M.+Ryanauthor=A.+C.+Phillipsauthor=K.+H.+Vousden&title=Regulation+and+function+of+the+p53+tumor+suppressor+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0955-0674%2800%2900216-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0955-0674%252800%252900216-7%26sid%3Dliteratum%253Aachs%26aulast%3DRyan%26aufirst%3DK.%2BM.%26aulast%3DPhillips%26aufirst%3DA.%2BC.%26aulast%3DVousden%26aufirst%3DK.%2BH.%26atitle%3DRegulation%2520and%2520function%2520of%2520the%2520p53%2520tumor%2520suppressor%2520protein%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2001%26volume%3D3%26spage%3D332%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span> <span> </span><span class="NLM_article-title">A common gain of function of p53 cancer mutants in inducing genetic instability</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">949</span>– <span class="NLM_lpage">956</span>, <span class="refDoi"> DOI: 10.1038/onc.2009.376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1038%2Fonc.2009.376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=19881536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlers7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=949-956&author=D.+P.+Liuauthor=H.+Songauthor=Y.+Xu&title=A+common+gain+of+function+of+p53+cancer+mutants+in+inducing+genetic+instability&doi=10.1038%2Fonc.2009.376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A common gain of function of p53 cancer mutants in inducing genetic instability</span></div><div class="casAuthors">Liu, D. P.; Song, H.; Xu, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">949-956</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The crit. tumor suppressor p53 is mutated in over half of all human cancers.  The majority of p53 cancer mutations are missense mutations, which can be classified into contact mutations that directly disrupt the DNA-binding of p53 but have modest impact on p53 conformation and structural mutations that greatly disrupt p53 conformation.  Many p53 cancer mutants, including the hot spot mutations (R175H, R248W and R273H), not only lose p53-dependent tumor-suppressor activities, but also acquire new oncogenic activities to promote cancer.  Therefore, it is crit. to elucidate the gain of oncogenic function of p53 cancer mutants.  Using humanized p53-mutant knock-in mouse models, we have identified a gain of oncogenic function shared by the most common p53 contact mutants (R273H and R248W) and structural mutant (R175H).  This gain of function inactivates Mre11/ATM-dependent DNA damage responses, leading to chromosomal translocation and defective G2/M checkpoint.  Considering the crit. roles of ATM in maintaining genetic stability and therapeutic responses to many cancer treatments, the identification of this common gain of function of p53 cancer mutants will have important implication on the drug resistance of a significant portion of human cancers that express either the contact or structural p53 cancer mutants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq-JbSj599d7Vg90H21EOLACvtfcHk0lij2X_TFpUnuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlers7vE&md5=8d4a195fb45649d119a0d32cff39ff8c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fonc.2009.376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2009.376%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DD.%2BP.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DA%2520common%2520gain%2520of%2520function%2520of%2520p53%2520cancer%2520mutants%2520in%2520inducing%2520genetic%2520instability%26jtitle%3DOncogene%26date%3D2010%26volume%3D29%26spage%3D949%26epage%3D956%26doi%3D10.1038%2Fonc.2009.376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combs, G. F.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Selenium and anticarcinogenesis: underlying mechanisms</span>. <i>Curr. Opin. Clin. Nutr. Metab. Care</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">718</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1097/MCO.0b013e3283139674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1097%2FMCO.0b013e3283139674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=18827575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFOrtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=718-726&author=M.+I.+Jacksonauthor=G.+F.+Combs&title=Selenium+and+anticarcinogenesis%3A+underlying+mechanisms&doi=10.1097%2FMCO.0b013e3283139674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Selenium and anticarcinogenesis: underlying mechanisms</span></div><div class="casAuthors">Jackson, Matthew I.; Combs, Gerald F., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Clinical Nutrition and Metabolic Care</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">718-726</span>CODEN:
                <span class="NLM_cas:coden">COCMF3</span>;
        ISSN:<span class="NLM_cas:issn">1363-1950</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: To discuss recent research related to anticarcinogenic mechanisms of selenium action in light of the underlying chem./biochem. functions of the selenium species, likely to be executors of those effects.  Recent findings: Recent studies in a variety of model systems have increased the understanding of the anticarcinogenic mechanisms of selenium compds.  These include effects on gene expression, DNA damage and repair, signaling pathways, regulation of cell cycle and apoptosis, metastasis and angiogenesis.  These effects would appear to be related to the prodn. of reactive oxygen species produced by the redox cycling, modification of protein-thiols and methionine mimicry.  Three principle selenium metabolites appear to execute these effects: hydrogen selenide, methylselenol and selenomethionine.  The fact that various selenium compds. can be metabolized to one or more of these species but differ in anticarcinogenic activity indicates competing pathways of their metabolic and chem./biochem. disposition.  Increasing knowledge of selenoprotein polymorphisms has shown that at least some are related to cancer risk and may affect carcinogenesis indirectly by influencing selenium metab.  Summary: The anticarcinogenic effects of selenium compds. constitute intermediate mechanisms with several underlying chem./biochem. mechanisms such as redox cycling, alteration of protein-thiol redox status and methionine mimicry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBhBXcNOgihbVg90H21EOLACvtfcHk0lhEDUmTo7mmTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFOrtLnN&md5=a25c3f425a7f0ac275147c430a230fe0</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1097%2FMCO.0b013e3283139674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMCO.0b013e3283139674%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DM.%2BI.%26aulast%3DCombs%26aufirst%3DG.%2BF.%26atitle%3DSelenium%2520and%2520anticarcinogenesis%253A%2520underlying%2520mechanisms%26jtitle%3DCurr.%2520Opin.%2520Clin.%2520Nutr.%2520Metab.%2520Care%26date%3D2008%26volume%3D11%26spage%3D718%26epage%3D726%26doi%3D10.1097%2FMCO.0b013e3283139674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brigelius-Flohé, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banning, A.</span></span> <span> </span><span class="NLM_article-title">Part of the series: from dietary antioxidants to regulators in cellular signaling and gene regulation. Sulforaphane and selenium, partners in adaptive response and prevention of cancer</span>. <i>Free Radical Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">775</span>– <span class="NLM_lpage">787</span>, <span class="refDoi"> DOI: 10.1080/10715760600722643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1080%2F10715760600722643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=17015256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD28XovFGksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2006&pages=775-787&author=R.+Brigelius-Floh%C3%A9author=A.+Banning&title=Part+of+the+series%3A+from+dietary+antioxidants+to+regulators+in+cellular+signaling+and+gene+regulation.+Sulforaphane+and+selenium%2C+partners+in+adaptive+response+and+prevention+of+cancer&doi=10.1080%2F10715760600722643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Part of the series: from dietary antioxidants to regulators in cellular signaling and gene regulation. Sulforaphane and selenium, partners in adaptive response and prevention of cancer</span></div><div class="casAuthors">Brigelius-Flohe, Regina; Banning, Antje</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">775-787</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1071-5762</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The assocn. of decreased cancer risk with dietary intake of cruciferous vegetables and selenium is stronger than that reported for fruits and vegetables in general.  Sulforaphane is an active constituent in cruciferae.  The chemopreventive effects of sulforaphane and selenium have been attributed to antioxidant actions in a simplistic way.  Sulforaphane induces phase 2 enzymes via activation of the Nrf2/Keap1 system that protect against carcinogens and oxidants.  The induced enzymes include selenoproteins thioredoxin reductase-1 (TrxR1) and gastrointestinal glutathione peroxidase (GI-GPx, GPx2), which contain antioxidant response elements (ARE) in their promoter regions.  Translational realization of the enhanced transcripts depends on adequate Se supply, which explains the synergism of Nrf2 activators and selenium.  Regarding tumorigenesis, the role of TrxR1 is ambiguous: it is essential for fast tumor cell growth but also diminishes vascularization of tumors.  The anticarcinogenic role of GI-GPx is evident from enhanced gastrointestinal tumor formation in gpx2/gpx1 double knock-out mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF3Y2ft_DuOrVg90H21EOLACvtfcHk0ljUly2uem4kaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovFGksL8%253D&md5=ca0f610ca33f0e577c1eecac1e54b446</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1080%2F10715760600722643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10715760600722643%26sid%3Dliteratum%253Aachs%26aulast%3DBrigelius-Floh%25C3%25A9%26aufirst%3DR.%26aulast%3DBanning%26aufirst%3DA.%26atitle%3DPart%2520of%2520the%2520series%253A%2520from%2520dietary%2520antioxidants%2520to%2520regulators%2520in%2520cellular%2520signaling%2520and%2520gene%2520regulation.%2520Sulforaphane%2520and%2520selenium%252C%2520partners%2520in%2520adaptive%2520response%2520and%2520prevention%2520of%2520cancer%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2006%26volume%3D40%26spage%3D775%26epage%3D787%26doi%3D10.1080%2F10715760600722643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zakrzewski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huras, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiełczewska, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of isoselenocyanates</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1055%2Fs-0035-1560481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslCks7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2016&pages=85-96&author=J.+Zakrzewskiauthor=B.+Hurasauthor=A.+Kie%C5%82czewska&title=Synthesis+of+isoselenocyanates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Isoselenocyanates</span></div><div class="casAuthors">Zakrzewski, Jerzy; Huras, Bogumila; Kielczewska, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-96</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">1437-210X</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Isoselenocyanates were prepd. by two methods from either the corresponding isonitriles or directly from the corresponding amines.  Using phase-transfer conditions (50% aq NaOH, CH2Cl2, Aliquat 336), isonitriles underwent selenation with selenium to give isoselenocyanates in 61-89% yields; generating the isonitriles in situ from amines using chloroform (Hofmann isonitrile synthesis) followed by selenation yielded isoselenocyanates in 4-70% yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjY9nicMw6N7Vg90H21EOLACvtfcHk0ljUly2uem4kaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslCks7jF&md5=717b404fccd35de570d3260eb936bd59</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1055%2Fs-0035-1560481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0035-1560481%26sid%3Dliteratum%253Aachs%26aulast%3DZakrzewski%26aufirst%3DJ.%26aulast%3DHuras%26aufirst%3DB.%26aulast%3DKie%25C5%2582czewska%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520isoselenocyanates%26jtitle%3DSynthesis%26date%3D2016%26volume%3D48%26spage%3D85%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dittmer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambetti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teresky, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, A. J.</span></span> <span> </span><span class="NLM_article-title">Gain of function mutations in p53</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1038/ng0593-42</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1038%2Fng0593-42" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=8099841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADyaK3sXkt1ajsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1993&pages=42-46&author=D.+Dittmerauthor=S.+Patiauthor=G.+Zambettiauthor=S.+Chuauthor=A.+K.+Tereskyauthor=M.+Mooreauthor=C.+Finlayauthor=A.+J.+Levine&title=Gain+of+function+mutations+in+p53&doi=10.1038%2Fng0593-42"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Gain of function mutations in p53</span></div><div class="casAuthors">Dittmer, Dirk; Pati, Sibani; Zambetti, Gerard; Chu, Shelley; Teresky, Angelika K.; Moore, Mary; Finlay, Cathy; Levine, Arnold J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-6</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    </div><div class="casAbstract">The expression of murine or human mutant p53 proteins in cells with no endogenous p53 proteins confers new or addnl. phenotypes upon these cells.  Mutant p53 proteins expressed in cell lines lacking p53 resulted in either enhanced tumorigenic potential in nude mice ((10)3 cells) or enhanced plating efficiency in agar cell culture (human SAOS-2 cells).  Also, mutant human p53 alleles, unlike the wild-type p53 protein, could also enhance the expression of a test gene regulated by the multi-drug resistance enhancer-promoter element.  These data demonstrate a gain of function assocd. with p53 mutations in addn. to the loss of function shown previously to be assocd. with mutations in this tumor suppressor gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkTIQCdFur4bVg90H21EOLACvtfcHk0lhEEvgY_ATegQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkt1ajsbo%253D&md5=2762983a216e065e72914e8750012380</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fng0593-42&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng0593-42%26sid%3Dliteratum%253Aachs%26aulast%3DDittmer%26aufirst%3DD.%26aulast%3DPati%26aufirst%3DS.%26aulast%3DZambetti%26aufirst%3DG.%26aulast%3DChu%26aufirst%3DS.%26aulast%3DTeresky%26aufirst%3DA.%2BK.%26aulast%3DMoore%26aufirst%3DM.%26aulast%3DFinlay%26aufirst%3DC.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26atitle%3DGain%2520of%2520function%2520mutations%2520in%2520p53%26jtitle%3DNat.%2520Genet.%26date%3D1993%26volume%3D4%26spage%3D42%26epage%3D46%26doi%3D10.1038%2Fng0593-42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freed-Pastor, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prives, C.</span></span> <span> </span><span class="NLM_article-title">Mutant p53: one name, many proteins</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1268</span>– <span class="NLM_lpage">1286</span>, <span class="refDoi"> DOI: 10.1101/gad.190678.112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1101%2Fgad.190678.112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=22713868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVegs7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=1268-1286&author=W.+A.+Freed-Pastorauthor=C.+Prives&title=Mutant+p53%3A+one+name%2C+many+proteins&doi=10.1101%2Fgad.190678.112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Mutant p53: one name, many proteins</span></div><div class="casAuthors">Freed-Pastor, William A.; Prives, Carol</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1268-1286</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  There is now strong evidence that mutation not only abrogates p53 tumor-suppressive functions, but in some instances can also endow mutant proteins with novel activities.  Such neomorphic p53 proteins are capable of dramatically altering tumor cell behavior, primarily through their interactions with other cellular proteins and regulation of cancer cell transcriptional programs.  Different missense mutations in p53 may confer unique activities and thereby offer insight into the mutagenic events that drive tumor progression.  Here we review mechanisms by which mutant p53 exerts its cellular effects, with a particular focus on the burgeoning mutant p53 transcriptome, and discuss the biol. and clin. consequences of mutant p53 gain of function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfNmynVk_whbVg90H21EOLACvtfcHk0ljFyDiSXoUprA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVegs7%252FJ&md5=c48dc33a3065178fadcef58975626703</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1101%2Fgad.190678.112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.190678.112%26sid%3Dliteratum%253Aachs%26aulast%3DFreed-Pastor%26aufirst%3DW.%2BA.%26aulast%3DPrives%26aufirst%3DC.%26atitle%3DMutant%2520p53%253A%2520one%2520name%252C%2520many%2520proteins%26jtitle%3DGenes%2520Dev.%26date%3D2012%26volume%3D26%26spage%3D1268%26epage%3D1286%26doi%3D10.1101%2Fgad.190678.112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bykov, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issaeva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shilov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultcrantz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugacheva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chumakov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiman, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selivanova, S.</span></span> <span> </span><span class="NLM_article-title">Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">282</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1038/nm0302-282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1038%2Fnm0302-282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=11875500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD38Xit1Citrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=282-288&author=V.+J.+Bykovauthor=N.+Issaevaauthor=A.+Shilovauthor=M.+Hultcrantzauthor=E.+Pugachevaauthor=P.+Chumakovauthor=J.+Bergmanauthor=K.+G.+Wimanauthor=S.+Selivanova&title=Restoration+of+the+tumor+suppressor+function+to+mutant+p53+by+a+low-molecular-weight+compound&doi=10.1038%2Fnm0302-282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound</span></div><div class="casAuthors">Bykov, Vladimir J. N.; Issaeva, Natalia; Shilov, Alexandre; Hultcrantz, Monica; Pugacheva, Lena; Chumakov, Peter; Bergman, Jan; Wiman, Klas G.; Selivanova, Galina</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">282-288</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The tumor suppressor p53 inhibits tumor growth primarily through its ability to induce apoptosis.  Mutations in p53 occur in at least 50% of human tumors.  The authors hypothesized that reactivation of mutant p53 in such tumors should trigger massive apoptosis and eliminate the tumor cells.  To test this, the authors screened a library of low-mol.-wt. compds. to identify compds. that can restore wild-type function to mutant p53.  The authors found one compd. capable of inducing apoptosis in human tumor cells through restoration of the transcriptional transactivation function to mutant p53.  This mol., named PRIMA-1, restored sequence-specific DNA binding and the active conformation to mutant p53 proteins in vitro and in living cells.  PRIMA-1 rescued both DNA contact and structural p53 mutants.  In vivo studies in mice revealed an anti-tumor effect with no apparent toxicity.  This mol. may serve as a lead compd. for the development of anticancer drugs targeting mutant p53.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7Z3M-K-Q0srVg90H21EOLACvtfcHk0lhVYdIlJnHiTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xit1Citrk%253D&md5=c607dd789a5fc1fbc1ad1a3edcf8701b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnm0302-282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0302-282%26sid%3Dliteratum%253Aachs%26aulast%3DBykov%26aufirst%3DV.%2BJ.%26aulast%3DIssaeva%26aufirst%3DN.%26aulast%3DShilov%26aufirst%3DA.%26aulast%3DHultcrantz%26aufirst%3DM.%26aulast%3DPugacheva%26aufirst%3DE.%26aulast%3DChumakov%26aufirst%3DP.%26aulast%3DBergman%26aufirst%3DJ.%26aulast%3DWiman%26aufirst%3DK.%2BG.%26aulast%3DSelivanova%26aufirst%3DS.%26atitle%3DRestoration%2520of%2520the%2520tumor%2520suppressor%2520function%2520to%2520mutant%2520p53%2520by%2520a%2520low-molecular-weight%2520compound%26jtitle%3DNat.%2520Med.%26date%3D2002%26volume%3D8%26spage%3D282%26epage%3D288%26doi%3D10.1038%2Fnm0302-282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpizo, D. R.</span></span> <span> </span><span class="NLM_article-title">Allele-specific p53 mutant reactivation</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">614</span>– <span class="NLM_lpage">625</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2012.03.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1016%2Fj.ccr.2012.03.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=22624712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC38XntlymsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=614-625&author=X.+Yuauthor=A.+Vazquezauthor=A.+J.+Levineauthor=D.+R.+Carpizo&title=Allele-specific+p53+mutant+reactivation&doi=10.1016%2Fj.ccr.2012.03.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Allele-Specific p53 Mutant Reactivation</span></div><div class="casAuthors">Yu, Xin; Vazquez, Alexei; Levine, Arnold J.; Carpizo, Darren R.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">614-625</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Rescuing the function of mutant p53 protein is an attractive cancer therapeutic strategy.  Using the National Cancer Institute's anticancer drug screen data, we identified two compds. from the thiosemicarbazone family that manifest increased growth inhibitory activity in mutant p53 cells, particularly for the p53R175 mutant.  Mechanistic studies reveal that NSC319726 restores WT structure and function to the p53R175 mutant.  This compd. kills p53R172H knockin mice with extensive apoptosis and inhibits xenograft tumor growth in a 175-allele-specific mutant p53-dependent manner.  This activity depends upon the zinc ion chelating properties of the compd. as well as redox changes.  These data identify NSC319726 as a p53R175 mutant reactivator and as a lead compd. for p53-targeted drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprhl9-HrS8cLVg90H21EOLACvtfcHk0lhVYdIlJnHiTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntlymsLw%253D&md5=fb82e1673c17b5f6084a1972d24a936a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.03.042%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%26aulast%3DVazquez%26aufirst%3DA.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26aulast%3DCarpizo%26aufirst%3DD.%2BR.%26atitle%3DAllele-specific%2520p53%2520mutant%2520reactivation%26jtitle%3DCancer%2520Cell%26date%3D2012%26volume%3D21%26spage%3D614%26epage%3D625%26doi%3D10.1016%2Fj.ccr.2012.03.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barrera, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belshaw, N. J.</span></span> <span> </span><span class="NLM_article-title">Epigenetic and antioxidant effects of dietary isothiocyanates and selenium: potential implications for cancer chemoprevention</span>. <i>Proc. Nutr. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">245</span>, <span class="refDoi"> DOI: 10.1017/S002966511200016X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1017%2FS002966511200016X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=22391025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvVaqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2012&pages=237-245&author=L.+N.+Barreraauthor=A.+Cassidyauthor=I.+T.+Johnsonauthor=Y.+Baoauthor=N.+J.+Belshaw&title=Epigenetic+and+antioxidant+effects+of+dietary+isothiocyanates+and+selenium%3A+potential+implications+for+cancer+chemoprevention&doi=10.1017%2FS002966511200016X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic and antioxidant effects of dietary isothiocyanates and selenium: potential implications for cancer chemoprevention</span></div><div class="casAuthors">Barrera, Lawrence N.; Cassidy, Aedin; Johnson, Ian T.; Bao, Yongping; Belshaw, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Nutrition Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">237-245</span>CODEN:
                <span class="NLM_cas:coden">PNUSA4</span>;
        ISSN:<span class="NLM_cas:issn">0029-6651</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">A review.  There is evidence from epidemiol. studies suggesting that increased consumption of cruciferous vegetables may protect against specific cancers more effectively than total fruit and vegetable intake.  These beneficial effects are attributed to the glucosinolate breakdown products, isothiocyanates (ITC).  Similarly, selenium (Se) consumption has also been inversely assocd. with cancer risk and as an integral part of many selenoproteins may influence multiple pathways in the development of cancer.  This paper will briefly review the current state of knowledge concerning the effect of Se and ITC in cancer development with a particular emphasis on its antioxidant properties, and will also address whether alterations in DNA methylation may be a potential mechanism whereby these dietary constituents protect against the carcinogenic process.  Furthermore, we will discuss the advantages of combining ITC and Se to benefit from their complementary mechanisms of action to potentially protect against the alterations leading to neoplasia.  Based on this review it may be concluded that an understanding of the impact of ITC and Se on aberrant DNA methylation in relation to factors modulating gene-specific and global methylation patterns, in addn. to the effect of these food constituents as modulators of key selenoenzymes, such as gastrointestinal glutathione peroxidase-2 (GPx2) and thioredoxin reductase-1 (TrxR1), may provide insights into the potential synergy among various components of a plant-based diet that may counteract the genetic and epigenetic alterations that initiate and sustain neoplasia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOAN3MShxZA7Vg90H21EOLACvtfcHk0lgEmN6f9z2Gyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvVaqu7w%253D&md5=211de5c9230244fd169f242e256c2d03</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1017%2FS002966511200016X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS002966511200016X%26sid%3Dliteratum%253Aachs%26aulast%3DBarrera%26aufirst%3DL.%2BN.%26aulast%3DCassidy%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DI.%2BT.%26aulast%3DBao%26aufirst%3DY.%26aulast%3DBelshaw%26aufirst%3DN.%2BJ.%26atitle%3DEpigenetic%2520and%2520antioxidant%2520effects%2520of%2520dietary%2520isothiocyanates%2520and%2520selenium%253A%2520potential%2520implications%2520for%2520cancer%2520chemoprevention%26jtitle%3DProc.%2520Nutr.%2520Soc.%26date%3D2012%26volume%3D71%26spage%3D237%26epage%3D245%26doi%3D10.1017%2FS002966511200016X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhunapantula, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huh, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">7820</span>– <span class="NLM_lpage">7826</span>, <span class="refDoi"> DOI: 10.1021/jm800993r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800993r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWisbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7820-7826&author=A.+K.+Sharmaauthor=A.+Sharmaauthor=D.+Desaiauthor=S.+V.+Madhunapantulaauthor=S.+J.+Huhauthor=G.+P.+Robertsonauthor=S.+Amin&title=Synthesis+and+anticancer+activity+comparison+of+phenylalkyl+isoselenocyanates+with+corresponding+naturally+occurring+and+synthetic+isothiocyanates&doi=10.1021%2Fjm800993r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Anticancer Activity Comparison of Phenylalkyl Isoselenocyanates with Corresponding Naturally Occurring and Synthetic Isothiocyanates</span></div><div class="casAuthors">Sharma, Arun K.; Sharma, Arati; Desai, Dhimant; Madhunapantula, SubbaRao V.; Huh, Sung Jin; Robertson, Gavin P.; Amin, Shantu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7820-7826</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Synthesis and identification of novel phenylalkyl isoselenocyanates (ISCs), isosteric selenium analogs of naturally occurring phenylalkyl isothiocyanates (ITCs), as effective cytotoxic and antitumor agents are described.  The structure-activity relationship comparison of ISCs with ITCs and effect of the increasing alkyl chain length in inhibiting cancer cell growth were evaluated on melanoma, prostate, breast, glioblastoma, sarcoma, and colon cancer cell lines. IC50 values for ISC compds. were generally lower than their corresponding ITC analogs.  Similarly, in UACC 903 human melanoma cells, the inhibition of cell proliferation and induction of apoptosis were more pronounced with ISCs compared to ITCs.  Further, ISCs and ITCs effectively inhibited melanoma tumor growth in mice following i.p. xenograft.  A similar redn. in tumor size was obsd. at 3 times lower doses of ISCs compared to corresponding ITCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNqKH0v41XDLVg90H21EOLACvtfcHk0lgVnSR_YVrKcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWisbvE&md5=6828d8e92e21093d62aa69a9c3412ea2</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm800993r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800993r%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DDesai%26aufirst%3DD.%26aulast%3DMadhunapantula%26aufirst%3DS.%2BV.%26aulast%3DHuh%26aufirst%3DS.%2BJ.%26aulast%3DRobertson%26aufirst%3DG.%2BP.%26aulast%3DAmin%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520anticancer%2520activity%2520comparison%2520of%2520phenylalkyl%2520isoselenocyanates%2520with%2520corresponding%2520naturally%2520occurring%2520and%2520synthetic%2520isothiocyanates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7820%26epage%3D7826%26doi%3D10.1021%2Fjm800993r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Westland, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merz, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khullar, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devdhar, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenan, M. M.</span></span> <span> </span><span class="NLM_article-title">2-Mercaptoacetamidine and derivatives as antiradiation agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1313</span>– <span class="NLM_lpage">1321</span>, <span class="refDoi"> DOI: 10.1021/jm00282a027</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00282a027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADyaE3sXlt1Ghug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1972&pages=1313-1321&author=R.+D.+Westlandauthor=M.+M.+Merzauthor=S.+M.+Alexanderauthor=L.+S.+Newtonauthor=L.+Bauerauthor=T.+T.+Conwayauthor=J.+M.+Bartonauthor=K.+K.+Khullarauthor=P.+B.+Devdharauthor=M.+M.+Grenan&title=2-Mercaptoacetamidine+and+derivatives+as+antiradiation+agents&doi=10.1021%2Fjm00282a027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">2-Mercaptoacetamidine and derivatives as antiradiation agents</span></div><div class="casAuthors">Westland, Roger D.; Merz, Mary M.; Alexander, Susan M.; Newton, Linda S.; Bauer, Ludwig; Conway, Terry T.; Barton, Jerry M.; Khullar, Krishan K.; Devdhar, Prabhakar B.; Grenan, Marie M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1313-21</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A series of 2-mercaptoacetamidines and their disulfides were generally more active antiradiation agents in mice when given orally than parenterally, whereas the corresponding Bunte salts and phosphorothioates were more effective when given i.p.  One of the most effective compds. i.p. was Na H S-[N-[(3,5-dimethyl-1-adamantyl)methyl]amidino]methyl phosphorothioate (I) [37764-43-5] (93% survival at 8, 60% at 4 mg/kg; LD50 125 mg/kg); this compd. was also effective orally (100% survival at 100 mg/kg; LD50 425 mg/kg).  2,2'-Dithiobis[N-[(1-adamantyl)methyl]acetamidine]-2-HCl [37764-44-6] given orally gave 80% survival at 50 mg/kg and 53% at 25 mg/kg, but was ineffective i.p.; similar results were obtained with 2,2'-dithiobis[N-[(3,5-dimethyl-1-adamantyl)methyl]acetamidine]-2HCl (II) [37717-22-9].  To synthesize I, ClCH2CN was reacted with MeOH-NaOMe to form MeOC(:NH)CH2Cl, which was converted with 3,5-dimethyl-1-adamantylmethylamine-HCl to the N-substituted 2-chloroacetamidine; this was displaced with O3PS3- to form I.  Acid hydrolysis of I to the thiol followed by mild H2O2 oxidn. yielded II.  The mice were given 975 rads of 60Co γ-radiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou2qvrvu-H2LVg90H21EOLACvtfcHk0lgS_CqN1hlWqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXlt1Ghug%253D%253D&md5=6d277fadb0415c740b2dd1ca4376f130</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm00282a027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00282a027%26sid%3Dliteratum%253Aachs%26aulast%3DWestland%26aufirst%3DR.%2BD.%26aulast%3DMerz%26aufirst%3DM.%2BM.%26aulast%3DAlexander%26aufirst%3DS.%2BM.%26aulast%3DNewton%26aufirst%3DL.%2BS.%26aulast%3DBauer%26aufirst%3DL.%26aulast%3DConway%26aufirst%3DT.%2BT.%26aulast%3DBarton%26aufirst%3DJ.%2BM.%26aulast%3DKhullar%26aufirst%3DK.%2BK.%26aulast%3DDevdhar%26aufirst%3DP.%2BB.%26aulast%3DGrenan%26aufirst%3DM.%2BM.%26atitle%3D2-Mercaptoacetamidine%2520and%2520derivatives%2520as%2520antiradiation%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1972%26volume%3D15%26spage%3D1313%26epage%3D1321%26doi%3D10.1021%2Fjm00282a027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirole, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastenhuber, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senturk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boroda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisterzi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderluh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladanyi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sordella, R.</span></span> <span> </span><span class="NLM_article-title">TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e17929</span> <span class="refDoi"> DOI: 10.7554/eLife.17929</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.7554%2FeLife.17929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=27759562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVahtr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&author=N.+H.+Shiroleauthor=D.+Palauthor=E.+R.+Kastenhuberauthor=S.+Senturkauthor=J.+Borodaauthor=P.+Pisterziauthor=M.+Millerauthor=G.+Munozauthor=M.+Anderluhauthor=M.+Ladanyiauthor=S.+W.+Loweauthor=R.+Sordella&title=TP53+exon-6+truncating+mutations+produce+separation+of+function+isoforms+with+pro-tumorigenic+functions&doi=10.7554%2FeLife.17929"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions</span></div><div class="casAuthors">Shirole, Nitin H.; Pal, Debjani; Kastenhuber, Edward R.; Senturk, Serif; Boroda, Joseph; Pisterzi, Paola; Miller, Madison; Munoz, Gustavo; Anderluh, Marko; Ladanyi, Marc; Lowe, Scott W.; Sordella, Raffaella</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e17929/1-e17929/25</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">TP53 truncating mutations are common in human tumors and are thought to give rise to p53-null alleles.  Here, we show that TP53 exon-6 truncating mutations occur at higher than expected frequencies and produce proteins that lack canonical p53 tumor suppressor activities but promote cancer cell proliferation, survival, and metastasis.  Functionally and molecularly, these p53 mutants resemble the naturally occurring alternative p53 splice variant, p53-psi.  Accordingly, these mutants can localize to the mitochondria where they promote tumor phenotypes by binding and activating the mitochondria inner pore permeability regulator, Cyclophilin D (CypD).  Together, our studies reveal that TP53 exon-6 truncating mutations, contrary to current beliefs, act beyond p53 loss to promote tumorigenesis, and could inform the development of strategies to target cancers driven by these prevalent mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0GG_YVZz-17Vg90H21EOLACvtfcHk0lgS_CqN1hlWqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVahtr7L&md5=cc9b3f76c87125ce733e3bea6cca6040</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.7554%2FeLife.17929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.17929%26sid%3Dliteratum%253Aachs%26aulast%3DShirole%26aufirst%3DN.%2BH.%26aulast%3DPal%26aufirst%3DD.%26aulast%3DKastenhuber%26aufirst%3DE.%2BR.%26aulast%3DSenturk%26aufirst%3DS.%26aulast%3DBoroda%26aufirst%3DJ.%26aulast%3DPisterzi%26aufirst%3DP.%26aulast%3DMiller%26aufirst%3DM.%26aulast%3DMunoz%26aufirst%3DG.%26aulast%3DAnderluh%26aufirst%3DM.%26aulast%3DLadanyi%26aufirst%3DM.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26aulast%3DSordella%26aufirst%3DR.%26atitle%3DTP53%2520exon-6%2520truncating%2520mutations%2520produce%2520separation%2520of%2520function%2520isoforms%2520with%2520pro-tumorigenic%2520functions%26jtitle%3DeLife%26date%3D2016%26volume%3D5%26doi%3D10.7554%2FeLife.17929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, M. J.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry</span>. <i>Clin. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">641</span>– <span class="NLM_lpage">653</span>, <span class="refDoi"> DOI: 10.1016/j.clinthera.2008.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1016%2Fj.clinthera.2008.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=18498913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWltLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2008&pages=641-653&author=M.+Y.+Liuauthor=S.+N.+Mengauthor=H.+Z.+Wuauthor=S.+Wangauthor=M.+J.+Wei&title=Pharmacokinetics+of+single-dose+and+multiple-dose+memantine+in+healthy+chinese+volunteers+using+an+analytic+method+of+liquid+chromatography-tandem+mass+spectrometry&doi=10.1016%2Fj.clinthera.2008.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of single-dose and multiple-dose memantine in healthy Chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry</span></div><div class="casAuthors">Liu, Ming-Yan; Meng, Sheng-Nan; Wu, Hui-Zhe; Wang, Shuang; Wei, Min-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">641-653</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">This study consisted of 2 phases: development of a liq. chromatog.-tandem mass spectrometry (LC/MS) method for detn. of memantine in human plasma and characterization of single-dose and multiple-dose pharmacokinetic profiles of memantine in healthy Chinese volunteers using the LC/MS method.  An analytic method of LC/MS for detn. of memantine in human plasma was developed and validated and was applied to this single-center, open-label, single-dose and multiple-dose pharmacokinetic study conducted in healthy native Chinese volunteers.  Subjects were randomized to receive a single dose of 5, 10, or 20 mg of memantine to study the linear characteristics of pharmacokinetics, or a multiple dose of 5 mg once daily for 14 days to study the drug accumulation.  The pharmacokinetic parameters calcd. included Cmax, Tmax, AUC, t1/2, mean residence time (MRT), max. steady-state plasma concn. (Cssmax), min. steady-state plasma concn. (Cssmin), av. steady-state plasma concn. (Cssav), and fluctuation percentage (DF).  All values were expressed as mean (SD).  Sequential blood samples were collected from 0 to 360 h for single-dose pharmacokinetic detns. after the dose on day 1; in the multiple-dose pharmacokinetic arm, the sequential blood samples were also obtained from 0 to 360 h on day 14 after collecting the predose samples at 0 h on days 11, 12, and 13.  Memantine concns. in plasma were detd. by LC/MS method.  A calibration curve was constructed by 7 memantine concns. and processed by least-squares linear regression anal. (w = 1/x2).  Safety assessments, including adverse events (AEs), were performed at all study visits.  The LC/MS method for detn. of memantine in human plasma was developed and validated.  The std. calibration curve for spiked human plasma contg. memantine was linear in the concn. range of 0.2 to 200.0 ng/mL.  The correlation coeff. was greater than 0.9960 (n = 6).  The lower limit of quantification for memantine in human plasma was 0.2 ng/mL, and the intraday and interday coeffs. of variation were all lower than 15%.  The mean recoveries of the 0.4, 20.0, and 180.0 ng/mL levels were 78.87%, 81.55%, and 81.98%, resp.  The coeffs. of variation were all lower than 15% after being treated at room temp. for 24 h, for 45 days at -40°, and within 3 freeze-and-thaw cycles in plasma samples.  Forty native Chinese subjects (10 [5 men, 5 women] subjects per group; mean [SD] age, 21.6 [1.6] [range, 19-27] years; wt., 63.0 [7.7] [range, 52-82] kg; height, 170.0 [7.0] [range, 155-185] cm) were enrolled in the study.  After single-dose oral administration, the main pharmacokinetic parameters found for memantine at doses of 5, 10, and 20 mg were as follows: Cmax, 6.20 (0.75), 11.60 (1.95), and 25.34 (8.34) ng/mL, resp.; Tmax, 5.70 (1.64), 6.00 (1.33), and 6.89 (1.41) h; AUC0-t, 486.19 (80.00), 889.32 (239.49), and 1772.91 (784.07) ng/h/mL; AUC0-∞, 540.05 (89.68), 932.07 (230.82), and 1853.29 (776.85) ng/h/mL; t1/2, 66.86 (11.75), 63.57 (12.58), and 62.06 (9.26) h; and MRT, 99.37 (16.96), 91.73 (18.16), and 89.56 (13.77) h.  The main pharmacokinetic parameters found for memantine at doses of 5 mg once daily for 14 days were as follows: Tmax, 6.80 (2.46) h; Cssmax, 19.69 (2.00) ng/mL; Cssmin, 12.76 (2.80) ng/mL; Cssav, 16.10 (2.46) ng/mL; t1/2, 64.57 (15.78) h; MRT, 93.17 (23.38) h; AUCss, 386.37 (59.00) ng/h/mL; and DF, 44.47% (15.27%).  One female subject withdrew from the study after a single 20-mg dose due to an AE (dizziness and vomiting); no other subjects experienced an AE.  In these healthy Chinese subjects, the t1/2 and MRT values were fixed and did not increase following the increased dose, and the AUC0-∞ and Cmax values increased following the increasing dosage of memantine.  Linear pharmacokinetics was found at doses from 5 to 20 mg.  The multiple-dose pharmacokinetic parameters (other than Cmax) were nearly similar compared with the single-dose administration.  The max. plasma concn. of memantine after multiple-dose administration was greater than that after a single-dose administration, suggesting memantine accumulation with multiple-dose administration of 5 mg and requiring further confirmation in larger studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHbDkJE8GH-rVg90H21EOLACvtfcHk0lgS_CqN1hlWqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWltLnE&md5=e13f114fcc42624cb8b6ecf7f472cc3c</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2008.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2008.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DM.%2BY.%26aulast%3DMeng%26aufirst%3DS.%2BN.%26aulast%3DWu%26aufirst%3DH.%2BZ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DM.%2BJ.%26atitle%3DPharmacokinetics%2520of%2520single-dose%2520and%2520multiple-dose%2520memantine%2520in%2520healthy%2520chinese%2520volunteers%2520using%2520an%2520analytic%2520method%2520of%2520liquid%2520chromatography-tandem%2520mass%2520spectrometry%26jtitle%3DClin.%2520Ther.%26date%3D2008%26volume%3D30%26spage%3D641%26epage%3D653%26doi%3D10.1016%2Fj.clinthera.2008.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minocha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spyker, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, H. E.</span></span> <span> </span><span class="NLM_article-title">Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">216</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1128/aac.28.2.216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1128%2FAAC.28.2.216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=3834831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADyaL2MXltFGltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=216-221&author=F.+G.+Haydenauthor=A.+Minochaauthor=D.+A.+Spykerauthor=H.+E.+Hoffman&title=Comparative+single-dose+pharmacokinetics+of+amantadine+hydrochloride+and+rimantadine+hydrochloride+in+young+and+elderly+adults&doi=10.1128%2Faac.28.2.216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults</span></div><div class="casAuthors">Hayden, Frederick G.; Minocha, Anil; Spyker, Daniel A.; Hoffman, Howard E.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">216-21</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    </div><div class="casAbstract">The single-dose pharmacokinetics of amantadine  [768-94-5] and rimantadine  [13392-28-4] were compared in a randomized, 2-period, crossover study involving 6 young (≤35 yr) and 6 elderly (≥60 yr) adults.  Subjects ingested single 200-mg oral doses after an overnight fast, and serial plasma (0 to 96 h), nasal mucus (0 to 8 h), and urine (0 to 24 h) samples were collected for assay of drug concn. by electron capture gas chromatog.  For both groups combined, rimantadine differed significantly from amantadine in peak plasma concn. (0.25 vs. 0.65 μg/mL), plasma elimination half-life (36.5 vs. 16.7 h), and percentage of administered dose excreted unchanged in urine (0.6 vs. 45.7%).  No significant age-related differences were noted for rimantadine.  Urinary excretion (0 to 24 h) of rimantadine and its hydroxylated metabolites averaged 19% of the administered dose.  The max. nasal mucus drug concn. was similar for both drugs (0.42 vs. 0.45 μg/g), and the ratio of max. nasal mucus to plasma concn. was over 2-fold higher after rimantadine than after amantadine.  These findings may in part explain the clin. effectiveness of rimantadine in influenza A virus infections at dosages that have lower toxicity than those of amantadine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8h2MHRwaLlLVg90H21EOLACvtfcHk0lgB_OY88tynaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXltFGltL8%253D&md5=979561b6722c747463126c4c3b095b7f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1128%2FAAC.28.2.216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.28.2.216%26sid%3Dliteratum%253Aachs%26aulast%3DHayden%26aufirst%3DF.%2BG.%26aulast%3DMinocha%26aufirst%3DA.%26aulast%3DSpyker%26aufirst%3DD.%2BA.%26aulast%3DHoffman%26aufirst%3DH.%2BE.%26atitle%3DComparative%2520single-dose%2520pharmacokinetics%2520of%2520amantadine%2520hydrochloride%2520and%2520rimantadine%2520hydrochloride%2520in%2520young%2520and%2520elderly%2520adults%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1985%26volume%3D28%26spage%3D216%26epage%3D221%26doi%3D10.1128%2Faac.28.2.216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liebes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochster, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chachoua, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sewak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosmidis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shore, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecht, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, F.-L.</span></span> <span> </span><span class="NLM_article-title">Thirty day multiple dose administration of PEITC: A phase I study with steady state pharmacokinetics showing good tolerance through 120 mg daily</span>. <i>Proc Am Assoc Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">834</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=834&author=L.+Liebesauthor=H.+Hochsterauthor=C.+C.+Conawayauthor=A.+Chachouaauthor=S.+Sewakauthor=K.+Farrellauthor=A.+Cosmidisauthor=S.+Mendozaauthor=R.+Shoreauthor=J.+Crowellauthor=S.+S.+Hechtauthor=S.+Carmellaauthor=F.-L.+Chung&title=Thirty+day+multiple+dose+administration+of+PEITC%3A+A+phase+I+study+with+steady+state+pharmacokinetics+showing+good+tolerance+through+120+mg+daily"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiebes%26aufirst%3DL.%26aulast%3DHochster%26aufirst%3DH.%26aulast%3DConaway%26aufirst%3DC.%2BC.%26aulast%3DChachoua%26aufirst%3DA.%26aulast%3DSewak%26aufirst%3DS.%26aulast%3DFarrell%26aufirst%3DK.%26aulast%3DCosmidis%26aufirst%3DA.%26aulast%3DMendoza%26aufirst%3DS.%26aulast%3DShore%26aufirst%3DR.%26aulast%3DCrowell%26aufirst%3DJ.%26aulast%3DHecht%26aufirst%3DS.%2BS.%26aulast%3DCarmella%26aufirst%3DS.%26aulast%3DChung%26aufirst%3DF.-L.%26atitle%3DThirty%2520day%2520multiple%2520dose%2520administration%2520of%2520PEITC%253A%2520A%2520phase%2520I%2520study%2520with%2520steady%2520state%2520pharmacokinetics%2520showing%2520good%2520tolerance%2520through%2520120%2520mg%2520daily%26jtitle%3DProc%2520Am%2520Assoc%2520Cancer%2520Res.%26date%3D2001%26volume%3D42%26spage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span> <span> </span><span class="NLM_article-title">Simultaneous determination of LogD, LogP, and pK(a) of drugs by using a reverse phase HPLC coupled with a 96-well plate auto injector</span>. <i>Comb. Chem. High Throughput Screening</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">250</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.2174/138620709787581693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.2174%2F138620709787581693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=19275530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1CgtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=250-257&author=P.+C.+Chiangauthor=Y.+Hu&title=Simultaneous+determination+of+LogD%2C+LogP%2C+and+pK%28a%29+of+drugs+by+using+a+reverse+phase+HPLC+coupled+with+a+96-well+plate+auto+injector&doi=10.2174%2F138620709787581693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Simultaneous determination of LogD, LogP, and pKa of drugs by using a reverse phase HPLC coupled with a 96-well plate auto injector</span></div><div class="casAuthors">Chiang, Po-Chang; Hu, Yiding</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">250-257</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  For years, the physicochem. properties of drug candidates were used to predict their in vivo pharmacokinetic behaviors.  Several theories and empirical correlations have been established by various researchers with the overall goal of expediting the drug candidate selection process, with greater confidence and faster turnaround.  This study describes a 96-well reverse phase HPLC method, simultaneously detg. LogD, LogP, and pKa values of drugs in a throughput mode.  The LogD and LogP values of each compd. were detd., based on the octanol-aq. partitioning behavior of the charged and non-charged species under different pH values.  The pKa value was detd. by the Polynomial fit between LogP and LogD and the equation LogD (pKa) ≈ LogP - 0.301.  The advantages of this method are: low sample consumption, suitability for low soly. compds., less restriction on compd. purity, potential for higher throughput, precise data, and multiple detns. in one assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3h7viwTwxUrVg90H21EOLACvtfcHk0lgB_OY88tynaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1CgtL8%253D&md5=de5cf4ce8d5273e341f3c8a4b07f3a1d</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.2174%2F138620709787581693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138620709787581693%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DP.%2BC.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DSimultaneous%2520determination%2520of%2520LogD%252C%2520LogP%252C%2520and%2520pK%2528a%2529%2520of%2520drugs%2520by%2520using%2520a%2520reverse%2520phase%2520HPLC%2520coupled%2520with%2520a%252096-well%2520plate%2520auto%2520injector%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2009%26volume%3D12%26spage%3D250%26epage%3D257%26doi%3D10.2174%2F138620709787581693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/medium/jm0c01971_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01971&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/medium/jm0c01971_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of Ad-ITCs and Ad-compound <b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01971&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/medium/jm0c01971_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effects of Ad-ITCs on the proliferation of breast cancer cell lines expressing mutant p53 or WT p53. (A–C) The mutant p53 (p53<sup>R280K</sup> MDA-MB-231 and p53<sup>R273H</sup> MDA-MB-468) and WT p53 (MCF-7) cells, respectively, were treated with DMSO (as a control) or different Ad-ITCs or Ad-compound <b>13</b> at the indicated concentrations for 24 h. Percent cell proliferation determined by WST-1 was calculated as the ratio of OD<sub>450</sub> values obtained for cells grown in the presence of the respective Ad-ITC or Ad-compound <b>13</b> compared with that of DMSO. Experiments were performed in triplicate. Error bars represent the standard deviation (SD).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01971&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/medium/jm0c01971_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of Ad-ITCs on apoptosis induction and p53 levels in breast cancer cell lines with mutant p53 or WT p53. (A–C) The mutant p53 (p53<sup>R280K</sup> MDA-MB-231 and p53<sup>R273H</sup> MDA-MB-468) and WT p53 (MCF-7) cells, respectively, were treated with DMSO (as a control) or different Ad-ITCs or Ad-compound <b>13</b> at the indicated concentrations for 24 h. Apoptosis was measured by Annexin-V staining by flow cytometry using a BD LSRFORTESSA instrument. Percent values of Annexin-V positive stained cells were calculated as the ratio of stained cells obtained for cells grown in the presence of the respective Ad-ITC or Ad-compound <b>13</b> compared with the presence of DMSO. (D) SARs for the depletion of mutant p53 levels by Ad-ITCs. The mutant p53 (p53<sup>R280K</sup> MDA-MB-231 and p53 <sup>R273H</sup> MDA-MB-468) and WT p53 (MCF-7) cells, respectively, were treated with DMSO (as a control) or 6 or 12 μM of different Ad-ITCs or Ad-compound <b>13</b> for 24 h. Cells were harvested, and lysates were prepared. 20 or 50 μg of the mutant p53 or WT p53 cell lysate fractions, respectively, was resolved by SDS-PAGE and probed with the p53 DO-1 antibody. Blots were stripped and reprobed with anti-GAPDH as a loading control. Experiments were performed in triplicate. Error bars represent the SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01971&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/medium/jm0c01971_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of Ad-ITC <b>6</b> on canonical p53 targets, cell cycle progression, and activation of ATM. (A) qRT-PCR of p53 regulated downstream target genes p21 and NOXA in mutant p53 (p53<sup>R280K</sup> MDA-MB-231, p53<sup>R273H</sup> MDA-MB-468) and WT p53 (MCF-7) cell treated with DMSO or 6 μM Ad-ITC <b>6</b> for 4 h. (***<i>p</i> ≤ 0.0005 and *<i>p</i> ≤ 0.05). (B<b>)</b> Cells were treated with DMSO or 6 μM Ad-ITC <b>6</b> for 24 h and analyzed by flow cytometry. (C) Cells were treated with DMSO or 6 μM Ad-ITC <b>6</b> for 24 h. Blots were probed using the anti-pATM S1981 antibody and reprobed with the GAPDH antibody. Experiments were performed in triplicate. Error bars represent the SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01971&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/medium/jm0c01971_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of Ad-ITC <b>6</b> on the proliferation of MDA-MB-436 (p53 null) and HCC1937 (truncated mutant p53) cells. Cells were treated with DMSO (as a control) or Ad-ITC <b>6</b> at the indicated concentrations for 24 (A) or 72 h (B). Percent cell proliferation determined by WST-1 was calculated as the ratio of OD<sub>450</sub> values obtained for cells grown in the presence of the Ad-ITC <b>6</b> compared with the presence of DMSO. Experiments were performed in triplicate. Error bars represent the SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01971&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/medium/jm0c01971_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Ad-ISeC <b>14</b> showed an enhanced potency to inhibit the growth of TNBC with mutant p53. (A) Structure of Ad-ISeC <b>14</b>. (B) The mutant p53 (p53<sup>R280K</sup> MDA-MB-231 and p53<sup>R273H</sup> MDA-MB-468) and WT p53 (MCF-7) cells, respectively, were treated with DMSO or Ad-ISeC <b>14</b> for 24 h. Percent cell proliferation determined by WST-1 was calculated as the ratio of OD<sub>450</sub> obtained for cells grown in the presence of Ad-ISeC <b>14</b> compared with the presence of DMSO. (C) The mutant p53 and WT p53 cells were treated with DMSO or Ad-ISeC <b>14</b> for 24 h. Apoptosis was measured by Annexin-V staining. Percent values of Annexin-V positive stained cells were calculated as the ratio of stained cells obtained for cells grown in the presence of the Ad-ISeC <b>14</b> compared with the presence of DMSO. (D) The mutant p53 and WT p53 cells were treated with DMSO or Ad-ISeC <b>14</b> (6 or 12 μM) for 24 h, and mutant p53 expression was analyzed. 20 or 50 μg of the mutant or WT p53 cell lysate fractions, respectively, was resolved by SDS-PAGE and probed with the p53 DO-1 antibody. Blots were reprobed with anti-GAPDH as a loading control. (E) Effects of Ad-ISeC <b>14</b> on canonical p53 targets. qRT-PCR of p53 regulated downstream target genes p21 and NOXA in mutant p53 and WT p53 cell treated with DMSO or 6 μM Ad-ISeC <b>14</b> for 4 h. (***<i>p</i> ≤ 0.0005, **<i>p</i> ≤ 0.005, and *<i>p</i> ≤ 0.05). Experiments were performed in triplicate. Error bars represent the SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01971/20210520/images/large/jm0c01971_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01971&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35016" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35016" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 51 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerzon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krumkalns, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindle, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, M. A.</span></span> <span> </span><span class="NLM_article-title">The adamantyl group in medicinal agents. I. Hypoglycemic N-Arylsulfonyl-N’-adamantylureas</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1963</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">760</span>– <span class="NLM_lpage">763</span>, <span class="refDoi"> DOI: 10.1021/jm00342a029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00342a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADyaF2cXitlSnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1963&pages=760-763&author=K.+Gerzonauthor=E.+V.+Krumkalnsauthor=R.+L.+Brindleauthor=F.+J.+Marshallauthor=M.+A.+Root&title=The+adamantyl+group+in+medicinal+agents.+I.+Hypoglycemic+N-Arylsulfonyl-N%E2%80%99-adamantylureas&doi=10.1021%2Fjm00342a029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Adamantyl group in medical agents. I. Hypoglycemic N-arylsulfonyl-N'-adamantylureas</span></div><div class="casAuthors">Gerzon, Koert; Krumalns, Eriks V.; Brindle, Richard L.; Marshall, Frederick J.; Root, Mary A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1963</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">760-3</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">To assess the possible pharmacodynamic effects of the sym. lipophilic adamantyl group, a no. of N-arylsulfonyl-N'-adamantylureas, ArSO2NHCONHR (I), were prepd. for evaluation as hypoglycemic agents.  (All m.ps. were taken in sealed, submerged capillary tubes).  Adamantane-1-carboxamide (9 g.) in 200 ml. dry Et2O added to 10 g. LiAlH4 suspended in 500 ml. dry Et2O with stirring, the mixt. refluxed 4 hrs., cooled to -5° with stirring, treated dropwise by 10 ml. H2O, followed by 30 ml. 10% aq. NaOH and 10 ml. H2O, the solids filtered off and washed with 500 ml. Et2O, the combined Et2O solns. dried and evapd. in vacuo, the residue dissolved in 50 ml. Et2O, and the soln. filtered and treated with dry HCl gave 7 g. 1-aminomethyladamantane-HCl, m. 320° (EtOH).  1-Methyladamantane brominated by the procedure reported for 1-bromoadamantane (Stetter, et al., CA 53, 21709f; 54, 1356a) gave 93% 3-methyl-1-bromoadamantane (II), b0.05 65-7°, whose structure was supported by its nuclear magnetic resonance (n.m.r.) spectrum.  From II was prepd. by the MeCN-H2SO4 method (S., et al., CA 54, 9950d) 1-acetamido-3-methyladamantane (III), m. 108-9° (sublimation at 90-100°/0.05 mm.).  Deacetylation of III by KOH in O(CH2CH2OH)2, followed by Et2O extn. gave an Et2O soln. contg. product and ∼5% unchanged III, which was treated with dry HCl to give 87% 1-amino-3-methyladamantane-HCl, m. 295-300°.  1,3-Dimethyladamantane brominated as above gave 77.5 g. 1-bromo-3,5-dimethyladamantane (IV), b0.03 67-9°, n25D 1.5178 (structure supported by n.m.r. spectrum), which was converted into 96% 1-acetamido analog of IV, m. 80-2° (sublimation), and the latter into 87% 1-amino analog of IV HCl salt, m. 290-5°.  Adamantane (V) (100 g.) and 85 g. tert-BuCl in 400 ml. anhyd. cyclohexane treated portionwise during 8 hrs. with 4.6 g. (total) AlCl3 (in 0.5 g. batches AlCl3), when the reaction was complete (as judged from escaping isobutane gas), 100 ml. N HCl added with stirring, followed by 500 ml. Et2O, and the org. layer sepd., washed with 50 ml. cold H2O and 50 ml. 5% aq. NaHCO3, dried, and evapd. in vacuo gave 115 g. crude 1-chloroadamantane (VI), m. 152-6°, contg. (gas chromatography) 90-5% VI and 5-10% V; recrystn. of a sample from EtOH at - 50° gave pure VI, as detd. by mixed m.p. with authentic VI and by x-ray diffraction patterns.  Crude VI was converted by the MeCN-H2SO4 method into 83% crude 1-acetamidoadamantane (VII), m. 144-6°; pure VII m. 147-9° (EtOH).  Crude VII (108 g.) sapond. gave 51 g. pure 1-aminoadamantane (VIII), m. 160-200°.  VIII (302.5 g.) and 535 g. 4-MeC6H4SO2NHCO2Et in 6 l. dry PhMe refluxed 5 hrs., cooled to room temp., the cryst. solid filtered off and dissolved (without application of heat) in ∼2 l. CHCl3 which had previously been shaken with 50 g. Al2O3 to remove traces EtOH, the soln. washed with cold 5% HCl and H2O until neutral, dried (MgSO4), concd. in vacuo to 1/2 its vol., warmed to 50°, dild. with hot petr. ether (b. 60-71°) to start crystn., and chilled overnight gave 400 g. I (Ar = 4-MeC6H4, R = 1-adamantyl) (IX), m. 178-9° (CHCl3-petr. ether).  The following I were prepd. (Ar, R, m.p., relative potency with respect to hypoglycemic activity given): 4-MeC6H4, Bu (Tolbutamide), -, 1; 4-MeC6H4, 1-adamantyl, 178-9°, 15.5; 4-MeC6H4, cyclohexyl (Tolcyclamide), -, 12.8; 4-EtC6H4, 1-adamantyl, 153-5°, 14.8; 4-EtC6H4, cyclohexyl, -, 9.3; 4-MeSC6H4, 1-adamantyl, 155-8°, 8.7; 4-MeSC6H4, cyclohexyl (Thiohexamide), -, 4.1; 4-ClC6H4, 1-adamantyl, 150-1°, 5.1; 4-ClC6H4, cyclohexyl, -, 5.6; 4-ClC6H4, Pr, -, 2.1; 4-iso-PrC6H4, 1-adamantyl, 190-2°, 2.9; 4-AcC6H4, 1-adamantyl, 163-5°, 1.6; 4-AcC6H4, cyclohexyl (Acetohexamide), -, 4.0; 4,3-Me(H2N)C6H3, 1-adamantyl, 175° (decompn.), 0; 4,3-Me(H2N)C6H3, cyclohexyl (Metahexamide), -, 5.0; 4-MeC6H4, 2-adamantyl, 206-8°, 4.0; 4-MeC6H4, 3-methyl-l-adamantyl, 184-6°, 2.8; 4-MeC6H4, 3,5-dimethyl-1-adamantyl, 166-8°, 0; 4-EtC6H4, 1-adamantylmethyl, 203-5°, 0.2; 4-AcC6H4, 1-adamantylmethyl, 204-6°, 0.  The pharmacol. evaluation of the compds. is discussed; particularly with respect to IX.  Preliminary clinical data thus far indicate IX to be a most satisfactory, potent oral hypoglycemic agent with an effective av. dose, single or divided, of 400 reg./day.  IX is equal to Chlorpropamide on a wt. basis and possesses about 5 times the potency of Tolbutamide.  The activity of IX is rapid in onset with tentative duration of 4-6 hrs., indicating that IX is rapidly absorbed and utilized by the body.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv8XqLXlCyArVg90H21EOLACvtfcHk0lhtu-BBNGL7zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2cXitlSnsQ%253D%253D&md5=3628367dabac00a8be059ae056ebf268</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm00342a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00342a029%26sid%3Dliteratum%253Aachs%26aulast%3DGerzon%26aufirst%3DK.%26aulast%3DKrumkalns%26aufirst%3DE.%2BV.%26aulast%3DBrindle%26aufirst%3DR.%2BL.%26aulast%3DMarshall%26aufirst%3DF.%2BJ.%26aulast%3DRoot%26aufirst%3DM.%2BA.%26atitle%3DThe%2520adamantyl%2520group%2520in%2520medicinal%2520agents.%2520I.%2520Hypoglycemic%2520N-Arylsulfonyl-N%25E2%2580%2599-adamantylureas%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1963%26volume%3D6%26spage%3D760%26epage%3D763%26doi%3D10.1021%2Fjm00342a029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rapala, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraay, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerzon, K.</span></span> <span> </span><span class="NLM_article-title">The adamantyl group in medicinal agents. II. Anabolic steroid 17β-adamantoates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1965</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">580</span>– <span class="NLM_lpage">583</span>, <span class="refDoi"> DOI: 10.1021/jm00329a007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00329a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADyaF2MXks1egtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1965&pages=580-583&author=R.+T.+Rapalaauthor=R.+J.+Kraayauthor=K.+Gerzon&title=The+adamantyl+group+in+medicinal+agents.+II.+Anabolic+steroid+17%CE%B2-adamantoates&doi=10.1021%2Fjm00329a007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The adamantyl group in medicinal agents. II. Anabolic steroid 17β-adamantoates</span></div><div class="casAuthors">Rapala, Richard T.; Kraay, Russell J.; Gerzon, Koert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">580-3</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The synthesis of several steroidal 17β-adamantoate esters is described.  The adamantoic ester of 19-nortestosterone produces a profound and unique effect on anabolic potency as compared with other esters.  The long duration of high myotropic activity with diminished androgenicity may be an indication that the ester is acting in toto as opposed to prior hydrolysis to the parent compound.  The action of this anabolic ester over a period of several weeks after a single injection is confirmed by the radioactive aminoisobutyric acid (AIB)14C uptake data.  Cf. CA 60, 4022f.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYaAvLSr6ziLVg90H21EOLACvtfcHk0ljP7-l6L2B94Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXks1egtLg%253D&md5=b6ffd526ca97131eebb2c3303d585db7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm00329a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00329a007%26sid%3Dliteratum%253Aachs%26aulast%3DRapala%26aufirst%3DR.%2BT.%26aulast%3DKraay%26aufirst%3DR.%2BJ.%26aulast%3DGerzon%26aufirst%3DK.%26atitle%3DThe%2520adamantyl%2520group%2520in%2520medicinal%2520agents.%2520II.%2520Anabolic%2520steroid%252017%25CE%25B2-adamantoates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1965%26volume%3D8%26spage%3D580%26epage%3D583%26doi%3D10.1021%2Fjm00329a007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerzon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kau, D.</span></span> <span> </span><span class="NLM_article-title">The adamantyl group in medicinal agents. III. Nucleoside 5′-adamantoates. The adamantoyl function as a protecting group</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1021/jm00314a014</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00314a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADyaF2sXnsVyrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1967&pages=189-199&author=K.+Gerzonauthor=D.+Kau&title=The+adamantyl+group+in+medicinal+agents.+III.+Nucleoside+5%E2%80%B2-adamantoates.+The+adamantoyl+function+as+a+protecting+group&doi=10.1021%2Fjm00314a014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The adamantyl group in medicinal agents.  III.  Nucleoside 5'-adamantoates.  The adamantoyl function as a protecting group</span></div><div class="casAuthors">Gerzon, Koert; Kau, Don</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">189-99</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The prepn. and biol. evaluation are described for the 5'-adamantoates of the deoxyribonucleosides, thymidine, 2'-deoxy-5-fluorouridine, and deoxyadenosine, and of the ribonucleosides, adenosine, inosine, 6-thioinosine, and 6-azauridine.  The adamantoylation of the deoxyribonucleosides proceeds preferentially to give the 5'-esters in which the adamantoyl function can serve as a base-sensitive protecting group in nucleoside synthesis.  The adamantoate of 6-thioinosine suppresses antibody formation in the mouse following challenge by sheep erythrocytes.  The adamantoate of adenosine inhibits ADP-induced platelet aggregation in vitro.  The antitumor activity of the adamantoates of several nucleoside analogs is recorded.  The possible mode of action of adamantane-contg. agents is described in terms of a precise binding of the adamantane moiety to complementary, hydrophobic regions in the receptor site protein mol.  48 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowa4XCHx8yKbVg90H21EOLACvtfcHk0lgv8J0ntQkcYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXnsVyrsw%253D%253D&md5=4490b497819a795404b06c7fcbc70b06</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm00314a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00314a014%26sid%3Dliteratum%253Aachs%26aulast%3DGerzon%26aufirst%3DK.%26aulast%3DKau%26aufirst%3DD.%26atitle%3DThe%2520adamantyl%2520group%2520in%2520medicinal%2520agents.%2520III.%2520Nucleoside%25205%25E2%2580%25B2-adamantoates.%2520The%2520adamantoyl%2520function%2520as%2520a%2520protecting%2520group%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1967%26volume%3D10%26spage%3D189%26epage%3D199%26doi%3D10.1021%2Fjm00314a014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wanka, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiner, P. R.</span></span> <span> </span><span class="NLM_article-title">The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">3516</span>– <span class="NLM_lpage">3604</span>, <span class="refDoi"> DOI: 10.1021/cr100264t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr100264t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVajs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2013&pages=3516-3604&author=L.+Wankaauthor=K.+Iqbalauthor=P.+R.+Schreiner&title=The+lipophilic+bullet+hits+the+targets%3A+medicinal+chemistry+of+adamantane+derivatives&doi=10.1021%2Fcr100264t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The Lipophilic Bullet Hits the Targets: Medicinal Chemistry of Adamantane Derivatives</span></div><div class="casAuthors">Wanka, Lukas; Iqbal, Khalid; Schreiner, Peter R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">3516-3604</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This review focuses on the medicinal chem. of the parent hydrocarbon, adamantane, and its derivs.  We will describe the development of adamantane-based chemotherapeutics for viral infections including Influenza A, Herpes simplex, Hepatitis C, and HIV.  Adamantane derivs. to be used as antimalarials will also be covered there.  Emerging adamantane resistant strains of Influenza A may lead to an end of the use of aminoadamantanes against these infections, whereas the utilization of the pronounced lipophilic properties of adamantane derivs. in pharmaceuticals for neurol. disorders still prospers.  This latest review article gives clogP data on adamantyl derivs. comparing them with nonadamantyl-analogs.  Adamantane is not a magic bullet, but it certainly is more than just a lipophilic add-on, as we have tried to show in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEwNNxUUkDQ7Vg90H21EOLACvtfcHk0li4YAGsZQe5Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVajs70%253D&md5=19e864e9e5dc1bfdb5d2db3f08f81671</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fcr100264t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr100264t%26sid%3Dliteratum%253Aachs%26aulast%3DWanka%26aufirst%3DL.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DSchreiner%26aufirst%3DP.%2BR.%26atitle%3DThe%2520lipophilic%2520bullet%2520hits%2520the%2520targets%253A%2520medicinal%2520chemistry%2520of%2520adamantane%2520derivatives%26jtitle%3DChem.%2520Rev.%26date%3D2013%26volume%3D113%26spage%3D3516%26epage%3D3604%26doi%3D10.1021%2Fcr100264t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cady, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt-Rohr, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soto, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degrado, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, M.</span></span> <span> </span><span class="NLM_article-title">Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>463</i></span>,  <span class="NLM_fpage">689</span>– <span class="NLM_lpage">692</span>, <span class="refDoi"> DOI: 10.1038/nature08722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1038%2Fnature08722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=20130653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVygu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=463&publication_year=2010&pages=689-692&author=S.+D.+Cadyauthor=K.+Schmidt-Rohrauthor=J.+Wangauthor=C.+S.+Sotoauthor=W.+F.+Degradoauthor=M.+Hong&title=Structure+of+the+amantadine+binding+site+of+influenza+M2+proton+channels+in+lipid+bilayers&doi=10.1038%2Fnature08722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers</span></div><div class="casAuthors">Cady, Sarah D.; Schmidt-Rohr, Klaus; Wang, Jun; Soto, Cinque S.; De Grado, William F.; Hong, Mei</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">463</span>
        (<span class="NLM_cas:issue">7281</span>),
    <span class="NLM_cas:pages">689-692</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The M2 protein of influenza A virus is a membrane-spanning tetrameric proton channel targeted by the antiviral drugs amantadine and rimantadine.  Resistance to these drugs has compromised their effectiveness against many influenza strains, including pandemic H1N1.  A recent crystal structure of M2(22-46) showed electron densities attributed to a single amantadine in the amino-terminal half of the pore, indicating a phys. occlusion mechanism for inhibition.  However, a soln. NMR structure of M2(18-60) showed four rimantadines bound to the carboxy-terminal lipid-facing surface of the helixes, suggesting an allosteric mechanism.  Here we show by solid-state NMR spectroscopy that two amantadine-binding sites exist in M2 in phospholipid bilayers.  The high-affinity site, occupied by a single amantadine, is located in the N-terminal channel lumen, surrounded by residues mutated in amantadine-resistant viruses.  Quantification of the protein-amantadine distances resulted in a 0.3 Å-resoln. structure of the high-affinity binding site.  The second, low-affinity, site was obsd. on the C-terminal protein surface, but only when the drug reaches high concns. in the bilayer.  The orientation and dynamics of the drug are distinct in the two sites, as shown by 2H NMR.  These results indicate that amantadine phys. occludes the M2 channel, thus paving the way for developing new antiviral drugs against influenza viruses.  The study demonstrates the ability of solid-state NMR to elucidate small-mol. interactions with membrane proteins and det. high-resoln. structures of their complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3_-eACNO4ZbVg90H21EOLACvtfcHk0li4YAGsZQe5Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVygu70%253D&md5=9db7a0cb6fe8eb60124cb620ead6aa45</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnature08722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08722%26sid%3Dliteratum%253Aachs%26aulast%3DCady%26aufirst%3DS.%2BD.%26aulast%3DSchmidt-Rohr%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSoto%26aufirst%3DC.%2BS.%26aulast%3DDegrado%26aufirst%3DW.%2BF.%26aulast%3DHong%26aufirst%3DM.%26atitle%3DStructure%2520of%2520the%2520amantadine%2520binding%2520site%2520of%2520influenza%2520M2%2520proton%2520channels%2520in%2520lipid%2520bilayers%26jtitle%3DNature%26date%3D2010%26volume%3D463%26spage%3D689%26epage%3D692%26doi%3D10.1038%2Fnature08722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kozubík, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horváth, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Švihálková-Šindlerová, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souček, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmanová, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sova, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroutil, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Žák, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistr, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turánek, J.</span></span> <span> </span><span class="NLM_article-title">High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2004.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1016%2Fj.bcp.2004.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=15652229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVSgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2005&pages=373-383&author=A.+Kozub%C3%ADkauthor=V.+Horv%C3%A1thauthor=L.+%C5%A0vih%C3%A1lkov%C3%A1-%C5%A0indlerov%C3%A1author=K.+Sou%C4%8Dekauthor=J.+Hofmanov%C3%A1author=P.+Sovaauthor=A.+Kroutilauthor=F.+%C5%BD%C3%A1kauthor=A.+Mistrauthor=J.+Tur%C3%A1nek&title=High+effectiveness+of+platinum%28IV%29+complex+with+adamantylamine+in+overcoming+resistance+to+cisplatin+and+suppressing+proliferation+of+ovarian+cancer+cells+in+vitro&doi=10.1016%2Fj.bcp.2004.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro</span></div><div class="casAuthors">Kozubik, Alois; Horvath, Viktor; Svihalkova-Sindlerova, Lenka; Soucek, Karel; Hofmanova, Jirina; Sova, Petr; Kroutil, Ales; Zak, Frantisek; Mistr, Adolf; Turanek, Jaroslav</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">373-383</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">[(OC-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV)], coded as LA-12, is an octahedral platinum(IV) complex contg. a bulky hydrophobic ligand - adamantylamine.  The use of bulky hydrophobic amines as non-leaving ligands, may increase uptake of the compd. by the cancer cells.  Therefore, the effects of LA-12 on sensitive (A2780) and cisplatin resistant (A2780cis) ovarian cancer cell lines were investigated and compared to those of cisplatin.  IC50 and IC90 concns. of LA-12 were 6- (A2780) or 18-fold (A2780cis) lower than those for cisplatin (MTT assay).  Equitoxic concns. (IC50 or IC90) of both compds. caused a significant and similar time- and dose-dependent inhibition of cell proliferation and an increase in the no. of floating cells which corresponded to the decrease of total cell viability.  A different type and dynamics of cell cycle perturbation after cisplatin and LA-12 treatment were detected.  Exposure to LA-12 resulted in transient accumulation of A2780 and A2780cis cells in S phase, while cisplatin caused G2/M arrest in sensitive and S phase arrest in resistant cells.  A relatively low rate of apoptosis after exposure to IC50 or IC90 of both complexes was obsd., markedly higher in resistant A2780cis cells.  Western blot anal. indicated a concn.-dependent p53 level increase in both lines (higher after cisplatin treatment).  PARP cleavage was obsd. only in A2780cis cells.  In conclusion, LA-12 was found to be significantly more efficient than cisplatin, and it was able to overcome the acquired cisplatin resistance (showing resistance factor 2.84-fold lower than those for cisplatin).  In spite of the low rate of apoptosis, LA-12 caused increase of p53 level and cell cycle perturbations in the ovarian cancer cell lines studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFHh3HYlDbu7Vg90H21EOLACvtfcHk0lg1s7IiB9a25w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVSgsw%253D%253D&md5=a72e3252412e5973a04c0c58314e37d9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2004.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2004.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DKozub%25C3%25ADk%26aufirst%3DA.%26aulast%3DHorv%25C3%25A1th%26aufirst%3DV.%26aulast%3D%25C5%25A0vih%25C3%25A1lkov%25C3%25A1-%25C5%25A0indlerov%25C3%25A1%26aufirst%3DL.%26aulast%3DSou%25C4%258Dek%26aufirst%3DK.%26aulast%3DHofmanov%25C3%25A1%26aufirst%3DJ.%26aulast%3DSova%26aufirst%3DP.%26aulast%3DKroutil%26aufirst%3DA.%26aulast%3D%25C5%25BD%25C3%25A1k%26aufirst%3DF.%26aulast%3DMistr%26aufirst%3DA.%26aulast%3DTur%25C3%25A1nek%26aufirst%3DJ.%26atitle%3DHigh%2520effectiveness%2520of%2520platinum%2528IV%2529%2520complex%2520with%2520adamantylamine%2520in%2520overcoming%2520resistance%2520to%2520cisplatin%2520and%2520suppressing%2520proliferation%2520of%2520ovarian%2520cancer%2520cells%2520in%2520vitro%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2005%26volume%3D69%26spage%3D373%26epage%3D383%26doi%3D10.1016%2Fj.bcp.2004.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vondálová
Blanářová, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šafaříková, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herůdková, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krkoška, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tománková, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahounová, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andřra, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouchal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharaishvili, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Král, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sova, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozub́k, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyršlová Vaculová, A.</span></span> <span> </span><span class="NLM_article-title">Cisplatin or LA-12 enhance killing effects of TRAIL in prostate cancer cells through Bid-dependent stimulation of mitochondrial apoptotic pathway but not caspase-10</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>, <span class="NLM_elocation-id">e0188584</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0188584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1371%2Fjournal.pone.0188584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=29182622" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&author=O.+Vond%C3%A1lov%C3%A1%0ABlan%C3%A1%C5%99ov%C3%A1author=B.+%C5%A0afa%C5%99%C3%ADkov%C3%A1author=J.+Her%C5%AFdkov%C3%A1author=M.+Krko%C5%A1kaauthor=S.+Tom%C3%A1nkov%C3%A1author=Z.+Kahounov%C3%A1author=L.+And%C5%99raauthor=J.+Bouchalauthor=G.+Kharaishviliauthor=M.+Kr%C3%A1lauthor=P.+Sovaauthor=A.+Kozub%CC%81kauthor=A.+Hyr%C5%A1lov%C3%A1+Vaculov%C3%A1&title=Cisplatin+or+LA-12+enhance+killing+effects+of+TRAIL+in+prostate+cancer+cells+through+Bid-dependent+stimulation+of+mitochondrial+apoptotic+pathway+but+not+caspase-10&doi=10.1371%2Fjournal.pone.0188584"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0188584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0188584%26sid%3Dliteratum%253Aachs%26aulast%3DVond%25C3%25A1lov%25C3%25A1%2BBlan%25C3%25A1%25C5%2599ov%25C3%25A1%26aufirst%3DO.%26aulast%3D%25C5%25A0afa%25C5%2599%25C3%25ADkov%25C3%25A1%26aufirst%3DB.%26aulast%3DHer%25C5%25AFdkov%25C3%25A1%26aufirst%3DJ.%26aulast%3DKrko%25C5%25A1ka%26aufirst%3DM.%26aulast%3DTom%25C3%25A1nkov%25C3%25A1%26aufirst%3DS.%26aulast%3DKahounov%25C3%25A1%26aufirst%3DZ.%26aulast%3DAnd%25C5%2599ra%26aufirst%3DL.%26aulast%3DBouchal%26aufirst%3DJ.%26aulast%3DKharaishvili%26aufirst%3DG.%26aulast%3DKr%25C3%25A1l%26aufirst%3DM.%26aulast%3DSova%26aufirst%3DP.%26aulast%3DKozub%25CC%2581k%26aufirst%3DA.%26aulast%3DHyr%25C5%25A1lov%25C3%25A1%2BVaculov%25C3%25A1%26aufirst%3DA.%26atitle%3DCisplatin%2520or%2520LA-12%2520enhance%2520killing%2520effects%2520of%2520TRAIL%2520in%2520prostate%2520cancer%2520cells%2520through%2520Bid-dependent%2520stimulation%2520of%2520mitochondrial%2520apoptotic%2520pathway%2520but%2520not%2520caspase-10%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26doi%3D10.1371%2Fjournal.pone.0188584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herůdkov́, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paruch, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khirsariya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souček, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krkoška, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanářová, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sova, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozubík, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaculová, A. H.</span></span> <span> </span><span class="NLM_article-title">CHK1 inhibitor SCH900776 effectively potentiates the cytotoxic effects of platinum-based chemotherapeutic drugs in human colon cancer cells</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">830</span>– <span class="NLM_lpage">841</span>, <span class="refDoi"> DOI: 10.1016/j.neo.2017.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1016%2Fj.neo.2017.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=28888100" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=830-841&author=J.+Her%C5%AFdkov%CC%81author=K.+Paruchauthor=P.+Khirsariyaauthor=K.+Sou%C4%8Dekauthor=M.+Krko%C5%A1kaauthor=O.+V.+Blan%C3%A1%C5%99ov%C3%A1author=P.+Sovaauthor=A.+Kozub%C3%ADkauthor=A.+H.+Vaculov%C3%A1&title=CHK1+inhibitor+SCH900776+effectively+potentiates+the+cytotoxic+effects+of+platinum-based+chemotherapeutic+drugs+in+human+colon+cancer+cells&doi=10.1016%2Fj.neo.2017.08.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.neo.2017.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neo.2017.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DHer%25C5%25AFdkov%25CC%2581%26aufirst%3DJ.%26aulast%3DParuch%26aufirst%3DK.%26aulast%3DKhirsariya%26aufirst%3DP.%26aulast%3DSou%25C4%258Dek%26aufirst%3DK.%26aulast%3DKrko%25C5%25A1ka%26aufirst%3DM.%26aulast%3DBlan%25C3%25A1%25C5%2599ov%25C3%25A1%26aufirst%3DO.%2BV.%26aulast%3DSova%26aufirst%3DP.%26aulast%3DKozub%25C3%25ADk%26aufirst%3DA.%26aulast%3DVaculov%25C3%25A1%26aufirst%3DA.%2BH.%26atitle%3DCHK1%2520inhibitor%2520SCH900776%2520effectively%2520potentiates%2520the%2520cytotoxic%2520effects%2520of%2520platinum-based%2520chemotherapeutic%2520drugs%2520in%2520human%2520colon%2520cancer%2520cells%26jtitle%3DNeoplasia%26date%3D2017%26volume%3D19%26spage%3D830%26epage%3D841%26doi%3D10.1016%2Fj.neo.2017.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Procházka, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turánek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesařík, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knotigová, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polášková, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrysík, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozubík, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Žák, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sova, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuzil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machala, M.</span></span> <span> </span><span class="NLM_article-title">Apoptosis and inhibition of gap-junctional intercellular communication induced by LA-12, a novel hydrophobic platinum(IV) complex</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>462</i></span>,  <span class="NLM_fpage">54</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2007.03.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1016%2Fj.abb.2007.03.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=17466256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsF2msbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2007&pages=54-61&author=L.+Proch%C3%A1zkaauthor=J.+Tur%C3%A1nekauthor=R.+Tesa%C5%99%C3%ADkauthor=P.+Knotigov%C3%A1author=P.+Pol%C3%A1%C5%A1kov%C3%A1author=Z.+Andrys%C3%ADkauthor=A.+Kozub%C3%ADkauthor=F.+%C5%BD%C3%A1kauthor=P.+Sovaauthor=J.+Neuzilauthor=M.+Machala&title=Apoptosis+and+inhibition+of+gap-junctional+intercellular+communication+induced+by+LA-12%2C+a+novel+hydrophobic+platinum%28IV%29+complex&doi=10.1016%2Fj.abb.2007.03.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis and inhibition of gap-junctional intercellular communication induced by LA-12, a novel hydrophobic platinum(IV) complex</span></div><div class="casAuthors">Prochazka, Lubomir; Turanek, Jaroslav; Tesarik, Radek; Knotigova, Pavlina; Polaskova, Pavlina; Andrysik, Zdenek; Kozubik, Alois; Zak, Frantisek; Sova, Petr; Neuzil, Jiri; Machala, Miroslav</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-61</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A new hydrophobic platinum(IV) complex, LA-12, a very efficient anticancer drug lacking cross-resistance with cisplatin (CDDP), is now being tested in clin. trials.  Here we investigated the apoptogenic activity of LA-12 and its effect on gap-junctional intercellular communication (GJIC) in the rat liver epithelial cell line WB-F344.  LA-12 induced apoptosis much more efficiently than did CDDP due to a combination of rapid penetration into the cell and attack on DNA, leading to fast activation of p53 and caspase-3.  Exposure of WB-F344 cells to LA-12 led to rapid induction of the time- and dose-dependent decrease in GJIC.  On the mol. level, loss of GJIC induced by LA-12 was mediated by activation of extracellular signal-regulated kinase (ERK)-1 and ERK-2, as demonstrated by the use of inhibitors of ERK activation.  Inhibition of GJIC was linked to rapid hyperphosphorylation of connexin-43 and disappearance of connexon clusters from membranes, which was not obsd. in the case of CDDP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5ne7yLiSpkbVg90H21EOLACvtfcHk0ljapqmKWMqtvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsF2msbY%253D&md5=7970846f6ce5c2a8a781282ede0a92af</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2007.03.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2007.03.021%26sid%3Dliteratum%253Aachs%26aulast%3DProch%25C3%25A1zka%26aufirst%3DL.%26aulast%3DTur%25C3%25A1nek%26aufirst%3DJ.%26aulast%3DTesa%25C5%2599%25C3%25ADk%26aufirst%3DR.%26aulast%3DKnotigov%25C3%25A1%26aufirst%3DP.%26aulast%3DPol%25C3%25A1%25C5%25A1kov%25C3%25A1%26aufirst%3DP.%26aulast%3DAndrys%25C3%25ADk%26aufirst%3DZ.%26aulast%3DKozub%25C3%25ADk%26aufirst%3DA.%26aulast%3D%25C5%25BD%25C3%25A1k%26aufirst%3DF.%26aulast%3DSova%26aufirst%3DP.%26aulast%3DNeuzil%26aufirst%3DJ.%26aulast%3DMachala%26aufirst%3DM.%26atitle%3DApoptosis%2520and%2520inhibition%2520of%2520gap-junctional%2520intercellular%2520communication%2520induced%2520by%2520LA-12%252C%2520a%2520novel%2520hydrophobic%2520platinum%2528IV%2529%2520complex%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2007%26volume%3D462%26spage%3D54%26epage%3D61%26doi%3D10.1016%2Fj.abb.2007.03.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zefirov, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoppe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuznetsova, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chernyshov, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grishin, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloshitskaya, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuznetsov, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zefirova, O. N.</span></span> <span> </span><span class="NLM_article-title">Homologous series of novel adamantane–colchicine conjugates: synthesis and cytotoxic effect on human cancer cells</span>. <i>Mendeleev Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.1016/j.mencom.2018.05.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1016%2Fj.mencom.2018.05.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVCku7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=308-310&author=N.+A.+Zefirovauthor=M.+Hoppeauthor=I.+V.+Kuznetsovaauthor=N.+A.+Chernyshovauthor=Y.+K.+Grishinauthor=O.+A.+Maloshitskayaauthor=S.+A.+Kuznetsovauthor=O.+N.+Zefirova&title=Homologous+series+of+novel+adamantane%E2%80%93colchicine+conjugates%3A+synthesis+and+cytotoxic+effect+on+human+cancer+cells&doi=10.1016%2Fj.mencom.2018.05.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Homologous series of novel adamantane-colchicine conjugates: Synthesis and cytotoxic effect on human cancer cells</span></div><div class="casAuthors">Zefirov, Nikolay A.; Hoppe, Marius; Kuznetsova, Irina V.; Chernyshov, Nikita A.; Grishin, Yuri K.; Maloshitskaya, Olga A.; Kuznetsov, Sergei A.; Zefirova, Olga N.</div><div class="citationInfo"><span class="NLM_cas:title">Mendeleev Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">308-310</span>CODEN:
                <span class="NLM_cas:coden">MENCEX</span>;
        ISSN:<span class="NLM_cas:issn">0959-9436</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Homologues of N-[7-(adamantan-1-yloxy)-7-oxoheptanoyl]-N-deacetylcolchicine with sequential shift of the ester group in the chain connecting colchicine and adamantane moieties were synthesized to find an optimal position of this group.  All homologues possessed very high cytotoxicity to human lung carcinoma cell line A549 demonstrating a weak dependence of toxic activity on the ester group position.  The cytotoxicity (EC50 = 5.9 nm) of the most active compd., I, was close to that of clin. used anti-tubulin anticancer drug taxol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM3WAZoNHwOLVg90H21EOLACvtfcHk0lgOdVf-J4B7nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVCku7bM&md5=b16ac9b8412bd681cbf012b02a7f6b8d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.mencom.2018.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mencom.2018.05.027%26sid%3Dliteratum%253Aachs%26aulast%3DZefirov%26aufirst%3DN.%2BA.%26aulast%3DHoppe%26aufirst%3DM.%26aulast%3DKuznetsova%26aufirst%3DI.%2BV.%26aulast%3DChernyshov%26aufirst%3DN.%2BA.%26aulast%3DGrishin%26aufirst%3DY.%2BK.%26aulast%3DMaloshitskaya%26aufirst%3DO.%2BA.%26aulast%3DKuznetsov%26aufirst%3DS.%2BA.%26aulast%3DZefirova%26aufirst%3DO.%2BN.%26atitle%3DHomologous%2520series%2520of%2520novel%2520adamantane%25E2%2580%2593colchicine%2520conjugates%253A%2520synthesis%2520and%2520cytotoxic%2520effect%2520on%2520human%2520cancer%2520cells%26jtitle%3DMendeleev%2520Commun.%26date%3D2018%26volume%3D28%26spage%3D308%26epage%3D310%26doi%3D10.1016%2Fj.mencom.2018.05.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vasilenko, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dueva, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlovskaya, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zefirov, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grishin, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butov, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palyulin, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuznetsova, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karganova, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zefirova, O. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osolodkin, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Averina, E. B.</span></span> <span> </span><span class="NLM_article-title">Tick-borne flavivirus reproduction inhibitors based on isoxazole core linked with adamantane</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">637</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2019.03.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1016%2Fj.bioorg.2019.03.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=30947098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmsVWktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2019&pages=629-637&author=D.+A.+Vasilenkoauthor=E.+V.+Duevaauthor=L.+I.+Kozlovskayaauthor=N.+A.+Zefirovauthor=Y.+K.+Grishinauthor=G.+M.+Butovauthor=V.+A.+Palyulinauthor=T.+S.+Kuznetsovaauthor=G.+G.+Karganovaauthor=O.+N.+Zefirovaauthor=D.+I.+Osolodkinauthor=E.+B.+Averina&title=Tick-borne+flavivirus+reproduction+inhibitors+based+on+isoxazole+core+linked+with+adamantane&doi=10.1016%2Fj.bioorg.2019.03.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Tick-borne flavivirus reproduction inhibitors based on isoxazole core linked with adamantane</span></div><div class="casAuthors">Vasilenko, Dmitry A.; Dueva, Evgenia V.; Kozlovskaya, Liubov I.; Zefirov, Nikolay A.; Grishin, Yuri K.; Butov, Gennady M.; Palyulin, Vladimir A.; Kuznetsova, Tamara S.; Karganova, Galina G.; Zefirova, Olga N.; Osolodkin, Dmitry I.; Averina, Elena B.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">629-637</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Infections caused by flaviviruses pose a huge threat for public health all over the world.  The search for therapeutically relevant compds. targeting tick-borne flaviviruses requires the exploration of novel chemotypes.  In the present work a large series of novel polyfunctionalized isoxazole derivs. bearing substituents with various steric and electronic effects was obtained by our unique versatile synthetic procedure and their antiviral activity against tick-borne encephalitis, Omsk hemorrhagic fever, and Powassan viruses was studied in vitro.  The majority of studied isoxazoles showed activity in low micromolar range.  No appreciable cytotoxicity was obsd. for tested compds.  The lead compds., 5-aminoisoxazole derivs. contg. adamantyl moiety, exhibited strong antiviral activity and excellent therapeutic index.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7Y0wrHHE5RLVg90H21EOLACvtfcHk0lhPYlFDDlyU2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmsVWktLo%253D&md5=264567cd6427bf27dacd6a98ec5ea77e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2019.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2019.03.028%26sid%3Dliteratum%253Aachs%26aulast%3DVasilenko%26aufirst%3DD.%2BA.%26aulast%3DDueva%26aufirst%3DE.%2BV.%26aulast%3DKozlovskaya%26aufirst%3DL.%2BI.%26aulast%3DZefirov%26aufirst%3DN.%2BA.%26aulast%3DGrishin%26aufirst%3DY.%2BK.%26aulast%3DButov%26aufirst%3DG.%2BM.%26aulast%3DPalyulin%26aufirst%3DV.%2BA.%26aulast%3DKuznetsova%26aufirst%3DT.%2BS.%26aulast%3DKarganova%26aufirst%3DG.%2BG.%26aulast%3DZefirova%26aufirst%3DO.%2BN.%26aulast%3DOsolodkin%26aufirst%3DD.%2BI.%26aulast%3DAverina%26aufirst%3DE.%2BB.%26atitle%3DTick-borne%2520flavivirus%2520reproduction%2520inhibitors%2520based%2520on%2520isoxazole%2520core%2520linked%2520with%2520adamantane%26jtitle%3DBioorg.%2520Chem.%26date%3D2019%26volume%3D87%26spage%3D629%26epage%3D637%26doi%3D10.1016%2Fj.bioorg.2019.03.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Svingen, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tefferi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kottke, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sausville, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, S. H.</span></span> <span> </span><span class="NLM_article-title">Effects of the Bcr/Abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">249</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10656455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtVCjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=237-249&author=P.+A.+Svingenauthor=A.+Tefferiauthor=T.+J.+Kottkeauthor=G.+Kaurauthor=V.+L.+Narayananauthor=E.+A.+Sausvilleauthor=S.+H.+Kaufmann&title=Effects+of+the+Bcr%2FAbl+kinase+inhibitors+AG957+and+NSC+680410+on+chronic+myelogenous+leukemia+cells+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the bcr/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro</span></div><div class="casAuthors">Svingen, Phyllis A.; Tefferi, Ayalew; Kottke, Timothy J.; Kaur, Gurmeet; Narayanan, Ven L.; Sausville, Edward A.; Kaufmann, Scott H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">237-249</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The tyrphostin AG957 (NSC 654705) inhibits p210bcr/abl, the transforming kinase responsible for most cases of chronic myelogenous leukemia (CML).  The present studies were performed to det. the fate of AG957-treated cells and assess the selectivity of AG957 for CML myeloid progenitors.  When K562 cells (derived from a patient with blast crisis CML) were treated with AG957, dose-and time-dependent p210bcr/abl down-regulation was followed by mitochondrial release of cytochrome c, activation of caspase-9 and caspase-3, and apoptotic morphol. changes.  These apoptotic changes were inhibited by transfection with cDNA encoding dominant neg. caspase-9 but not dominant-neg. FADD or blocking anti-Fas antibodies.  In addnl. expts., a 24-h AG957 exposure caused dose-dependent inhibition of K562 colony formation in soft agar.  To extend these studies to clin. samples of CML, peripheral blood mononuclear cells from 10 chronic phase CML patients and normal controls were assayed for the growth of hematopoietic colonies in vitro in the presence of increasing concns. of AG957.  These assays demonstrated selectivity of AG957 for CML progenitors, with median IC50s (CML vs. normal) of 7.3 vs. >20 μM AG957 in granulocyte colony-forming cells (P < 0.001), 5.3 vs. >20 μM in granulocyte/macrophage colony-forming cells (P < 0.05), and 15.5 vs. > 20 μM in erythroid colony-forming cells (P > 0.05).  The adamantyl ester of AG957 (NSC 680410) down-regulated p210bcr/abl in K562 cells and inhibited granulocyte colony formation in CML specimens at lower concns. without enhanced toxicity in normal progenitors.  These observations not only demonstrate that AG957-induced p210bcr/abl down-regulation is followed by activation of the cytochrome c/Apaf-1/caspase-9 pathway but also indicate that this class of kinase inhibitor exhibits selectivity worthy of further evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBU5e7XVihMbVg90H21EOLACvtfcHk0lgIS9nlqWYxlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtVCjs78%253D&md5=377b9d70f9d6dbf4666b9aaf634b3c71</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSvingen%26aufirst%3DP.%2BA.%26aulast%3DTefferi%26aufirst%3DA.%26aulast%3DKottke%26aufirst%3DT.%2BJ.%26aulast%3DKaur%26aufirst%3DG.%26aulast%3DNarayanan%26aufirst%3DV.%2BL.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DKaufmann%26aufirst%3DS.%2BH.%26atitle%3DEffects%2520of%2520the%2520Bcr%252FAbl%2520kinase%2520inhibitors%2520AG957%2520and%2520NSC%2520680410%2520on%2520chronic%2520myelogenous%2520leukemia%2520cells%2520in%2520vitro%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2000%26volume%3D6%26spage%3D237%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, F.-L.</span></span> <span> </span><span class="NLM_article-title">Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.2174/1389200023337496</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.2174%2F1389200023337496" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=12083319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD38XkslyrsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=233-255&author=C.+Conawayauthor=Y.-M.+Yangauthor=F.-L.+Chung&title=Isothiocyanates+as+cancer+chemopreventive+agents%3A+their+biological+activities+and+metabolism+in+rodents+and+humans&doi=10.2174%2F1389200023337496"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans</span></div><div class="casAuthors">Conaway, C. Clifford; Yang, Yang-Ming; Chung, Fung-Lung</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">233-255</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Isothiocyanates (ITCs) are a group of naturally occurring compds. that occur as thioglucoside conjugates, termed glucosinolates, in plants and cruciferous vegetables such as watercress, Brussels sprouts, broccoli, cabbage, kai choi, kale, horseradish, radish and turnip.  ITCs inhibit the development of tumors in many of the exptl. models investigated, and are being investigated as possible chemopreventive agents for specific human cancers.  The goal of this review is to provide a mechanistic understanding for the biol. activities of ITCs and to relate the metab. of ITCs to their action as chemopreventive agents.  In vivo animal studies have been conducted to address issues of tissue disposition, pharmacokinetics, and metab. of ITCs.  Methods for anal. of ITCs and their metabolites in urine and plasma have been developed.  The metab. of several naturally occurring ITCs as constituents of foodstuffs or as drugs has also been investigated in human studies.  Finally, based on recent epidemiol. studies, the role of dietary consumption of vegetables contg. ITCs in prevention of human cancers and human cancer susceptibility is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpzGn2a4nB0rVg90H21EOLACvtfcHk0lgtCKSH4833TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkslyrsrY%253D&md5=2fc1107e0b6a547ff6e79bbef6402b39</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F1389200023337496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200023337496%26sid%3Dliteratum%253Aachs%26aulast%3DConaway%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DY.-M.%26aulast%3DChung%26aufirst%3DF.-L.%26atitle%3DIsothiocyanates%2520as%2520cancer%2520chemopreventive%2520agents%253A%2520their%2520biological%2520activities%2520and%2520metabolism%2520in%2520rodents%2520and%2520humans%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2002%26volume%3D3%26spage%3D233%26epage%3D255%26doi%3D10.2174%2F1389200023337496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahey, J. W.</span></span> <span> </span><span class="NLM_article-title">Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism</span>. <i>J. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">3027S</span>– <span class="NLM_lpage">3033S</span>, <span class="refDoi"> DOI: 10.1093/jn/131.11.3027S</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1093%2Fjn%2F131.11.3027S" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=11694642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosVGit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2001&pages=3027S-3033S&author=P.+Talalayauthor=J.+W.+Fahey&title=Phytochemicals+from+cruciferous+plants+protect+against+cancer+by+modulating+carcinogen+metabolism&doi=10.1093%2Fjn%2F131.11.3027S"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism</span></div><div class="casAuthors">Talalay, Paul; Fahey, Jed W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nutrition</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">11S</span>),
    <span class="NLM_cas:pages">3027S-3033S</span>CODEN:
                <span class="NLM_cas:coden">JONUAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-3166</span>.
    
            (<span class="NLM_cas:orgname">American Society for Nutritional Sciences</span>)
        </div><div class="casAbstract">A review on the role of cruciferous vegetables in the protective effects of vegetables against the risk of cancer and on the role of phase 2 enzymes in detg. susceptibility to carcinogens and in redn. of this susceptibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBLSyOd4Dqy7Vg90H21EOLACvtfcHk0ljPNA9hPJJpow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosVGit7g%253D&md5=2857f6075d29b5951964b389fdc5138c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fjn%2F131.11.3027S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjn%252F131.11.3027S%26sid%3Dliteratum%253Aachs%26aulast%3DTalalay%26aufirst%3DP.%26aulast%3DFahey%26aufirst%3DJ.%2BW.%26atitle%3DPhytochemicals%2520from%2520cruciferous%2520plants%2520protect%2520against%2520cancer%2520by%2520modulating%2520carcinogen%2520metabolism%26jtitle%3DJ.%2520Nutr.%26date%3D2001%26volume%3D131%26spage%3D3027S%26epage%3D3033S%26doi%3D10.1093%2Fjn%2F131.11.3027S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">WHOIARC</span> <i>handbook on cancer prevention. Cruciferous
vegetables, isothiocyanates
and indoles</i>, vol.  <span class="NLM_volume">9</span>. <span class="NLM_publisher-loc">Lyon</span>: <span class="NLM_publisher-name">IARC Press</span>, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=WHOIARC&title=handbook+on+cancer+prevention.+Cruciferous%0Avegetables%2C+isothiocyanates%0Aand+indoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3Dhandbook%2520on%2520cancer%2520prevention.%2520Cruciferous%250Avegetables%252C%2520isothiocyanates%250Aand%2520indoles%26volume%3D9%26pub%3DIARC%2520Press%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecht, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Z.</span></span> <span> </span><span class="NLM_article-title">Essential role of p53 in phenethyl isothiocyanate-induced apoptosis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4102</span>– <span class="NLM_lpage">4106</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=9751619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADyaK1cXmtlCks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=4102-4106&author=C.+Huangauthor=W.-Y.+Maauthor=J.+Liauthor=S.+S.+Hechtauthor=Z.+Dong&title=Essential+role+of+p53+in+phenethyl+isothiocyanate-induced+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Essential role of p53 in phenethyl isothiocyanate-induced apoptosis</span></div><div class="casAuthors">Huang, Chuanshu; Ma, Wei-Ya; Li, Jingxia; Hecht, Stephen S.; Dong, Zigang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4102-4106</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Phenethyl isothiocyanate (PEITC) is a natural product that is among the most effective cancer chemopreventive agents known.  Mechanistic studies indicate that the chemopreventive activity of PEITC is assocd. with its favorable modification of carcinogen metab. and its induction of apoptosis.  Here, the authors found that PEITC blocks tumor promoter (12-O-tetradecanoylphorbol-13-acetate or epidermal growth factor)-induced cell transformation in mouse epidermal JB6 cells, and this inhibitory activity on cell transformation is correlated with induction of apoptosis.  Most importantly, apoptosis induction by PEITC occurs through a p53-dependent pathway.  This was demonstrated not only by results that PEITC induction of p53 protein expression and p53-dependent transactivation but also by PEITC-induced apoptosis in p53 +/+ cells but not in p53 -/- cells.  In contrast, PEITC induced apoptosis in cells with both normal or deficient sphingomyelinase activity.  The results demonstrate for the first time that p53 elevation is required for PEITC-induced apoptosis, which may be involved in its cancer chemopreventive activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprtsEny5gd8LVg90H21EOLACvtfcHk0ljPNA9hPJJpow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtlCks7w%253D&md5=69a814f87715b54f9c66e739be57ccf3</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DW.-Y.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHecht%26aufirst%3DS.%2BS.%26aulast%3DDong%26aufirst%3DZ.%26atitle%3DEssential%2520role%2520of%2520p53%2520in%2520phenethyl%2520isothiocyanate-induced%2520apoptosis%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D4102%26epage%3D4106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kensler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egner, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agyeman, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visvanathan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groopman, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahey, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span> <span> </span><span class="NLM_article-title">Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane</span>. <i>Top. Curr. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>329</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1007/128_2012_339</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1007%2F128_2012_339" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2012&pages=163-177&author=T.+W.+Kenslerauthor=P.+A.+Egnerauthor=A.+S.+Agyemanauthor=K.+Visvanathanauthor=J.+D.+Groopmanauthor=J.+G.+Chenauthor=T.+Y.+Chenauthor=J.+W.+Faheyauthor=P.+Talalay&title=Keap1-nrf2+signaling%3A+a+target+for+cancer+prevention+by+sulforaphane&doi=10.1007%2F128_2012_339"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2F128_2012_339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F128_2012_339%26sid%3Dliteratum%253Aachs%26aulast%3DKensler%26aufirst%3DT.%2BW.%26aulast%3DEgner%26aufirst%3DP.%2BA.%26aulast%3DAgyeman%26aufirst%3DA.%2BS.%26aulast%3DVisvanathan%26aufirst%3DK.%26aulast%3DGroopman%26aufirst%3DJ.%2BD.%26aulast%3DChen%26aufirst%3DJ.%2BG.%26aulast%3DChen%26aufirst%3DT.%2BY.%26aulast%3DFahey%26aufirst%3DJ.%2BW.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DKeap1-nrf2%2520signaling%253A%2520a%2520target%2520for%2520cancer%2520prevention%2520by%2520sulforaphane%26jtitle%3DTop.%2520Curr.%2520Chem.%26date%3D2012%26volume%3D329%26spage%3D163%26epage%3D177%26doi%3D10.1007%2F128_2012_339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A.-N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owuor, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebbar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandlekar, S.</span></span> <span> </span><span class="NLM_article-title">Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE)</span>. <i>Drug Metab. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">271</span>, <span class="refDoi"> DOI: 10.1081/DMR-120000652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1081%2FDMR-120000652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=11768769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvVGrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2001&pages=255-271&author=A.-N.+T.+Kongauthor=E.+Owuorauthor=R.+Yuauthor=V.+Hebbarauthor=C.+Chenauthor=R.+Huauthor=S.+Mandlekar&title=Induction+of+xenobiotic+enzymes+by+the+MAP+kinase+pathway+and+the+antioxidant+or+electrophile+response+element+%28ARE%2FEpRE%29&doi=10.1081%2FDMR-120000652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE)</span></div><div class="casAuthors">Kong, A.-N. Tony; Owuor, Edward; Yu, Rong; Hebbar, Vidya; Chen, Chi; Hu, Rong; Mandlekar, Sandhya</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3 & 4</span>),
    <span class="NLM_cas:pages">255-271</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review.  Cellular responses to xenobiotic-induced stress can signal proliferation, differentiation, homeostasis, apoptosis, or necrosis.  To better understand the underlying mol. mechanisms after exposure to xenobiotics or drugs, the authors studied the signal transduction pathways, the mitogen-activated protein kinase (MAPK), and the basic Leu zipper transcription factor Nrf2, activated by different agents in the induction of Phase II drug metabolizing enzymes (DMEs).  The MAPKs, characterized as Pro-directed Ser/Thr kinases, are essential components of signaling pathways that convert various extracellular signals into intracellular responses through serial phosphorylation cascades.  Once activated, MAPKs can phosphorylate many transcription factors, such as c-Jun, ATF-2, and ultimately lead to changes in gene expression.  Two classes of Phase II gene inducers, which are also cancer chemopreventive agents, were studied: (1) the phenolic antioxidants, namely butylated hydroxyanisole (BHA) and its active de-methylated metabolite t-butylhydroquinone (tBHQ), and phenolic flavonoids such as green tea polyphenols (GTP) and (-)-epigallocatechin-3-gallate (EGCG); and (2) the naturally occurring isothiocyanates, namely phenethyl isothiocyanate (PEITC), and sulforaphane.  BHA and tBHQ are both well-known phenolic antioxidants used as food preservatives, and strongly activate c-Jun N-terminal kinase 1 (JNK1), extracellular signal-regulated protein kinase 2 (ERK2), or p38, in a time- and dose-dependent fashion.  Free radical scavengers N-acetyl-L-cysteine (NAC), or glutathione (GSH), inhibited ERK2 activation and, to a much lesser extent, JNK1 activation by BHA/tBHQ, implicating the role of oxidative stress.  Under conditions where MAPKs were activated, BHA or GTP also activated ARE/EpRE (antioxidant/electrophile response element), with the induction of Phase II genes such as NQO.  Transfection studies with various cDNAs encoding wild-type or dominant-neg. mutants of MAPKs and/or transcription factor Nrf2, substantially modulated ARE-mediated luciferase reporter activity in the presence or absence of phenolic compds.  Other phyto-chems. including PEITC, and sulforaphane, also differentially regulated the activities of MAPKs, Nrf2, and ARE-mediated luciferase reporter gene activity and Phase II enzyme induction.  A model is proposed where these xenobiotics (BHA, tBHQ, GTP, EGCG, PEITC, sulforaphane) activate the MAPK pathway via an electrophilic-mediated stress response, leading to the transcription activation of Nrf2/Maf heterodimers on ARE/EpRE enhancers, with the subsequent induction of cellular defense/detoxifying genes including Phase II DMEs, which may protect the cells against toxic environmental insults and thereby enhance cell survival.  The studies of these signaling pathways may yield insights into the fate of cells upon exposure to xenobiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1E2JZvCBt_LVg90H21EOLACvtfcHk0ljxQbhKyPivCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvVGrug%253D%253D&md5=286ab0d39c981d58df9922b6ac205b69</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1081%2FDMR-120000652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FDMR-120000652%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DA.-N.%2BT.%26aulast%3DOwuor%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DR.%26aulast%3DHebbar%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DR.%26aulast%3DMandlekar%26aufirst%3DS.%26atitle%3DInduction%2520of%2520xenobiotic%2520enzymes%2520by%2520the%2520MAP%2520kinase%2520pathway%2520and%2520the%2520antioxidant%2520or%2520electrophile%2520response%2520element%2520%2528ARE%252FEpRE%2529%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2001%26volume%3D33%26spage%3D255%26epage%3D271%26doi%3D10.1081%2FDMR-120000652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lew, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marynowski, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhir, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. V.</span></span> <span> </span><span class="NLM_article-title">Phenethyl isothiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2223</span>– <span class="NLM_lpage">2234</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgl087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1093%2Fcarcin%2Fbgl087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=16774948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKltrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=2223-2234&author=D.+Xiaoauthor=K.+L.+Lewauthor=Y.+Zengauthor=H.+Xiaoauthor=S.+W.+Marynowskiauthor=R.+Dhirauthor=S.+V.+Singh&title=Phenethyl+isothiocyanate-induced+apoptosis+in+PC-3+human+prostate+cancer+cells+is+mediated+by+reactive+oxygen+species-dependent+disruption+of+the+mitochondrial+membrane+potential&doi=10.1093%2Fcarcin%2Fbgl087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Phenethyl isothiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential</span></div><div class="casAuthors">Xiao, Dong; Lew, Karen L.; Zeng, Yan; Xiao, Hui; Marynowski, Stanley W.; Dhir, Rajiv; Singh, Shivendra V.</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2223-2234</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The present study was undertaken to gain insights into the mol. mechanism of apoptosis induction by phenethyl isothiocyanate (PEITC), which is a cancer chemopreventive constituent of cruciferous vegetables, using PC-3 human prostate cancer cells as a model.  The PEITC-induced cell death in PC-3 cells was assocd. with disruption of the mitochondrial membrane potential, release of apoptogenic mols. (cytochrome c and Smac/DIABLO) from mitochondria to the cytosol and generation of reactive oxygen species (ROS), which were blocked in the presence of a combined mimetic of superoxide dismutase and catalase (Euk134).  Ectopic expression of Bcl-xL, whose protein level is reduced markedly on treatment of PC-3 cells with PEITC, conferred partial protection against PEITC-induced apoptosis only at higher drug concns. (>10 μM).  Administration of 12 μmol PEITC/day (Monday through Friday) by oral gavage significantly retarded growth of PC-3 xenografts in athymic mice.  For instance, 31 days after the initiation of PEITC administration, the av. tumor vol. in control mice (721 ± 153 mm3) was ∼2-fold higher compared with mice receiving 12 μmol PEITC/day.  The PEITC-mediated inhibition of PC-3 xenograft growth was assocd. with induction of Bax and Bid proteins.  In conclusion, the present study indicates that the PEITC-induced apoptosis in PC-3 cells is mediated by ROS-dependent disruption of the mitochondrial membrane potential and regulated by Bax and Bid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8l37CPKtL67Vg90H21EOLACvtfcHk0liX1l-FCcqfAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKltrvF&md5=f07fbc7212da95ec54960c6c558aa979</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgl087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgl087%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DD.%26aulast%3DLew%26aufirst%3DK.%2BL.%26aulast%3DZeng%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DH.%26aulast%3DMarynowski%26aufirst%3DS.%2BW.%26aulast%3DDhir%26aufirst%3DR.%26aulast%3DSingh%26aufirst%3DS.%2BV.%26atitle%3DPhenethyl%2520isothiocyanate-induced%2520apoptosis%2520in%2520PC-3%2520human%2520prostate%2520cancer%2520cells%2520is%2520mediated%2520by%2520reactive%2520oxygen%2520species-dependent%2520disruption%2520of%2520the%2520mitochondrial%2520membrane%2520potential%26jtitle%3DCarcinogenesis%26date%3D2006%26volume%3D27%26spage%3D2223%26epage%3D2234%26doi%3D10.1093%2Fcarcin%2Fbgl087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trachootham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelicano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiao, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Achanta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arlinghaus, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span> <span> </span><span class="NLM_article-title">Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">241</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2006.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1016%2Fj.ccr.2006.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=16959615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVSlu73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=241-252&author=D.+Trachoothamauthor=Y.+Zhouauthor=H.+Zhangauthor=Y.+Demizuauthor=Z.+Chenauthor=H.+Pelicanoauthor=P.+J.+Chiaoauthor=G.+Achantaauthor=R.+B.+Arlinghausauthor=J.+Liuauthor=P.+Huang&title=Selective+killing+of+oncogenically+transformed+cells+through+a+ROS-mediated+mechanism+by+beta-phenylethyl+isothiocyanate&doi=10.1016%2Fj.ccr.2006.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate</span></div><div class="casAuthors">Trachootham, Dunyaporn; Zhou, Yan; Zhang, Hui; Demizu, Yusuke; Chen, Zhao; Pelicano, Helene; Chiao, Paul J.; Achanta, Geetha; Arlinghaus, Ralph B.; Liu, Jinsong; Huang, Peng</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">241-252</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) stimulate cell proliferation and induce genetic instability, and their increase in cancer cells is often viewed as an adverse event.  Here, we show that such abnormal increases in ROS can be exploited to selectively kill cancer cells using β-phenylethyl isothiocyanate (PEITC).  Oncogenic transformation of ovarian epithelial cells with H-RasV12 or expression of Bcr-Abl in hematopoietic cells causes elevated ROS generation and renders the malignant cells highly sensitive to PEITC, which effectively disables the glutathione antioxidant system and causes severe ROS accumulation preferentially in the transformed cells due to their active ROS output.  Excessive ROS causes oxidative mitochondrial damage, inactivation of redox-sensitive mols., and massive cell death.  In vivo, PEITC exhibits therapeutic activity and prolongs animal survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobBpNa5uKXTrVg90H21EOLACvtfcHk0lhdB3dgdDurSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVSlu73L&md5=ad819c3ac413b9b8c121a966172bb847</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DTrachootham%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DDemizu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPelicano%26aufirst%3DH.%26aulast%3DChiao%26aufirst%3DP.%2BJ.%26aulast%3DAchanta%26aufirst%3DG.%26aulast%3DArlinghaus%26aufirst%3DR.%2BB.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DP.%26atitle%3DSelective%2520killing%2520of%2520oncogenically%2520transformed%2520cells%2520through%2520a%2520ROS-mediated%2520mechanism%2520by%2520beta-phenylethyl%2520isothiocyanate%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D10%26spage%3D241%26epage%3D252%26doi%3D10.1016%2Fj.ccr.2006.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pasqua, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govind, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCracken, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodrick, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fine, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, F.-L.</span></span> <span> </span><span class="NLM_article-title">Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">816</span>, <span class="refDoi"> DOI: 10.1021/jm101199t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101199t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFOhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=809-816&author=X.+Wangauthor=A.+J.+Di+Pasquaauthor=S.+Govindauthor=E.+McCrackenauthor=C.+Hongauthor=L.+Miauthor=Y.+Maoauthor=J.+Y.+C.+Wuauthor=Y.+Tomitaauthor=J.+C.+Woodrickauthor=R.+L.+Fineauthor=F.-L.+Chung&title=Selective+depletion+of+mutant+p53+by+cancer+chemopreventive+isothiocyanates+and+their+structure-activity+relationships&doi=10.1021%2Fjm101199t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Depletion of Mutant p53 by Cancer Chemopreventive Isothiocyanates and Their Structure-Activity Relationships</span></div><div class="casAuthors">Wang, Xiantao; Di Pasqua, Anthony J.; Govind, Sudha; McCracken, Erin; Hong, Charles; Mi, Lixin; Mao, Yuehua; Wu, Jessie Yu-Chieh; Tomita, York; Woodrick, Jordan C.; Fine, Robert L.; Chung, Fung-Lung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">809-816</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Isothiocyanates (ITCs) derived from cruciferous vegetables induce apoptosis in cancer cells.  We demonstrate that certain naturally occurring ITCs selectively deplete mutant p53 but not the wild-type and do so via a transcription-independent mechanism.  Direct p53 binding followed by conformational changes appears to be a mechanism by which mutant p53 is depleted.  Structure-activity relationship studies (SARs) using naturally occurring and synthetic ITCs show that depletion is influenced by the ITC side-chain moiety.  Furthermore, we show that cells with p53 mutations are more sensitive to cytotoxicity induced by phenethyl isothiocyanate (PEITC) than those with the wild-type protein. 2,2-Diphenylethyl ITC, a synthetic ITC, is one of the most potent depletors of mutant p53 studies and induces apoptosis to the greatest extent in mutant p53 breast cancer cells.  Collectively, this study shows that mutant p53 depletion may be an important novel target for cancer chemoprevention and therapy by natural and synthetic ITCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ3clkiGruC7Vg90H21EOLACvtfcHk0lijuC2TU2x6DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFOhtw%253D%253D&md5=9ac787929f66c785e4868a47cf1e448a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm101199t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101199t%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DDi%2BPasqua%26aufirst%3DA.%2BJ.%26aulast%3DGovind%26aufirst%3DS.%26aulast%3DMcCracken%26aufirst%3DE.%26aulast%3DHong%26aufirst%3DC.%26aulast%3DMi%26aufirst%3DL.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DJ.%2BY.%2BC.%26aulast%3DTomita%26aufirst%3DY.%26aulast%3DWoodrick%26aufirst%3DJ.%2BC.%26aulast%3DFine%26aufirst%3DR.%2BL.%26aulast%3DChung%26aufirst%3DF.-L.%26atitle%3DSelective%2520depletion%2520of%2520mutant%2520p53%2520by%2520cancer%2520chemopreventive%2520isothiocyanates%2520and%2520their%2520structure-activity%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D809%26epage%3D816%26doi%3D10.1021%2Fjm101199t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinclair, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruz, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallakury, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agostino, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blandino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avantaggiati, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, F.-L.</span></span> <span> </span><span class="NLM_article-title">Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1615</span>– <span class="NLM_lpage">1627</span>, <span class="refDoi"> DOI: 10.1038/cdd.2016.48</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1038%2Fcdd.2016.48" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=27258787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsF2ktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=1615-1627&author=M.+Aggarwalauthor=R.+Saxenaauthor=E.+Sinclairauthor=Y.+Fuauthor=A.+Jacobsauthor=M.+Dybaauthor=X.+Wangauthor=I.+Cruzauthor=D.+Berryauthor=B.+Kallakuryauthor=S.+C.+Muellerauthor=S.+D.+Agostinoauthor=G.+Blandinoauthor=M.+L.+Avantaggiatiauthor=F.-L.+Chung&title=Reactivation+of+mutant+p53+by+a+dietary-related+compound+phenethyl+isothiocyanate+inhibits+tumor+growth&doi=10.1038%2Fcdd.2016.48"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth</span></div><div class="casAuthors">Aggarwal, M.; Saxena, R.; Sinclair, E.; Fu, Y.; Jacobs, A.; Dyba, M.; Wang, X.; Cruz, I.; Berry, D.; Kallakury, B.; Mueller, S. C.; Agostino, S. D.; Blandino, G.; Avantaggiati, M. L.; Chung, F-L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1615-1627</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in the p53 tumor-suppressor gene are prevalent in human cancers.  The majority of p53 mutations are missense, which can be classified into contact mutations (that directly disrupts the DNA-binding activity of p53) and structural mutations (that disrupts the conformation of p53).  Both of the mutations can disable the normal wild-type (WT) p53 activities.  Nevertheless, it has been amply documented that small mols. can rescue activity from mutant p53 by restoring WT tumor-suppressive functions.  These compds. hold promise for cancer therapy and have now entered clin. trials.  In this study, we show that cruciferous-vegetable-derived phenethyl isothiocyanate (PEITC) can reactivate p53 mutant under in vitro and in vivo conditions, revealing a new mechanism of action for a dietary-related compd.  PEITC exhibits growth-inhibitory activity in cells expressing p53 mutants with preferential activity toward p53R175, one of the most frequent 'hotspot' mutations within the p53 sequence.  Mechanistic studies revealed that PEITC induces apoptosis in a p53R175 mutant-dependent manner by restoring p53 WT conformation and transactivation functions.  Accordingly, in PEITC-treated cells the reactivated p53R175 mutant induces apoptosis by activating canonical WT p53 targets, inducing a delay in S and G2/M phase, and by phosphorylating ATM/CHK2.  Interestingly, the growth-inhibitory effects of PEITC depend on the redox state of the cell.  Further, PEITC treatments render the p53R175 mutant sensitive to degrdn. by the proteasome and autophagy in a concn.-dependent manner.  PEITC-induced reactivation of p53R175 and its subsequent sensitivity to the degrdn. pathways likely contribute to its anticancer activities.  We further show that dietary supplementation of PEITC is able to reactivate WT activity in vivo as well, inhibiting tumor growth in xenograft mouse model.  These findings provide the first example of mutant p53 reactivation by a dietary compd. and have important implications for cancer prevention and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE57uMyty4PbVg90H21EOLACvtfcHk0liZWxdn7ebqJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsF2ktbc%253D&md5=7145bbe706d3d73def415ebc31bc9dc9</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2016.48&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2016.48%26sid%3Dliteratum%253Aachs%26aulast%3DAggarwal%26aufirst%3DM.%26aulast%3DSaxena%26aufirst%3DR.%26aulast%3DSinclair%26aufirst%3DE.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DJacobs%26aufirst%3DA.%26aulast%3DDyba%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DCruz%26aufirst%3DI.%26aulast%3DBerry%26aufirst%3DD.%26aulast%3DKallakury%26aufirst%3DB.%26aulast%3DMueller%26aufirst%3DS.%2BC.%26aulast%3DAgostino%26aufirst%3DS.%2BD.%26aulast%3DBlandino%26aufirst%3DG.%26aulast%3DAvantaggiati%26aufirst%3DM.%2BL.%26aulast%3DChung%26aufirst%3DF.-L.%26atitle%3DReactivation%2520of%2520mutant%2520p53%2520by%2520a%2520dietary-related%2520compound%2520phenethyl%2520isothiocyanate%2520inhibits%2520tumor%2520growth%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2016%26volume%3D23%26spage%3D1615%26epage%3D1627%26doi%3D10.1038%2Fcdd.2016.48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asif, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinclair, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruz, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallakury, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, F.-L.</span></span> <span> </span><span class="NLM_article-title">p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1186/s13046-019-1267-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1186%2Fs13046-019-1267-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=31307507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A280%3ADC%252BB3MznsFCruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2019&pages=307-323&author=M.+Aggarwalauthor=R.+Saxenaauthor=N.+Asifauthor=E.+Sinclairauthor=J.+Tanauthor=I.+Cruzauthor=D.+Berryauthor=B.+Kallakuryauthor=Q.+Phamauthor=T.+T.+Y.+Wangauthor=F.-L.+Chung&title=p53+mutant-type+in+human+prostate+cancer+cells+determines+the+sensitivity+to+phenethyl+isothiocyanate+induced+growth+inhibition&doi=10.1186%2Fs13046-019-1267-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition</span></div><div class="casAuthors">Aggarwal Monika; Asif Nasir; Sinclair Elizabeth; Cruz Idalia; Berry Deborah; Kallakury Bhaskar; Chung Fung-Lung; Saxena Rahul; Tan Judy; Chung Fung-Lung; Pham Quynhchi; Wang Thomas T Y</div><div class="citationInfo"><span class="NLM_cas:title">Journal of experimental & clinical cancer research : CR</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">307</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  We reported previously that phenethyl isothiocyanate (PEITC), a dietary compound, can reactivate p53(R175H) mutant in vitro and in SK-BR-3 (p53(R175H)) breast xenograft model resulting in tumor inhibition.  Because of the diversity of human cancers with p53 mutations, these findings raise important questions whether this mechanism operates in different cancer types with same or different p53 mutations.  In this study, we investigated whether PEITC recuses mutant p53 in prostate cancer cells harboring different types of p53 mutants, structural and contact, in vitro and in vivo.  METHODS:  Cell proliferation, cell apoptosis and cell cycle arrest assays were performed to examine the effects of PEITC on prostate cancer cell lines with p53 mutation(s), wild-type p53, p53 null or normal prostate cells in vitro.  Western blot analysis was used to monitor the expression levels of p53 protein, activation of ATM and upregulation of canonical p53 targets.  Immunoprecipitation, subcellular protein fraction and qRT-PCR was performed to determine change in conformation and restoration of transactivation functions/ inhibition of gain-of-function (GOF) activities to p53 mutant(s).  Mice xenograft models were established to evaluate the antitumor efficacy of PEITC and PEITC-induced reactivation of p53 mutant(s) in vivo.  Immunohistochemistry of xenograft tumor tissues was performed to determine effects of PEITC on expression of Ki67 and mutant p53 in vivo.  RESULTS:  We demonstrated that PEITC inhibits the growth of prostate cancer cells with different "hotspot" p53 mutations (structural and contact), however, preferentially towards structural mutants.  PEITC inhibits proliferation and induces apoptosis by rescuing mutant p53 in p53(R248W) contact (VCaP) and p53(R175H) structural (LAPC-4) mutant cells with differential potency.  We further showed that PEITC inhibits the growth of DU145 cells that co-express p53(P223L) (structural) and p53(V274F) (contact) mutants by targeting p53(P223L) mutant selectively, but not p53(V274F).  The mutant p53 restored by PEITC induces apoptosis in DU145 cells by activating canonical p53 targets, delaying cells in G1 phase and phosphorylating ATM.  Importantly, PEITC reactivated p53(R175H) and p53(P223L/V274F) mutants in LAPC-4 and DU145 prostate xenograft models, respectively, resulting in significant tumor inhibition.  CONCLUSION:  Our studies provide the first evidence that PEITC's anti-cancer activity is cancer cell type-independent, but p53 mutant-type dependent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSGSMQLZZqLiIIRAdBLKY41fW6udTcc2eaFMWtNlJgbXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MznsFCruw%253D%253D&md5=210330f314ce7c6dde69001c129bfb04</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1186%2Fs13046-019-1267-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-019-1267-z%26sid%3Dliteratum%253Aachs%26aulast%3DAggarwal%26aufirst%3DM.%26aulast%3DSaxena%26aufirst%3DR.%26aulast%3DAsif%26aufirst%3DN.%26aulast%3DSinclair%26aufirst%3DE.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DCruz%26aufirst%3DI.%26aulast%3DBerry%26aufirst%3DD.%26aulast%3DKallakury%26aufirst%3DB.%26aulast%3DPham%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DT.%2BT.%2BY.%26aulast%3DChung%26aufirst%3DF.-L.%26atitle%3Dp53%2520mutant-type%2520in%2520human%2520prostate%2520cancer%2520cells%2520determines%2520the%2520sensitivity%2520to%2520phenethyl%2520isothiocyanate%2520induced%2520growth%2520inhibition%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2019%26volume%3D38%26spage%3D307%26epage%3D323%26doi%3D10.1186%2Fs13046-019-1267-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walerych, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Napoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collavin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Sal, G.</span></span> <span> </span><span class="NLM_article-title">The rebel angel: mutant p53 as the driving oncogene in breast cancer</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">2007</span>– <span class="NLM_lpage">2017</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgs232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1093%2Fcarcin%2Fbgs232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=22822097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1WqsLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=2007-2017&author=D.+Walerychauthor=M.+Napoliauthor=L.+Collavinauthor=G.+Del+Sal&title=The+rebel+angel%3A+mutant+p53+as+the+driving+oncogene+in+breast+cancer&doi=10.1093%2Fcarcin%2Fbgs232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The rebel angel: mutant p53 as the driving oncogene in breast cancer</span></div><div class="casAuthors">Walerych, Dawid; Napoli, Marco; Collavin, Licio; Del Sal, Giannino</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2007-2017</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Breast cancer is the most frequent invasive tumor diagnosed in women, causing over 400 000 deaths yearly worldwide.  Like other tumors, it is a disease with a complex, heterogeneous genetic and biochem. background.  No single genomic or metabolic condition can be regarded as decisive for its formation and progression.  However, a few key players can be pointed out and among them is the TP53 tumor suppressor gene, commonly mutated in breast cancer.  In particular, TP53 mutations are exceptionally frequent and apparently among the key driving factors in triple neg. breast cancer -the most aggressive breast cancer subgroup-whose management still represents a clin. challenge.  The majority of TP53 mutations result in the substitution of single aminoacids in the central region of the p53 protein, generating a spectrum of variants ('mutant p53s', for short).  These mutants lose the normal p53 oncosuppressive functions to various extents but can also acquire oncogenic properties by gain-of-function mechanisms.  This review discusses the mol. processes translating gene mutations to the pathol. consequences of mutant p53 tumorigenic activity, reconciling cell and animal models with clin. outcomes in breast cancer.  Existing and speculative therapeutic methods targeting mutant p53 are also discussed, taking into account the overlap of mutant and wild-type p53 regulatory mechanisms and the crosstalk between mutant p53 and other oncogenic pathways in breast cancer.  The studies described here concern breast cancer models and patients-unless it is indicated otherwise and justified by the importance of data obtained in other models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG-g77bT9kA7Vg90H21EOLACvtfcHk0liPE3GezPfWDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1WqsLfE&md5=e5a7d27e2aeaeb4ea58b7c5e68e80fd2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgs232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgs232%26sid%3Dliteratum%253Aachs%26aulast%3DWalerych%26aufirst%3DD.%26aulast%3DNapoli%26aufirst%3DM.%26aulast%3DCollavin%26aufirst%3DL.%26aulast%3DDel%2BSal%26aufirst%3DG.%26atitle%3DThe%2520rebel%2520angel%253A%2520mutant%2520p53%2520as%2520the%2520driving%2520oncogene%2520in%2520breast%2520cancer%26jtitle%3DCarcinogenesis%26date%3D2012%26volume%3D33%26spage%3D2007%26epage%3D2017%26doi%3D10.1093%2Fcarcin%2Fbgs232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blandino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Agostino, S.</span></span> <span> </span><span class="NLM_article-title">New therapeutic strategies to treat human cancers expressing mutant p53 proteins</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1186/s13046-018-0705-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1186%2Fs13046-018-0705-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=29448954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFOqur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&pages=30-42&author=G.+Blandinoauthor=S.+Di+Agostino&title=New+therapeutic+strategies+to+treat+human+cancers+expressing+mutant+p53+proteins&doi=10.1186%2Fs13046-018-0705-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">New therapeutic strategies to treat human cancers expressing mutant p53 proteins</span></div><div class="casAuthors">Blandino, Giovanni; Di Agostino, Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">30/1-30/13</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">The tumor suppressor p53 plays a crit. role to preserve DNA fidelity from diverse insults through the regulation of cell-cycle checkpoints, DNA repair, senescence and apoptosis.  The TP53 is the most frequently inactivated gene in human cancers.  This leads to the prodn. of mutant p53 proteins that loose wild-type p53 tumor suppression functions and concomitantly acquire new oncogenic properties among which deregulated cell proliferation, increased chemoresistance, disruption of tissue architecture, promotion of migration, invasion and metastasis and several other pro-oncogenic activities.  Mouse models show that the genetic reconstitution of the wild type p53 tumor suppression functions rescues tumor growth.  This strongly supports the notion that either restoring wt-p53 activity or inhibiting mutant p53 oncogenic activity could provide an efficient strategy to treat human cancers.  In this review we briefly summarize recent advances in the study of small mols. and compds. that subvert oncogenic activities of mutant p53 protein into wt-p53 tumor suppressor functions.  We highlight inhibitors of signaling pathways aberrantly modulated by oncogenic mutant p53 proteins as promising therapeutic strategies.  Finally, we consider the clin. applications of compds. targeting mutant p53 and the use of currently available drugs in the treatment of tumors expressing mutant p53 proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz6Z-uSiorsbVg90H21EOLACvtfcHk0lhwVbdu346BGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFOqur%252FL&md5=fcd91dd6662faba2aa60c7c104f20001</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1186%2Fs13046-018-0705-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-018-0705-7%26sid%3Dliteratum%253Aachs%26aulast%3DBlandino%26aufirst%3DG.%26aulast%3DDi%2BAgostino%26aufirst%3DS.%26atitle%3DNew%2520therapeutic%2520strategies%2520to%2520treat%2520human%2520cancers%2520expressing%2520mutant%2520p53%2520proteins%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2018%26volume%3D37%26spage%3D30%26epage%3D42%26doi%3D10.1186%2Fs13046-018-0705-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shah, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oloumi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turashvili, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haffari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bashashati, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prentice, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khattra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burleigh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yap, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shumansky, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crisan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuliany, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heravi-Moussavi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birol, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varhol, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhalla, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moradian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, S.-W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelmon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, S.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueda, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pharoah, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damaraju, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harkins, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadigotla, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigaroudinia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gascard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tlsty, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costello, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaves, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasserman, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huntsman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirst, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marra, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aparicio, S.</span></span> <span> </span><span class="NLM_article-title">The clonal and mutational evolution spectrum of primary triple-negative breast cancers</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>486</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1038/nature10933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1038%2Fnature10933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=22495314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtVersL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=486&publication_year=2012&pages=395-399&author=S.+P.+Shahauthor=A.+Rothauthor=R.+Goyaauthor=A.+Oloumiauthor=G.+Haauthor=Y.+Zhaoauthor=G.+Turashviliauthor=J.+Dingauthor=K.+Tseauthor=G.+Haffariauthor=A.+Bashashatiauthor=L.+M.+Prenticeauthor=J.+Khattraauthor=A.+Burleighauthor=D.+Yapauthor=V.+Bernardauthor=A.+McPhersonauthor=K.+Shumanskyauthor=A.+Crisanauthor=R.+Giulianyauthor=A.+Heravi-Moussaviauthor=J.+Rosnerauthor=D.+Laiauthor=I.+Birolauthor=R.+Varholauthor=A.+Tamauthor=N.+Dhallaauthor=T.+Zengauthor=K.+Maauthor=S.+K.+Chanauthor=M.+Griffithauthor=A.+Moradianauthor=S.-W.+G.+Chengauthor=G.+B.+Morinauthor=P.+Watsonauthor=K.+Gelmonauthor=S.+Chiaauthor=S.-F.+Chinauthor=C.+Curtisauthor=O.+M.+Ruedaauthor=P.+D.+Pharoahauthor=S.+Damarajuauthor=J.+Mackeyauthor=K.+Hoonauthor=T.+Harkinsauthor=V.+Tadigotlaauthor=M.+Sigaroudiniaauthor=P.+Gascardauthor=T.+Tlstyauthor=J.+F.+Costelloauthor=I.+M.+Meyerauthor=C.+J.+Eavesauthor=W.+W.+Wassermanauthor=S.+Jonesauthor=D.+Huntsmanauthor=M.+Hirstauthor=C.+Caldasauthor=M.+A.+Marraauthor=S.+Aparicio&title=The+clonal+and+mutational+evolution+spectrum+of+primary+triple-negative+breast+cancers&doi=10.1038%2Fnature10933"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The clonal and mutational evolution spectrum of primary triple-negative breast cancers</span></div><div class="casAuthors">Shah, Sohrab P.; Roth, Andrew; Goya, Rodrigo; Oloumi, Arusha; Ha, Gavin; Zhao, Yongjun; Turashvili, Gulisa; Ding, Jiarui; Tse, Kane; Haffari, Gholamreza; Bashashati, Ali; Prentice, Leah M.; Khattra, Jaswinder; Burleigh, Angela; Yap, Damian; Bernard, Virginie; McPherson, Andrew; Shumansky, Karey; Crisan, Anamaria; Giuliany, Ryan; Heravi-Moussavi, Alireza; Rosner, Jamie; Lai, Daniel; Birol, Inanc; Varhol, Richard; Tam, Angela; Dhalla, Noreen; Zeng, Thomas; Ma, Kevin; Chan, Simon K.; Griffith, Malachi; Moradian, Annie; Cheng, S.-W. Grace; Morin, Gregg B.; Watson, Peter; Gelmon, Karen; Chia, Stephen; Chin, Suet-Feung; Curtis, Christina; Rueda, Oscar M.; Pharoah, Paul D.; Damaraju, Sambasivarao; Mackey, John; Hoon, Kelly; Harkins, Timothy; Tadigotla, Vasisht; Sigaroudinia, Mahvash; Gascard, Philippe; Tlsty, Thea; Costello, Joseph F.; Meyer, Irmtraud M.; Eaves, Connie J.; Wasserman, Wyeth W.; Jones, Steven; Huntsman, David; Hirst, Martin; Caldas, Carlos; Marra, Marco A.; Aparicio, Samuel</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">486</span>
        (<span class="NLM_cas:issue">7403</span>),
    <span class="NLM_cas:pages">395-399</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Primary triple-neg. breast cancers (TNBCs), a tumor type defined by lack of estrogen receptor, progesterone receptor and ERBB2 gene amplification, represent approx. 16% of all breast cancers.  Here we show in 104 TNBC cases that at the time of diagnosis these cancers exhibit a wide and continuous spectrum of genomic evolution, with some having only a handful of coding somatic aberrations in a few pathways, whereas others contain hundreds of coding somatic mutations.  High-throughput RNA sequencing (RNA-seq) revealed that only approx. 36% of mutations are expressed.  Using deep re-sequencing measurements of allelic abundance for 2414 somatic mutations, we det. for the first time-to our knowledge-in an epithelial tumor subtype, the relative abundance of clonal frequencies among cases representative of the population.  We show that TNBCs vary widely in their clonal frequencies at the time of diagnosis, with the basal subtype of TNBC showing more variation than non-basal TNBC.  Although p53 (also known as TP53), PIK3CA and PTEN somatic mutations seem to be clonally dominant compared to other genes, in some tumors their clonal frequencies are incompatible with founder status.  Mutations in cytoskeletal, cell shape and motility proteins occurred at lower clonal frequencies, suggesting that they occurred later during tumor progression.  Taken together, our results show that understanding the biol. and therapeutic responses of patients with TNBC will require the detn. of individual tumor clonal genotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3aaF8K7Y8W7Vg90H21EOLACvtfcHk0lg7K3pZRazz5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtVersL4%253D&md5=862d24438c9062123d9b0826cf86da2c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnature10933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10933%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DS.%2BP.%26aulast%3DRoth%26aufirst%3DA.%26aulast%3DGoya%26aufirst%3DR.%26aulast%3DOloumi%26aufirst%3DA.%26aulast%3DHa%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DTurashvili%26aufirst%3DG.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DTse%26aufirst%3DK.%26aulast%3DHaffari%26aufirst%3DG.%26aulast%3DBashashati%26aufirst%3DA.%26aulast%3DPrentice%26aufirst%3DL.%2BM.%26aulast%3DKhattra%26aufirst%3DJ.%26aulast%3DBurleigh%26aufirst%3DA.%26aulast%3DYap%26aufirst%3DD.%26aulast%3DBernard%26aufirst%3DV.%26aulast%3DMcPherson%26aufirst%3DA.%26aulast%3DShumansky%26aufirst%3DK.%26aulast%3DCrisan%26aufirst%3DA.%26aulast%3DGiuliany%26aufirst%3DR.%26aulast%3DHeravi-Moussavi%26aufirst%3DA.%26aulast%3DRosner%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DD.%26aulast%3DBirol%26aufirst%3DI.%26aulast%3DVarhol%26aufirst%3DR.%26aulast%3DTam%26aufirst%3DA.%26aulast%3DDhalla%26aufirst%3DN.%26aulast%3DZeng%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DK.%26aulast%3DChan%26aufirst%3DS.%2BK.%26aulast%3DGriffith%26aufirst%3DM.%26aulast%3DMoradian%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DS.-W.%2BG.%26aulast%3DMorin%26aufirst%3DG.%2BB.%26aulast%3DWatson%26aufirst%3DP.%26aulast%3DGelmon%26aufirst%3DK.%26aulast%3DChia%26aufirst%3DS.%26aulast%3DChin%26aufirst%3DS.-F.%26aulast%3DCurtis%26aufirst%3DC.%26aulast%3DRueda%26aufirst%3DO.%2BM.%26aulast%3DPharoah%26aufirst%3DP.%2BD.%26aulast%3DDamaraju%26aufirst%3DS.%26aulast%3DMackey%26aufirst%3DJ.%26aulast%3DHoon%26aufirst%3DK.%26aulast%3DHarkins%26aufirst%3DT.%26aulast%3DTadigotla%26aufirst%3DV.%26aulast%3DSigaroudinia%26aufirst%3DM.%26aulast%3DGascard%26aufirst%3DP.%26aulast%3DTlsty%26aufirst%3DT.%26aulast%3DCostello%26aufirst%3DJ.%2BF.%26aulast%3DMeyer%26aufirst%3DI.%2BM.%26aulast%3DEaves%26aufirst%3DC.%2BJ.%26aulast%3DWasserman%26aufirst%3DW.%2BW.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DHuntsman%26aufirst%3DD.%26aulast%3DHirst%26aufirst%3DM.%26aulast%3DCaldas%26aufirst%3DC.%26aulast%3DMarra%26aufirst%3DM.%2BA.%26aulast%3DAparicio%26aufirst%3DS.%26atitle%3DThe%2520clonal%2520and%2520mutational%2520evolution%2520spectrum%2520of%2520primary%2520triple-negative%2520breast%2520cancers%26jtitle%3DNature%26date%3D2012%26volume%3D486%26spage%3D395%26epage%3D399%26doi%3D10.1038%2Fnature10933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pitushkin, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burmistrov, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butov, G. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of homologs of 1-isothiocyanatoadamantane</span>. <i>Russ. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1475</span>– <span class="NLM_lpage">1479</span>, <span class="refDoi"> DOI: 10.1134/S1070428018100068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1134%2FS1070428018100068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFejsrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2018&pages=1475-1479&author=D.+A.+Pitushkinauthor=V.+V.+Burmistrovauthor=G.+M.+Butov&title=Synthesis+of+homologs+of+1-isothiocyanatoadamantane&doi=10.1134%2FS1070428018100068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Homologs of 1-Isothiocyanatoadamantane</span></div><div class="casAuthors">Pitushkin, D. A.; Burmistrov, V. V.; Butov, G. M.</div><div class="citationInfo"><span class="NLM_cas:title">Russian Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1475-1479</span>CODEN:
                <span class="NLM_cas:coden">RJOCEQ</span>;
        ISSN:<span class="NLM_cas:issn">1070-4280</span>.
    
            (<span class="NLM_cas:orgname">Pleiades Publishing, Ltd.</span>)
        </div><div class="casAbstract">Amines of the adamantane series reacted with carbon disulfide and di-tert-Bu dicarbonate in the presence of triethylamine and a catalytic amt. of 4-(dimethylamino)pyridine to give homologs of 1-isothiocyanatoadamantane in 80-86% yields.  Adamantan-2-amine, 1-(adamantan-1-yl)ethanamine, and adamantan-1-ylmethanamine turned out to be more reactive than adamantan-1-amine; in the latter case, the reaction time was twice as long.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCaq69-0R2cLVg90H21EOLACvtfcHk0lhRZpeyNDrmWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFejsrbJ&md5=281e07379c9bb2e0e1716abdd85959dc</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1134%2FS1070428018100068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1134%252FS1070428018100068%26sid%3Dliteratum%253Aachs%26aulast%3DPitushkin%26aufirst%3DD.%2BA.%26aulast%3DBurmistrov%26aufirst%3DV.%2BV.%26aulast%3DButov%26aufirst%3DG.%2BM.%26atitle%3DSynthesis%2520of%2520homologs%2520of%25201-isothiocyanatoadamantane%26jtitle%3DRuss.%2520J.%2520Org.%2520Chem.%26date%3D2018%26volume%3D54%26spage%3D1475%26epage%3D1479%26doi%3D10.1134%2FS1070428018100068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bumistrov, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitushkin, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasipov, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’yachenko, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butov, G. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 3-adamantylated hydantoins and their 2-thio(seleno) analogs</span>. <i>Chem. Heterocycl. Compd.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">619</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.1007/s10593-019-02507-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1007%2Fs10593-019-02507-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2019&pages=619-622&author=V.+V.+Bumistrovauthor=D.+A.+Pitushkinauthor=V.+V.+Vasipovauthor=V.+S.+D%E2%80%99yachenkoauthor=G.+M.+Butov&title=Synthesis+of+3-adamantylated+hydantoins+and+their+2-thio%28seleno%29+analogs&doi=10.1007%2Fs10593-019-02507-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs10593-019-02507-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10593-019-02507-4%26sid%3Dliteratum%253Aachs%26aulast%3DBumistrov%26aufirst%3DV.%2BV.%26aulast%3DPitushkin%26aufirst%3DD.%2BA.%26aulast%3DVasipov%26aufirst%3DV.%2BV.%26aulast%3DD%25E2%2580%2599yachenko%26aufirst%3DV.%2BS.%26aulast%3DButov%26aufirst%3DG.%2BM.%26atitle%3DSynthesis%2520of%25203-adamantylated%2520hydantoins%2520and%2520their%25202-thio%2528seleno%2529%2520analogs%26jtitle%3DChem.%2520Heterocycl.%2520Compd.%26date%3D2019%26volume%3D55%26spage%3D619%26epage%3D622%26doi%3D10.1007%2Fs10593-019-02507-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominy, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, P. J.</span></span> <span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(00)00129-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2800%2900129-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0ljUGmmS4qmj0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D46%26spage%3D3%26epage%3D26%26doi%3D10.1016%2FS0169-409X%2800%2900129-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cady, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGrado, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, M.</span></span> <span> </span><span class="NLM_article-title">Specific binding of adamantane drugs and direction of their polar amines in the pore of the influenza M2 transmembrane domain in lipid bilayers and dodecylphosphocholine micelles determined by NMR spectroscopy</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">4274</span>– <span class="NLM_lpage">4284</span>, <span class="refDoi"> DOI: 10.1021/ja102581n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja102581n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisl2qtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=4274-4284&author=S.+D.+Cadyauthor=J.+Wangauthor=Y.+Wuauthor=W.+F.+DeGradoauthor=M.+Hong&title=Specific+binding+of+adamantane+drugs+and+direction+of+their+polar+amines+in+the+pore+of+the+influenza+M2+transmembrane+domain+in+lipid+bilayers+and+dodecylphosphocholine+micelles+determined+by+NMR+spectroscopy&doi=10.1021%2Fja102581n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Specific Binding of Adamantane Drugs and Direction of Their Polar Amines in the Pore of the Influenza M2 Transmembrane Domain in Lipid Bilayers and Dodecylphosphocholine Micelles Determined by NMR Spectroscopy</span></div><div class="casAuthors">Cady, Sarah D.; Wang, Jun; Wu, Yibing; DeGrado, William F.; Hong, Mei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4274-4284</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The transmembrane domain of the influenza M2 protein (M2TM) forms a tetrameric proton channel important for the virus life-cycle.  The proton-channel activity is inhibited by amine-contg. adamantyl drugs amantadine and rimantadine, which have been shown to bind specifically to the pore of M2TM near Ser31.  However, whether the polar amine points to the N- or C-terminus of the channel has not yet been detd.  Elucidating the polar group direction will shed light on the mechanism by which drug binding inhibits this proton channel and will facilitate rational design of new inhibitors.  In this study, we det. the polar amine direction using M2TM reconstituted in lipid bilayers as well as dodecylphosphocholine (DPC) micelles. 13C-2H rotational-echo double-resonance NMR expts. of 13C-labeled M2TM and methyl-deuterated rimantadine in lipid bilayers showed that the polar amine pointed to the C-terminus of the channel, with the Me group close to Gly34.  Soln. NMR expts. of M2TM in DPC micelles indicate that drug binding causes significant chem. shift perturbations of the protein that are very similar to those seen for M2TM and M2(18-60) bound to lipid bilayers.  Specific 2H-labeling of the drugs permitted the assignment of drug-protein cross peaks, which indicate that amantadine and rimantadine bind to the pore in the same fashion as for bilayer-bound M2TM.  These results strongly suggest that adamantyl inhibition of M2TM is achieved not only by direct phys. occlusion of the channel, but also by perturbing the equil. const. of the proton-sensing residue His37.  The reprodn. of the pharmacol. relevant specific pore-binding site in DPC micelles, which was not obsd. with a different detergent, DHPC, underscores the significant influence of the detergent environment on the functional structure of this membrane protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHrFx8uRujFLVg90H21EOLACvtfcHk0lhwGmLTvHrtOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisl2qtbs%253D&md5=d2e9d577835a89045092bc2c0b87a24b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fja102581n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja102581n%26sid%3Dliteratum%253Aachs%26aulast%3DCady%26aufirst%3DS.%2BD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DDeGrado%26aufirst%3DW.%2BF.%26aulast%3DHong%26aufirst%3DM.%26atitle%3DSpecific%2520binding%2520of%2520adamantane%2520drugs%2520and%2520direction%2520of%2520their%2520polar%2520amines%2520in%2520the%2520pore%2520of%2520the%2520influenza%2520M2%2520transmembrane%2520domain%2520in%2520lipid%2520bilayers%2520and%2520dodecylphosphocholine%2520micelles%2520determined%2520by%2520NMR%2520spectroscopy%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D4274%26epage%3D4284%26doi%3D10.1021%2Fja102581n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, Q. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R. B.</span></span> <span> </span><span class="NLM_article-title">In depth analysis on the binding sites of adamantane derivatives in HCV (Hepatitis C Virus) p7 channel based on the NMR structure</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e93613</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0093613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1371%2Fjournal.pone.0093613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=24714586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1egsLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=Q.+S.+Duauthor=S.+Q.+Wangauthor=D.+Chenauthor=J.+Z.+Mengauthor=R.+B.+Huang&title=In+depth+analysis+on+the+binding+sites+of+adamantane+derivatives+in+HCV+%28Hepatitis+C+Virus%29+p7+channel+based+on+the+NMR+structure&doi=10.1371%2Fjournal.pone.0093613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">In depth analysis on the binding sites of adamantane derivatives in HCV (hepatitis C virus) p7 channel based on the NMR structure</span></div><div class="casAuthors">Du, Qi-Shi; Wang, Shu-Qing; Chen, Dong; Meng, Jian-Zong; Huang, Ri-Bo</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e93613/1-e93613/7, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: The recently solved soln. structure of HCV (hepatitis C virus) p7 ion channel provides a solid structure basis for drug design against HCV infection.  In the p7 channel the ligand amantadine (or rimantadine) was detd. in a hydrophobic pocket.  However the pharmocophore (-NH2) of the ligand was not assigned a specific binding site.  Results: The possible binding sites for amino group of adamantane derivs. is studied based on the NMR structure of p7 channel using QM calcn. and mol. modeling.  In the hydrophobic cavity and nearby three possible binding sites are proposed: His17, Phe20, and Trp21.  The ligand binding energies at the three binding sites are studied using high level QM method CCSD(T)/6-311+G(d,p) and AutoDock calcns., and the interaction details are analyzed.  The potential application of the binding sites for rational inhibitor design are discussed.  Conclusions: Some useful viewpoints are concluded as follows.  (1) The amino group (-NH2) of adamantane derivs. is protonated (-NH3+), and the pos. charged cation may form cation-π interactions with arom. amino acids.  (2) The arom. amino acids (His17, Phe20, and Trp21) are the possible binding sites for the protonated amino group (-NH3+) of adamantane derivs., and the cation-π bond energies are 3 to 5 times stronger than the energies of common hydrogen bonds.  (3) The higher inhibition potent of rimantadine than amantadine probably because of its higher pKa value (pKa = 10.40) and the higher pos. charge in the amino group.  The potential application of p7 channel structure for inhibitor design is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPPc6YBjnR3LVg90H21EOLACvtfcHk0lhwGmLTvHrtOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1egsLfJ&md5=d8eff0c5fa553a703a5e51dd4754ad54</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0093613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0093613%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DQ.%2BS.%26aulast%3DWang%26aufirst%3DS.%2BQ.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DMeng%26aufirst%3DJ.%2BZ.%26aulast%3DHuang%26aufirst%3DR.%2BB.%26atitle%3DIn%2520depth%2520analysis%2520on%2520the%2520binding%2520sites%2520of%2520adamantane%2520derivatives%2520in%2520HCV%2520%2528Hepatitis%2520C%2520Virus%2529%2520p7%2520channel%2520based%2520on%2520the%2520NMR%2520structure%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0093613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morse, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eklind, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecht, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, F.-L.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships for inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone lung tumorigenesis by arylalkyl isothiocyanates in A/J Mice</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1846</span>– <span class="NLM_lpage">1850</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=2004368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADyaK3MXit1Sktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1991&pages=1846-1850&author=M.+A.+Morseauthor=K.+I.+Eklindauthor=S.+S.+Hechtauthor=K.+G.+Jordanauthor=C.+I.+Choiauthor=D.+H.+Desaiauthor=S.+G.+Aminauthor=F.-L.+Chung&title=Structure-activity+relationships+for+inhibition+of+4-%28methylnitrosamino%29-1-%283-pyridyl%29-1-butanone+lung+tumorigenesis+by+arylalkyl+isothiocyanates+in+A%2FJ+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Dietary inhibitors of chemical carcinogenesis. Part 11. Structure-activity relationships for inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone lung tumorigenesis by arylalkyl isothiocyanates in A/J mice</span></div><div class="casAuthors">Morse, Mark A.; Eklind, Karin I.; Hecht, Stephen S.; Jordan, Kevin G.; Choi, Chang In; Desai, Dhimant H.; Amin, Shantu G.; Chung, Fung Lung</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1846-50</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Phenethyl isothiocyanate (PEITC), 3-phenylpropyl isothiocyante (PPITC), 4-phenylbutyl isothiocyanate (PBITC), and the newly synthesized 5-phenylpentyl isothiocyante (PPcITC), 6-phenylhexyl isothiocyanate (PHITC), and 4-(3-pyridyl)butyl isothiocyanate (PyBITC) were tested for their abilities to inhibit tumorigenicity and DNA methylation induced by the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (I) in the lungs of A/J mice.  Mice were administered isothiocyantes by gavage for 4 consecutive days at doses of 5, 1, or 0.2 Mmol/day prior to administration of 10 μmol of I by i.p. injection.  Mice were sacrificed 16 wk after I administration and pulmonary adenomas were quantitated.  PEITC effectively inhibited I-induced lung tumors at a dose of 5 μmol/day but was not inhibitory at doses 1 or 0.2 μmol/day.  PPITC, PBITC, PPeITC, and PHITC were all considerably more potent inhibitors or I lung tumorigenesis than PEITC.  While virtually no differences in inhibitory activity could be ascertained for PPITC, PBITC, and PPeITC, PHITC appeared to be the most potent tumor inhibitor of all of the compds.  At a dose of 0.2 μmol/day, PHITC pretreatment reduced tumor multiplicity by 85%.  PyBITC, an analog on both I and PBITC, was ineffective as an inhibitor.  Using the same protocol, the compds. were found to have qual. similar inhibitory effects on I induced DNA methylation when administered at 1 μmol/day.  These results extend previous findings that increased alkyl chain length enhances the inhibitory activity of an arylalkyl isothiocyanate toward I lung tumorigenesis, and demonstrate the exceptional chemopreventive potentials of 2 new isothiocyantes, PPeITC and PHITC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOc3fsBZbYvrVg90H21EOLACvtfcHk0lh54UqT1AXYNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXit1Sktb4%253D&md5=1fbdb5f10c997d6bbf5e499b4c02cb2b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorse%26aufirst%3DM.%2BA.%26aulast%3DEklind%26aufirst%3DK.%2BI.%26aulast%3DHecht%26aufirst%3DS.%2BS.%26aulast%3DJordan%26aufirst%3DK.%2BG.%26aulast%3DChoi%26aufirst%3DC.%2BI.%26aulast%3DDesai%26aufirst%3DD.%2BH.%26aulast%3DAmin%26aufirst%3DS.%2BG.%26aulast%3DChung%26aufirst%3DF.-L.%26atitle%3DStructure-activity%2520relationships%2520for%2520inhibition%2520of%25204-%2528methylnitrosamino%2529-1-%25283-pyridyl%2529-1-butanone%2520lung%2520tumorigenesis%2520by%2520arylalkyl%2520isothiocyanates%2520in%2520A%252FJ%2520Mice%26jtitle%3DCancer%2520Res.%26date%3D1991%26volume%3D51%26spage%3D1846%26epage%3D1850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaitanya, G. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, P. P.</span></span> <span> </span><span class="NLM_article-title">PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration</span>. <i>Cell Commun. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.1186/1478-811X-8-31</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1186%2F1478-811X-8-31" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=21176168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtlSmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=31-41&author=G.+V.+Chaitanyaauthor=J.+S.+Alexanderauthor=P.+P.+Babu&title=PARP-1+cleavage+fragments%3A+signatures+of+cell-death+proteases+in+neurodegeneration&doi=10.1186%2F1478-811X-8-31"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration</span></div><div class="casAuthors">Chaitanya, Ganta Vijay; Steve, Alexander J.; Babu, Phanithi Prakash</div><div class="citationInfo"><span class="NLM_cas:title">Cell Communication and Signaling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31</span>CODEN:
                <span class="NLM_cas:coden">CCSEC6</span>;
        ISSN:<span class="NLM_cas:issn">1478-811X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  The normal function of poly (ADP-ribose) polymerase-1 (PARP-1) is the routine repair of DNA damage by adding poly (ADP ribose) polymers in response to a variety of cellular stresses.  Recently, it has become widely appreciated that PARP-1 also participates in diverse physiol. and pathol. functions from cell survival to several forms of cell death and has been implicated in gene transcription, immune responses, inflammation, learning, memory, synaptic functions, angiogenesis and aging.  In the CNS, PARP inhibition attenuates injury in pathologies like cerebral ischemia, trauma and excitotoxicity demonstrating a central role of PARP-1 in these pathologies.  PARP-1 is also a preferred substrate for several 'suicidal' proteases and the proteolytic action of suicidal proteases (caspases, calpains, cathepsins, granzymes and matrix metalloproteinases (MMPs)) on PARP-1 produces several specific proteolytic cleavage fragments with different mol. wts.  These PARP-1 signature fragments are recognized biomarkers for specific patterns of protease activity in unique cell death programs.  This review focuses on specific suicidal proteases active towards PARP-1 to generate signature PARP-1 fragments that can identify key proteases and particular forms of cell death involved in pathophysiol.  The roles played by some of the PARP-1 fragments and their assocd. binding partners in the control of different forms of cell death are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe_v_-uK8kzrVg90H21EOLACvtfcHk0liwzG4v33aLkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtlSmtw%253D%253D&md5=0fb5d43adfc5c0607c81fab41f207316</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1186%2F1478-811X-8-31&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1478-811X-8-31%26sid%3Dliteratum%253Aachs%26aulast%3DChaitanya%26aufirst%3DG.%2BV.%26aulast%3DAlexander%26aufirst%3DJ.%2BS.%26aulast%3DBabu%26aufirst%3DP.%2BP.%26atitle%3DPARP-1%2520cleavage%2520fragments%253A%2520signatures%2520of%2520cell-death%2520proteases%2520in%2520neurodegeneration%26jtitle%3DCell%2520Commun.%2520Signaling%26date%3D2010%26volume%3D8%26spage%3D31%26epage%3D41%26doi%3D10.1186%2F1478-811X-8-31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jänicke, R. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprengart, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, A. G.</span></span> <span> </span><span class="NLM_article-title">Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">15540</span>– <span class="NLM_lpage">15545</span>, <span class="refDoi"> DOI: 10.1074/jbc.273.25.15540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1074%2Fjbc.273.25.15540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=9624143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADyaK1cXktVSmtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=15540-15545&author=R.+U.+J%C3%A4nickeauthor=P.+Ngauthor=M.+L.+Sprengartauthor=A.+G.+Porter&title=Caspase-3+is+required+for+alpha-fodrin+cleavage+but+dispensable+for+cleavage+of+other+death+substrates+in+apoptosis&doi=10.1074%2Fjbc.273.25.15540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase-3 is required for α-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis</span></div><div class="casAuthors">Janicke, Reiner U.; Ng, Patrick; Sprengart, Michael L.; Porter, Alan G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">15540-15545</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Although the commonly activated death protease caspase-3 appears not to be essential for apoptosis during development except in the brain, it was not shown whether substrates known to be cleaved by caspase-3 are still proteolyzed in its absence.  We have addressed this question with MCF-7 breast carcinoma cells that we recently showed lack caspase-3 owing to the functional deletion of the CASP-3 gene.  Tumor necrosis factor- or staurosporine-induced apoptosis of caspase-3-deficient MCF-7 cells resulted in cleavage of the death substrates PARP, Rb, PAK2, DNA-PKcs, gelsolin, and DFF-45, but not α-fodrin.  In contrast, all these substrates including α-fodrin were cleaved in apoptotic HeLa cells expressing caspase-3.  Introduction of CASP-3 cDNA, but not CASP-10 cDNA, into MCF-7 cells restored α-fodrin cleavage.  In addn., tumor necrosis factor- or staurosporine-induced apoptosis of MCF-7 cells stably expressing pro-caspase-3 also resulted in α-fodrin cleavage.  Although the specific caspase inhibitory peptides Z-VAD-fmk and Z-DEVD-fmk prevented apoptosis of MCF-7 cells, we were unable to detect activation of caspases 2 and 7, which are known to be inhibited by Z-DEVD-fmk.  Together our results suggest that caspase-3 is essential for cleavage of α-fodrin, but dispensable for the cleavage of PARP, Rb, PAK2, DNA-PKcs, gelsolin, and DFF-45 and imply that one or more caspases other than caspases 2, 3, and 7 is activated and plays a crucial role in the cleavage of these substrates in MCF-7 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-3gj7yUcV5LVg90H21EOLACvtfcHk0lgPnBC1bKAtiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXktVSmtbo%253D&md5=5ba1ea627c2a50289006718edd8185ad</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.25.15540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.25.15540%26sid%3Dliteratum%253Aachs%26aulast%3DJ%25C3%25A4nicke%26aufirst%3DR.%2BU.%26aulast%3DNg%26aufirst%3DP.%26aulast%3DSprengart%26aufirst%3DM.%2BL.%26aulast%3DPorter%26aufirst%3DA.%2BG.%26atitle%3DCaspase-3%2520is%2520required%2520for%2520alpha-fodrin%2520cleavage%2520but%2520dispensable%2520for%2520cleavage%2520of%2520other%2520death%2520substrates%2520in%2520apoptosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D15540%26epage%3D15545%26doi%3D10.1074%2Fjbc.273.25.15540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vousden, K. H.</span></span> <span> </span><span class="NLM_article-title">Regulation and function of the p53 tumor suppressor protein</span>. <i>Curr. Opin. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">337</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1016%2FS0955-0674%2800%2900216-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=332-337&author=K.+M.+Ryanauthor=A.+C.+Phillipsauthor=K.+H.+Vousden&title=Regulation+and+function+of+the+p53+tumor+suppressor+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0955-0674%2800%2900216-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0955-0674%252800%252900216-7%26sid%3Dliteratum%253Aachs%26aulast%3DRyan%26aufirst%3DK.%2BM.%26aulast%3DPhillips%26aufirst%3DA.%2BC.%26aulast%3DVousden%26aufirst%3DK.%2BH.%26atitle%3DRegulation%2520and%2520function%2520of%2520the%2520p53%2520tumor%2520suppressor%2520protein%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2001%26volume%3D3%26spage%3D332%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span> <span> </span><span class="NLM_article-title">A common gain of function of p53 cancer mutants in inducing genetic instability</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">949</span>– <span class="NLM_lpage">956</span>, <span class="refDoi"> DOI: 10.1038/onc.2009.376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1038%2Fonc.2009.376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=19881536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlers7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=949-956&author=D.+P.+Liuauthor=H.+Songauthor=Y.+Xu&title=A+common+gain+of+function+of+p53+cancer+mutants+in+inducing+genetic+instability&doi=10.1038%2Fonc.2009.376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A common gain of function of p53 cancer mutants in inducing genetic instability</span></div><div class="casAuthors">Liu, D. P.; Song, H.; Xu, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">949-956</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The crit. tumor suppressor p53 is mutated in over half of all human cancers.  The majority of p53 cancer mutations are missense mutations, which can be classified into contact mutations that directly disrupt the DNA-binding of p53 but have modest impact on p53 conformation and structural mutations that greatly disrupt p53 conformation.  Many p53 cancer mutants, including the hot spot mutations (R175H, R248W and R273H), not only lose p53-dependent tumor-suppressor activities, but also acquire new oncogenic activities to promote cancer.  Therefore, it is crit. to elucidate the gain of oncogenic function of p53 cancer mutants.  Using humanized p53-mutant knock-in mouse models, we have identified a gain of oncogenic function shared by the most common p53 contact mutants (R273H and R248W) and structural mutant (R175H).  This gain of function inactivates Mre11/ATM-dependent DNA damage responses, leading to chromosomal translocation and defective G2/M checkpoint.  Considering the crit. roles of ATM in maintaining genetic stability and therapeutic responses to many cancer treatments, the identification of this common gain of function of p53 cancer mutants will have important implication on the drug resistance of a significant portion of human cancers that express either the contact or structural p53 cancer mutants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq-JbSj599d7Vg90H21EOLACvtfcHk0lhHwEdkslVkSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlers7vE&md5=8d4a195fb45649d119a0d32cff39ff8c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fonc.2009.376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2009.376%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DD.%2BP.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DA%2520common%2520gain%2520of%2520function%2520of%2520p53%2520cancer%2520mutants%2520in%2520inducing%2520genetic%2520instability%26jtitle%3DOncogene%26date%3D2010%26volume%3D29%26spage%3D949%26epage%3D956%26doi%3D10.1038%2Fonc.2009.376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combs, G. F.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Selenium and anticarcinogenesis: underlying mechanisms</span>. <i>Curr. Opin. Clin. Nutr. Metab. Care</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">718</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1097/MCO.0b013e3283139674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1097%2FMCO.0b013e3283139674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=18827575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFOrtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=718-726&author=M.+I.+Jacksonauthor=G.+F.+Combs&title=Selenium+and+anticarcinogenesis%3A+underlying+mechanisms&doi=10.1097%2FMCO.0b013e3283139674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Selenium and anticarcinogenesis: underlying mechanisms</span></div><div class="casAuthors">Jackson, Matthew I.; Combs, Gerald F., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Clinical Nutrition and Metabolic Care</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">718-726</span>CODEN:
                <span class="NLM_cas:coden">COCMF3</span>;
        ISSN:<span class="NLM_cas:issn">1363-1950</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: To discuss recent research related to anticarcinogenic mechanisms of selenium action in light of the underlying chem./biochem. functions of the selenium species, likely to be executors of those effects.  Recent findings: Recent studies in a variety of model systems have increased the understanding of the anticarcinogenic mechanisms of selenium compds.  These include effects on gene expression, DNA damage and repair, signaling pathways, regulation of cell cycle and apoptosis, metastasis and angiogenesis.  These effects would appear to be related to the prodn. of reactive oxygen species produced by the redox cycling, modification of protein-thiols and methionine mimicry.  Three principle selenium metabolites appear to execute these effects: hydrogen selenide, methylselenol and selenomethionine.  The fact that various selenium compds. can be metabolized to one or more of these species but differ in anticarcinogenic activity indicates competing pathways of their metabolic and chem./biochem. disposition.  Increasing knowledge of selenoprotein polymorphisms has shown that at least some are related to cancer risk and may affect carcinogenesis indirectly by influencing selenium metab.  Summary: The anticarcinogenic effects of selenium compds. constitute intermediate mechanisms with several underlying chem./biochem. mechanisms such as redox cycling, alteration of protein-thiol redox status and methionine mimicry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBhBXcNOgihbVg90H21EOLACvtfcHk0lgqRgRiLZ8-kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFOrtLnN&md5=a25c3f425a7f0ac275147c430a230fe0</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1097%2FMCO.0b013e3283139674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMCO.0b013e3283139674%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DM.%2BI.%26aulast%3DCombs%26aufirst%3DG.%2BF.%26atitle%3DSelenium%2520and%2520anticarcinogenesis%253A%2520underlying%2520mechanisms%26jtitle%3DCurr.%2520Opin.%2520Clin.%2520Nutr.%2520Metab.%2520Care%26date%3D2008%26volume%3D11%26spage%3D718%26epage%3D726%26doi%3D10.1097%2FMCO.0b013e3283139674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brigelius-Flohé, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banning, A.</span></span> <span> </span><span class="NLM_article-title">Part of the series: from dietary antioxidants to regulators in cellular signaling and gene regulation. Sulforaphane and selenium, partners in adaptive response and prevention of cancer</span>. <i>Free Radical Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">775</span>– <span class="NLM_lpage">787</span>, <span class="refDoi"> DOI: 10.1080/10715760600722643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1080%2F10715760600722643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=17015256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD28XovFGksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2006&pages=775-787&author=R.+Brigelius-Floh%C3%A9author=A.+Banning&title=Part+of+the+series%3A+from+dietary+antioxidants+to+regulators+in+cellular+signaling+and+gene+regulation.+Sulforaphane+and+selenium%2C+partners+in+adaptive+response+and+prevention+of+cancer&doi=10.1080%2F10715760600722643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Part of the series: from dietary antioxidants to regulators in cellular signaling and gene regulation. Sulforaphane and selenium, partners in adaptive response and prevention of cancer</span></div><div class="casAuthors">Brigelius-Flohe, Regina; Banning, Antje</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">775-787</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1071-5762</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The assocn. of decreased cancer risk with dietary intake of cruciferous vegetables and selenium is stronger than that reported for fruits and vegetables in general.  Sulforaphane is an active constituent in cruciferae.  The chemopreventive effects of sulforaphane and selenium have been attributed to antioxidant actions in a simplistic way.  Sulforaphane induces phase 2 enzymes via activation of the Nrf2/Keap1 system that protect against carcinogens and oxidants.  The induced enzymes include selenoproteins thioredoxin reductase-1 (TrxR1) and gastrointestinal glutathione peroxidase (GI-GPx, GPx2), which contain antioxidant response elements (ARE) in their promoter regions.  Translational realization of the enhanced transcripts depends on adequate Se supply, which explains the synergism of Nrf2 activators and selenium.  Regarding tumorigenesis, the role of TrxR1 is ambiguous: it is essential for fast tumor cell growth but also diminishes vascularization of tumors.  The anticarcinogenic role of GI-GPx is evident from enhanced gastrointestinal tumor formation in gpx2/gpx1 double knock-out mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF3Y2ft_DuOrVg90H21EOLACvtfcHk0lgqRgRiLZ8-kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovFGksL8%253D&md5=ca0f610ca33f0e577c1eecac1e54b446</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1080%2F10715760600722643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10715760600722643%26sid%3Dliteratum%253Aachs%26aulast%3DBrigelius-Floh%25C3%25A9%26aufirst%3DR.%26aulast%3DBanning%26aufirst%3DA.%26atitle%3DPart%2520of%2520the%2520series%253A%2520from%2520dietary%2520antioxidants%2520to%2520regulators%2520in%2520cellular%2520signaling%2520and%2520gene%2520regulation.%2520Sulforaphane%2520and%2520selenium%252C%2520partners%2520in%2520adaptive%2520response%2520and%2520prevention%2520of%2520cancer%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2006%26volume%3D40%26spage%3D775%26epage%3D787%26doi%3D10.1080%2F10715760600722643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zakrzewski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huras, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiełczewska, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of isoselenocyanates</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1055%2Fs-0035-1560481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslCks7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2016&pages=85-96&author=J.+Zakrzewskiauthor=B.+Hurasauthor=A.+Kie%C5%82czewska&title=Synthesis+of+isoselenocyanates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Isoselenocyanates</span></div><div class="casAuthors">Zakrzewski, Jerzy; Huras, Bogumila; Kielczewska, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-96</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">1437-210X</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Isoselenocyanates were prepd. by two methods from either the corresponding isonitriles or directly from the corresponding amines.  Using phase-transfer conditions (50% aq NaOH, CH2Cl2, Aliquat 336), isonitriles underwent selenation with selenium to give isoselenocyanates in 61-89% yields; generating the isonitriles in situ from amines using chloroform (Hofmann isonitrile synthesis) followed by selenation yielded isoselenocyanates in 4-70% yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjY9nicMw6N7Vg90H21EOLACvtfcHk0lhiK3qtZ-Y_zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslCks7jF&md5=717b404fccd35de570d3260eb936bd59</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1055%2Fs-0035-1560481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0035-1560481%26sid%3Dliteratum%253Aachs%26aulast%3DZakrzewski%26aufirst%3DJ.%26aulast%3DHuras%26aufirst%3DB.%26aulast%3DKie%25C5%2582czewska%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520isoselenocyanates%26jtitle%3DSynthesis%26date%3D2016%26volume%3D48%26spage%3D85%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dittmer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambetti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teresky, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, A. J.</span></span> <span> </span><span class="NLM_article-title">Gain of function mutations in p53</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1038/ng0593-42</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1038%2Fng0593-42" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=8099841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADyaK3sXkt1ajsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1993&pages=42-46&author=D.+Dittmerauthor=S.+Patiauthor=G.+Zambettiauthor=S.+Chuauthor=A.+K.+Tereskyauthor=M.+Mooreauthor=C.+Finlayauthor=A.+J.+Levine&title=Gain+of+function+mutations+in+p53&doi=10.1038%2Fng0593-42"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Gain of function mutations in p53</span></div><div class="casAuthors">Dittmer, Dirk; Pati, Sibani; Zambetti, Gerard; Chu, Shelley; Teresky, Angelika K.; Moore, Mary; Finlay, Cathy; Levine, Arnold J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-6</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    </div><div class="casAbstract">The expression of murine or human mutant p53 proteins in cells with no endogenous p53 proteins confers new or addnl. phenotypes upon these cells.  Mutant p53 proteins expressed in cell lines lacking p53 resulted in either enhanced tumorigenic potential in nude mice ((10)3 cells) or enhanced plating efficiency in agar cell culture (human SAOS-2 cells).  Also, mutant human p53 alleles, unlike the wild-type p53 protein, could also enhance the expression of a test gene regulated by the multi-drug resistance enhancer-promoter element.  These data demonstrate a gain of function assocd. with p53 mutations in addn. to the loss of function shown previously to be assocd. with mutations in this tumor suppressor gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkTIQCdFur4bVg90H21EOLACvtfcHk0lhiK3qtZ-Y_zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkt1ajsbo%253D&md5=2762983a216e065e72914e8750012380</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fng0593-42&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng0593-42%26sid%3Dliteratum%253Aachs%26aulast%3DDittmer%26aufirst%3DD.%26aulast%3DPati%26aufirst%3DS.%26aulast%3DZambetti%26aufirst%3DG.%26aulast%3DChu%26aufirst%3DS.%26aulast%3DTeresky%26aufirst%3DA.%2BK.%26aulast%3DMoore%26aufirst%3DM.%26aulast%3DFinlay%26aufirst%3DC.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26atitle%3DGain%2520of%2520function%2520mutations%2520in%2520p53%26jtitle%3DNat.%2520Genet.%26date%3D1993%26volume%3D4%26spage%3D42%26epage%3D46%26doi%3D10.1038%2Fng0593-42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freed-Pastor, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prives, C.</span></span> <span> </span><span class="NLM_article-title">Mutant p53: one name, many proteins</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1268</span>– <span class="NLM_lpage">1286</span>, <span class="refDoi"> DOI: 10.1101/gad.190678.112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1101%2Fgad.190678.112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=22713868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVegs7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=1268-1286&author=W.+A.+Freed-Pastorauthor=C.+Prives&title=Mutant+p53%3A+one+name%2C+many+proteins&doi=10.1101%2Fgad.190678.112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Mutant p53: one name, many proteins</span></div><div class="casAuthors">Freed-Pastor, William A.; Prives, Carol</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1268-1286</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  There is now strong evidence that mutation not only abrogates p53 tumor-suppressive functions, but in some instances can also endow mutant proteins with novel activities.  Such neomorphic p53 proteins are capable of dramatically altering tumor cell behavior, primarily through their interactions with other cellular proteins and regulation of cancer cell transcriptional programs.  Different missense mutations in p53 may confer unique activities and thereby offer insight into the mutagenic events that drive tumor progression.  Here we review mechanisms by which mutant p53 exerts its cellular effects, with a particular focus on the burgeoning mutant p53 transcriptome, and discuss the biol. and clin. consequences of mutant p53 gain of function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfNmynVk_whbVg90H21EOLACvtfcHk0lhiK3qtZ-Y_zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVegs7%252FJ&md5=c48dc33a3065178fadcef58975626703</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1101%2Fgad.190678.112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.190678.112%26sid%3Dliteratum%253Aachs%26aulast%3DFreed-Pastor%26aufirst%3DW.%2BA.%26aulast%3DPrives%26aufirst%3DC.%26atitle%3DMutant%2520p53%253A%2520one%2520name%252C%2520many%2520proteins%26jtitle%3DGenes%2520Dev.%26date%3D2012%26volume%3D26%26spage%3D1268%26epage%3D1286%26doi%3D10.1101%2Fgad.190678.112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bykov, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issaeva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shilov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultcrantz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugacheva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chumakov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiman, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selivanova, S.</span></span> <span> </span><span class="NLM_article-title">Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">282</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1038/nm0302-282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1038%2Fnm0302-282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=11875500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD38Xit1Citrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=282-288&author=V.+J.+Bykovauthor=N.+Issaevaauthor=A.+Shilovauthor=M.+Hultcrantzauthor=E.+Pugachevaauthor=P.+Chumakovauthor=J.+Bergmanauthor=K.+G.+Wimanauthor=S.+Selivanova&title=Restoration+of+the+tumor+suppressor+function+to+mutant+p53+by+a+low-molecular-weight+compound&doi=10.1038%2Fnm0302-282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound</span></div><div class="casAuthors">Bykov, Vladimir J. N.; Issaeva, Natalia; Shilov, Alexandre; Hultcrantz, Monica; Pugacheva, Lena; Chumakov, Peter; Bergman, Jan; Wiman, Klas G.; Selivanova, Galina</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">282-288</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The tumor suppressor p53 inhibits tumor growth primarily through its ability to induce apoptosis.  Mutations in p53 occur in at least 50% of human tumors.  The authors hypothesized that reactivation of mutant p53 in such tumors should trigger massive apoptosis and eliminate the tumor cells.  To test this, the authors screened a library of low-mol.-wt. compds. to identify compds. that can restore wild-type function to mutant p53.  The authors found one compd. capable of inducing apoptosis in human tumor cells through restoration of the transcriptional transactivation function to mutant p53.  This mol., named PRIMA-1, restored sequence-specific DNA binding and the active conformation to mutant p53 proteins in vitro and in living cells.  PRIMA-1 rescued both DNA contact and structural p53 mutants.  In vivo studies in mice revealed an anti-tumor effect with no apparent toxicity.  This mol. may serve as a lead compd. for the development of anticancer drugs targeting mutant p53.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7Z3M-K-Q0srVg90H21EOLACvtfcHk0lgFNvhwRkx3eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xit1Citrk%253D&md5=c607dd789a5fc1fbc1ad1a3edcf8701b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnm0302-282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0302-282%26sid%3Dliteratum%253Aachs%26aulast%3DBykov%26aufirst%3DV.%2BJ.%26aulast%3DIssaeva%26aufirst%3DN.%26aulast%3DShilov%26aufirst%3DA.%26aulast%3DHultcrantz%26aufirst%3DM.%26aulast%3DPugacheva%26aufirst%3DE.%26aulast%3DChumakov%26aufirst%3DP.%26aulast%3DBergman%26aufirst%3DJ.%26aulast%3DWiman%26aufirst%3DK.%2BG.%26aulast%3DSelivanova%26aufirst%3DS.%26atitle%3DRestoration%2520of%2520the%2520tumor%2520suppressor%2520function%2520to%2520mutant%2520p53%2520by%2520a%2520low-molecular-weight%2520compound%26jtitle%3DNat.%2520Med.%26date%3D2002%26volume%3D8%26spage%3D282%26epage%3D288%26doi%3D10.1038%2Fnm0302-282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpizo, D. R.</span></span> <span> </span><span class="NLM_article-title">Allele-specific p53 mutant reactivation</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">614</span>– <span class="NLM_lpage">625</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2012.03.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1016%2Fj.ccr.2012.03.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=22624712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC38XntlymsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=614-625&author=X.+Yuauthor=A.+Vazquezauthor=A.+J.+Levineauthor=D.+R.+Carpizo&title=Allele-specific+p53+mutant+reactivation&doi=10.1016%2Fj.ccr.2012.03.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Allele-Specific p53 Mutant Reactivation</span></div><div class="casAuthors">Yu, Xin; Vazquez, Alexei; Levine, Arnold J.; Carpizo, Darren R.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">614-625</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Rescuing the function of mutant p53 protein is an attractive cancer therapeutic strategy.  Using the National Cancer Institute's anticancer drug screen data, we identified two compds. from the thiosemicarbazone family that manifest increased growth inhibitory activity in mutant p53 cells, particularly for the p53R175 mutant.  Mechanistic studies reveal that NSC319726 restores WT structure and function to the p53R175 mutant.  This compd. kills p53R172H knockin mice with extensive apoptosis and inhibits xenograft tumor growth in a 175-allele-specific mutant p53-dependent manner.  This activity depends upon the zinc ion chelating properties of the compd. as well as redox changes.  These data identify NSC319726 as a p53R175 mutant reactivator and as a lead compd. for p53-targeted drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprhl9-HrS8cLVg90H21EOLACvtfcHk0lgFNvhwRkx3eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntlymsLw%253D&md5=fb82e1673c17b5f6084a1972d24a936a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.03.042%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%26aulast%3DVazquez%26aufirst%3DA.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26aulast%3DCarpizo%26aufirst%3DD.%2BR.%26atitle%3DAllele-specific%2520p53%2520mutant%2520reactivation%26jtitle%3DCancer%2520Cell%26date%3D2012%26volume%3D21%26spage%3D614%26epage%3D625%26doi%3D10.1016%2Fj.ccr.2012.03.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barrera, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belshaw, N. J.</span></span> <span> </span><span class="NLM_article-title">Epigenetic and antioxidant effects of dietary isothiocyanates and selenium: potential implications for cancer chemoprevention</span>. <i>Proc. Nutr. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">245</span>, <span class="refDoi"> DOI: 10.1017/S002966511200016X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1017%2FS002966511200016X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=22391025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvVaqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2012&pages=237-245&author=L.+N.+Barreraauthor=A.+Cassidyauthor=I.+T.+Johnsonauthor=Y.+Baoauthor=N.+J.+Belshaw&title=Epigenetic+and+antioxidant+effects+of+dietary+isothiocyanates+and+selenium%3A+potential+implications+for+cancer+chemoprevention&doi=10.1017%2FS002966511200016X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic and antioxidant effects of dietary isothiocyanates and selenium: potential implications for cancer chemoprevention</span></div><div class="casAuthors">Barrera, Lawrence N.; Cassidy, Aedin; Johnson, Ian T.; Bao, Yongping; Belshaw, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Nutrition Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">237-245</span>CODEN:
                <span class="NLM_cas:coden">PNUSA4</span>;
        ISSN:<span class="NLM_cas:issn">0029-6651</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">A review.  There is evidence from epidemiol. studies suggesting that increased consumption of cruciferous vegetables may protect against specific cancers more effectively than total fruit and vegetable intake.  These beneficial effects are attributed to the glucosinolate breakdown products, isothiocyanates (ITC).  Similarly, selenium (Se) consumption has also been inversely assocd. with cancer risk and as an integral part of many selenoproteins may influence multiple pathways in the development of cancer.  This paper will briefly review the current state of knowledge concerning the effect of Se and ITC in cancer development with a particular emphasis on its antioxidant properties, and will also address whether alterations in DNA methylation may be a potential mechanism whereby these dietary constituents protect against the carcinogenic process.  Furthermore, we will discuss the advantages of combining ITC and Se to benefit from their complementary mechanisms of action to potentially protect against the alterations leading to neoplasia.  Based on this review it may be concluded that an understanding of the impact of ITC and Se on aberrant DNA methylation in relation to factors modulating gene-specific and global methylation patterns, in addn. to the effect of these food constituents as modulators of key selenoenzymes, such as gastrointestinal glutathione peroxidase-2 (GPx2) and thioredoxin reductase-1 (TrxR1), may provide insights into the potential synergy among various components of a plant-based diet that may counteract the genetic and epigenetic alterations that initiate and sustain neoplasia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOAN3MShxZA7Vg90H21EOLACvtfcHk0lj29c-HSNakPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvVaqu7w%253D&md5=211de5c9230244fd169f242e256c2d03</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1017%2FS002966511200016X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS002966511200016X%26sid%3Dliteratum%253Aachs%26aulast%3DBarrera%26aufirst%3DL.%2BN.%26aulast%3DCassidy%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DI.%2BT.%26aulast%3DBao%26aufirst%3DY.%26aulast%3DBelshaw%26aufirst%3DN.%2BJ.%26atitle%3DEpigenetic%2520and%2520antioxidant%2520effects%2520of%2520dietary%2520isothiocyanates%2520and%2520selenium%253A%2520potential%2520implications%2520for%2520cancer%2520chemoprevention%26jtitle%3DProc.%2520Nutr.%2520Soc.%26date%3D2012%26volume%3D71%26spage%3D237%26epage%3D245%26doi%3D10.1017%2FS002966511200016X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhunapantula, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huh, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">7820</span>– <span class="NLM_lpage">7826</span>, <span class="refDoi"> DOI: 10.1021/jm800993r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800993r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWisbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7820-7826&author=A.+K.+Sharmaauthor=A.+Sharmaauthor=D.+Desaiauthor=S.+V.+Madhunapantulaauthor=S.+J.+Huhauthor=G.+P.+Robertsonauthor=S.+Amin&title=Synthesis+and+anticancer+activity+comparison+of+phenylalkyl+isoselenocyanates+with+corresponding+naturally+occurring+and+synthetic+isothiocyanates&doi=10.1021%2Fjm800993r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Anticancer Activity Comparison of Phenylalkyl Isoselenocyanates with Corresponding Naturally Occurring and Synthetic Isothiocyanates</span></div><div class="casAuthors">Sharma, Arun K.; Sharma, Arati; Desai, Dhimant; Madhunapantula, SubbaRao V.; Huh, Sung Jin; Robertson, Gavin P.; Amin, Shantu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7820-7826</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Synthesis and identification of novel phenylalkyl isoselenocyanates (ISCs), isosteric selenium analogs of naturally occurring phenylalkyl isothiocyanates (ITCs), as effective cytotoxic and antitumor agents are described.  The structure-activity relationship comparison of ISCs with ITCs and effect of the increasing alkyl chain length in inhibiting cancer cell growth were evaluated on melanoma, prostate, breast, glioblastoma, sarcoma, and colon cancer cell lines. IC50 values for ISC compds. were generally lower than their corresponding ITC analogs.  Similarly, in UACC 903 human melanoma cells, the inhibition of cell proliferation and induction of apoptosis were more pronounced with ISCs compared to ITCs.  Further, ISCs and ITCs effectively inhibited melanoma tumor growth in mice following i.p. xenograft.  A similar redn. in tumor size was obsd. at 3 times lower doses of ISCs compared to corresponding ITCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNqKH0v41XDLVg90H21EOLACvtfcHk0ljmKYDIirdUVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWisbvE&md5=6828d8e92e21093d62aa69a9c3412ea2</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm800993r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800993r%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DDesai%26aufirst%3DD.%26aulast%3DMadhunapantula%26aufirst%3DS.%2BV.%26aulast%3DHuh%26aufirst%3DS.%2BJ.%26aulast%3DRobertson%26aufirst%3DG.%2BP.%26aulast%3DAmin%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520anticancer%2520activity%2520comparison%2520of%2520phenylalkyl%2520isoselenocyanates%2520with%2520corresponding%2520naturally%2520occurring%2520and%2520synthetic%2520isothiocyanates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7820%26epage%3D7826%26doi%3D10.1021%2Fjm800993r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Westland, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merz, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khullar, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devdhar, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenan, M. M.</span></span> <span> </span><span class="NLM_article-title">2-Mercaptoacetamidine and derivatives as antiradiation agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1313</span>– <span class="NLM_lpage">1321</span>, <span class="refDoi"> DOI: 10.1021/jm00282a027</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00282a027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADyaE3sXlt1Ghug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1972&pages=1313-1321&author=R.+D.+Westlandauthor=M.+M.+Merzauthor=S.+M.+Alexanderauthor=L.+S.+Newtonauthor=L.+Bauerauthor=T.+T.+Conwayauthor=J.+M.+Bartonauthor=K.+K.+Khullarauthor=P.+B.+Devdharauthor=M.+M.+Grenan&title=2-Mercaptoacetamidine+and+derivatives+as+antiradiation+agents&doi=10.1021%2Fjm00282a027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">2-Mercaptoacetamidine and derivatives as antiradiation agents</span></div><div class="casAuthors">Westland, Roger D.; Merz, Mary M.; Alexander, Susan M.; Newton, Linda S.; Bauer, Ludwig; Conway, Terry T.; Barton, Jerry M.; Khullar, Krishan K.; Devdhar, Prabhakar B.; Grenan, Marie M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1313-21</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A series of 2-mercaptoacetamidines and their disulfides were generally more active antiradiation agents in mice when given orally than parenterally, whereas the corresponding Bunte salts and phosphorothioates were more effective when given i.p.  One of the most effective compds. i.p. was Na H S-[N-[(3,5-dimethyl-1-adamantyl)methyl]amidino]methyl phosphorothioate (I) [37764-43-5] (93% survival at 8, 60% at 4 mg/kg; LD50 125 mg/kg); this compd. was also effective orally (100% survival at 100 mg/kg; LD50 425 mg/kg).  2,2'-Dithiobis[N-[(1-adamantyl)methyl]acetamidine]-2-HCl [37764-44-6] given orally gave 80% survival at 50 mg/kg and 53% at 25 mg/kg, but was ineffective i.p.; similar results were obtained with 2,2'-dithiobis[N-[(3,5-dimethyl-1-adamantyl)methyl]acetamidine]-2HCl (II) [37717-22-9].  To synthesize I, ClCH2CN was reacted with MeOH-NaOMe to form MeOC(:NH)CH2Cl, which was converted with 3,5-dimethyl-1-adamantylmethylamine-HCl to the N-substituted 2-chloroacetamidine; this was displaced with O3PS3- to form I.  Acid hydrolysis of I to the thiol followed by mild H2O2 oxidn. yielded II.  The mice were given 975 rads of 60Co γ-radiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou2qvrvu-H2LVg90H21EOLACvtfcHk0ljmKYDIirdUVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXlt1Ghug%253D%253D&md5=6d277fadb0415c740b2dd1ca4376f130</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm00282a027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00282a027%26sid%3Dliteratum%253Aachs%26aulast%3DWestland%26aufirst%3DR.%2BD.%26aulast%3DMerz%26aufirst%3DM.%2BM.%26aulast%3DAlexander%26aufirst%3DS.%2BM.%26aulast%3DNewton%26aufirst%3DL.%2BS.%26aulast%3DBauer%26aufirst%3DL.%26aulast%3DConway%26aufirst%3DT.%2BT.%26aulast%3DBarton%26aufirst%3DJ.%2BM.%26aulast%3DKhullar%26aufirst%3DK.%2BK.%26aulast%3DDevdhar%26aufirst%3DP.%2BB.%26aulast%3DGrenan%26aufirst%3DM.%2BM.%26atitle%3D2-Mercaptoacetamidine%2520and%2520derivatives%2520as%2520antiradiation%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1972%26volume%3D15%26spage%3D1313%26epage%3D1321%26doi%3D10.1021%2Fjm00282a027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirole, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastenhuber, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senturk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boroda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisterzi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderluh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladanyi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sordella, R.</span></span> <span> </span><span class="NLM_article-title">TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e17929</span> <span class="refDoi"> DOI: 10.7554/eLife.17929</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.7554%2FeLife.17929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=27759562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVahtr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&author=N.+H.+Shiroleauthor=D.+Palauthor=E.+R.+Kastenhuberauthor=S.+Senturkauthor=J.+Borodaauthor=P.+Pisterziauthor=M.+Millerauthor=G.+Munozauthor=M.+Anderluhauthor=M.+Ladanyiauthor=S.+W.+Loweauthor=R.+Sordella&title=TP53+exon-6+truncating+mutations+produce+separation+of+function+isoforms+with+pro-tumorigenic+functions&doi=10.7554%2FeLife.17929"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions</span></div><div class="casAuthors">Shirole, Nitin H.; Pal, Debjani; Kastenhuber, Edward R.; Senturk, Serif; Boroda, Joseph; Pisterzi, Paola; Miller, Madison; Munoz, Gustavo; Anderluh, Marko; Ladanyi, Marc; Lowe, Scott W.; Sordella, Raffaella</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e17929/1-e17929/25</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">TP53 truncating mutations are common in human tumors and are thought to give rise to p53-null alleles.  Here, we show that TP53 exon-6 truncating mutations occur at higher than expected frequencies and produce proteins that lack canonical p53 tumor suppressor activities but promote cancer cell proliferation, survival, and metastasis.  Functionally and molecularly, these p53 mutants resemble the naturally occurring alternative p53 splice variant, p53-psi.  Accordingly, these mutants can localize to the mitochondria where they promote tumor phenotypes by binding and activating the mitochondria inner pore permeability regulator, Cyclophilin D (CypD).  Together, our studies reveal that TP53 exon-6 truncating mutations, contrary to current beliefs, act beyond p53 loss to promote tumorigenesis, and could inform the development of strategies to target cancers driven by these prevalent mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0GG_YVZz-17Vg90H21EOLACvtfcHk0ljyLwydr8vVkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVahtr7L&md5=cc9b3f76c87125ce733e3bea6cca6040</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.7554%2FeLife.17929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.17929%26sid%3Dliteratum%253Aachs%26aulast%3DShirole%26aufirst%3DN.%2BH.%26aulast%3DPal%26aufirst%3DD.%26aulast%3DKastenhuber%26aufirst%3DE.%2BR.%26aulast%3DSenturk%26aufirst%3DS.%26aulast%3DBoroda%26aufirst%3DJ.%26aulast%3DPisterzi%26aufirst%3DP.%26aulast%3DMiller%26aufirst%3DM.%26aulast%3DMunoz%26aufirst%3DG.%26aulast%3DAnderluh%26aufirst%3DM.%26aulast%3DLadanyi%26aufirst%3DM.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26aulast%3DSordella%26aufirst%3DR.%26atitle%3DTP53%2520exon-6%2520truncating%2520mutations%2520produce%2520separation%2520of%2520function%2520isoforms%2520with%2520pro-tumorigenic%2520functions%26jtitle%3DeLife%26date%3D2016%26volume%3D5%26doi%3D10.7554%2FeLife.17929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, M. J.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry</span>. <i>Clin. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">641</span>– <span class="NLM_lpage">653</span>, <span class="refDoi"> DOI: 10.1016/j.clinthera.2008.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1016%2Fj.clinthera.2008.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=18498913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWltLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2008&pages=641-653&author=M.+Y.+Liuauthor=S.+N.+Mengauthor=H.+Z.+Wuauthor=S.+Wangauthor=M.+J.+Wei&title=Pharmacokinetics+of+single-dose+and+multiple-dose+memantine+in+healthy+chinese+volunteers+using+an+analytic+method+of+liquid+chromatography-tandem+mass+spectrometry&doi=10.1016%2Fj.clinthera.2008.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of single-dose and multiple-dose memantine in healthy Chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry</span></div><div class="casAuthors">Liu, Ming-Yan; Meng, Sheng-Nan; Wu, Hui-Zhe; Wang, Shuang; Wei, Min-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">641-653</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">This study consisted of 2 phases: development of a liq. chromatog.-tandem mass spectrometry (LC/MS) method for detn. of memantine in human plasma and characterization of single-dose and multiple-dose pharmacokinetic profiles of memantine in healthy Chinese volunteers using the LC/MS method.  An analytic method of LC/MS for detn. of memantine in human plasma was developed and validated and was applied to this single-center, open-label, single-dose and multiple-dose pharmacokinetic study conducted in healthy native Chinese volunteers.  Subjects were randomized to receive a single dose of 5, 10, or 20 mg of memantine to study the linear characteristics of pharmacokinetics, or a multiple dose of 5 mg once daily for 14 days to study the drug accumulation.  The pharmacokinetic parameters calcd. included Cmax, Tmax, AUC, t1/2, mean residence time (MRT), max. steady-state plasma concn. (Cssmax), min. steady-state plasma concn. (Cssmin), av. steady-state plasma concn. (Cssav), and fluctuation percentage (DF).  All values were expressed as mean (SD).  Sequential blood samples were collected from 0 to 360 h for single-dose pharmacokinetic detns. after the dose on day 1; in the multiple-dose pharmacokinetic arm, the sequential blood samples were also obtained from 0 to 360 h on day 14 after collecting the predose samples at 0 h on days 11, 12, and 13.  Memantine concns. in plasma were detd. by LC/MS method.  A calibration curve was constructed by 7 memantine concns. and processed by least-squares linear regression anal. (w = 1/x2).  Safety assessments, including adverse events (AEs), were performed at all study visits.  The LC/MS method for detn. of memantine in human plasma was developed and validated.  The std. calibration curve for spiked human plasma contg. memantine was linear in the concn. range of 0.2 to 200.0 ng/mL.  The correlation coeff. was greater than 0.9960 (n = 6).  The lower limit of quantification for memantine in human plasma was 0.2 ng/mL, and the intraday and interday coeffs. of variation were all lower than 15%.  The mean recoveries of the 0.4, 20.0, and 180.0 ng/mL levels were 78.87%, 81.55%, and 81.98%, resp.  The coeffs. of variation were all lower than 15% after being treated at room temp. for 24 h, for 45 days at -40°, and within 3 freeze-and-thaw cycles in plasma samples.  Forty native Chinese subjects (10 [5 men, 5 women] subjects per group; mean [SD] age, 21.6 [1.6] [range, 19-27] years; wt., 63.0 [7.7] [range, 52-82] kg; height, 170.0 [7.0] [range, 155-185] cm) were enrolled in the study.  After single-dose oral administration, the main pharmacokinetic parameters found for memantine at doses of 5, 10, and 20 mg were as follows: Cmax, 6.20 (0.75), 11.60 (1.95), and 25.34 (8.34) ng/mL, resp.; Tmax, 5.70 (1.64), 6.00 (1.33), and 6.89 (1.41) h; AUC0-t, 486.19 (80.00), 889.32 (239.49), and 1772.91 (784.07) ng/h/mL; AUC0-∞, 540.05 (89.68), 932.07 (230.82), and 1853.29 (776.85) ng/h/mL; t1/2, 66.86 (11.75), 63.57 (12.58), and 62.06 (9.26) h; and MRT, 99.37 (16.96), 91.73 (18.16), and 89.56 (13.77) h.  The main pharmacokinetic parameters found for memantine at doses of 5 mg once daily for 14 days were as follows: Tmax, 6.80 (2.46) h; Cssmax, 19.69 (2.00) ng/mL; Cssmin, 12.76 (2.80) ng/mL; Cssav, 16.10 (2.46) ng/mL; t1/2, 64.57 (15.78) h; MRT, 93.17 (23.38) h; AUCss, 386.37 (59.00) ng/h/mL; and DF, 44.47% (15.27%).  One female subject withdrew from the study after a single 20-mg dose due to an AE (dizziness and vomiting); no other subjects experienced an AE.  In these healthy Chinese subjects, the t1/2 and MRT values were fixed and did not increase following the increased dose, and the AUC0-∞ and Cmax values increased following the increasing dosage of memantine.  Linear pharmacokinetics was found at doses from 5 to 20 mg.  The multiple-dose pharmacokinetic parameters (other than Cmax) were nearly similar compared with the single-dose administration.  The max. plasma concn. of memantine after multiple-dose administration was greater than that after a single-dose administration, suggesting memantine accumulation with multiple-dose administration of 5 mg and requiring further confirmation in larger studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHbDkJE8GH-rVg90H21EOLACvtfcHk0ljyLwydr8vVkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWltLnE&md5=e13f114fcc42624cb8b6ecf7f472cc3c</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2008.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2008.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DM.%2BY.%26aulast%3DMeng%26aufirst%3DS.%2BN.%26aulast%3DWu%26aufirst%3DH.%2BZ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DM.%2BJ.%26atitle%3DPharmacokinetics%2520of%2520single-dose%2520and%2520multiple-dose%2520memantine%2520in%2520healthy%2520chinese%2520volunteers%2520using%2520an%2520analytic%2520method%2520of%2520liquid%2520chromatography-tandem%2520mass%2520spectrometry%26jtitle%3DClin.%2520Ther.%26date%3D2008%26volume%3D30%26spage%3D641%26epage%3D653%26doi%3D10.1016%2Fj.clinthera.2008.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minocha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spyker, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, H. E.</span></span> <span> </span><span class="NLM_article-title">Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">216</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1128/aac.28.2.216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.1128%2FAAC.28.2.216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=3834831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADyaL2MXltFGltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=216-221&author=F.+G.+Haydenauthor=A.+Minochaauthor=D.+A.+Spykerauthor=H.+E.+Hoffman&title=Comparative+single-dose+pharmacokinetics+of+amantadine+hydrochloride+and+rimantadine+hydrochloride+in+young+and+elderly+adults&doi=10.1128%2Faac.28.2.216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults</span></div><div class="casAuthors">Hayden, Frederick G.; Minocha, Anil; Spyker, Daniel A.; Hoffman, Howard E.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">216-21</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    </div><div class="casAbstract">The single-dose pharmacokinetics of amantadine  [768-94-5] and rimantadine  [13392-28-4] were compared in a randomized, 2-period, crossover study involving 6 young (≤35 yr) and 6 elderly (≥60 yr) adults.  Subjects ingested single 200-mg oral doses after an overnight fast, and serial plasma (0 to 96 h), nasal mucus (0 to 8 h), and urine (0 to 24 h) samples were collected for assay of drug concn. by electron capture gas chromatog.  For both groups combined, rimantadine differed significantly from amantadine in peak plasma concn. (0.25 vs. 0.65 μg/mL), plasma elimination half-life (36.5 vs. 16.7 h), and percentage of administered dose excreted unchanged in urine (0.6 vs. 45.7%).  No significant age-related differences were noted for rimantadine.  Urinary excretion (0 to 24 h) of rimantadine and its hydroxylated metabolites averaged 19% of the administered dose.  The max. nasal mucus drug concn. was similar for both drugs (0.42 vs. 0.45 μg/g), and the ratio of max. nasal mucus to plasma concn. was over 2-fold higher after rimantadine than after amantadine.  These findings may in part explain the clin. effectiveness of rimantadine in influenza A virus infections at dosages that have lower toxicity than those of amantadine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8h2MHRwaLlLVg90H21EOLACvtfcHk0ljTfCCK5q5rJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXltFGltL8%253D&md5=979561b6722c747463126c4c3b095b7f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1128%2FAAC.28.2.216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.28.2.216%26sid%3Dliteratum%253Aachs%26aulast%3DHayden%26aufirst%3DF.%2BG.%26aulast%3DMinocha%26aufirst%3DA.%26aulast%3DSpyker%26aufirst%3DD.%2BA.%26aulast%3DHoffman%26aufirst%3DH.%2BE.%26atitle%3DComparative%2520single-dose%2520pharmacokinetics%2520of%2520amantadine%2520hydrochloride%2520and%2520rimantadine%2520hydrochloride%2520in%2520young%2520and%2520elderly%2520adults%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1985%26volume%3D28%26spage%3D216%26epage%3D221%26doi%3D10.1128%2Faac.28.2.216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liebes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochster, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chachoua, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sewak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosmidis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shore, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecht, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, F.-L.</span></span> <span> </span><span class="NLM_article-title">Thirty day multiple dose administration of PEITC: A phase I study with steady state pharmacokinetics showing good tolerance through 120 mg daily</span>. <i>Proc Am Assoc Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">834</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=834&author=L.+Liebesauthor=H.+Hochsterauthor=C.+C.+Conawayauthor=A.+Chachouaauthor=S.+Sewakauthor=K.+Farrellauthor=A.+Cosmidisauthor=S.+Mendozaauthor=R.+Shoreauthor=J.+Crowellauthor=S.+S.+Hechtauthor=S.+Carmellaauthor=F.-L.+Chung&title=Thirty+day+multiple+dose+administration+of+PEITC%3A+A+phase+I+study+with+steady+state+pharmacokinetics+showing+good+tolerance+through+120+mg+daily"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiebes%26aufirst%3DL.%26aulast%3DHochster%26aufirst%3DH.%26aulast%3DConaway%26aufirst%3DC.%2BC.%26aulast%3DChachoua%26aufirst%3DA.%26aulast%3DSewak%26aufirst%3DS.%26aulast%3DFarrell%26aufirst%3DK.%26aulast%3DCosmidis%26aufirst%3DA.%26aulast%3DMendoza%26aufirst%3DS.%26aulast%3DShore%26aufirst%3DR.%26aulast%3DCrowell%26aufirst%3DJ.%26aulast%3DHecht%26aufirst%3DS.%2BS.%26aulast%3DCarmella%26aufirst%3DS.%26aulast%3DChung%26aufirst%3DF.-L.%26atitle%3DThirty%2520day%2520multiple%2520dose%2520administration%2520of%2520PEITC%253A%2520A%2520phase%2520I%2520study%2520with%2520steady%2520state%2520pharmacokinetics%2520showing%2520good%2520tolerance%2520through%2520120%2520mg%2520daily%26jtitle%3DProc%2520Am%2520Assoc%2520Cancer%2520Res.%26date%3D2001%26volume%3D42%26spage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span> <span> </span><span class="NLM_article-title">Simultaneous determination of LogD, LogP, and pK(a) of drugs by using a reverse phase HPLC coupled with a 96-well plate auto injector</span>. <i>Comb. Chem. High Throughput Screening</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">250</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.2174/138620709787581693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=10.2174%2F138620709787581693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=19275530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1CgtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=250-257&author=P.+C.+Chiangauthor=Y.+Hu&title=Simultaneous+determination+of+LogD%2C+LogP%2C+and+pK%28a%29+of+drugs+by+using+a+reverse+phase+HPLC+coupled+with+a+96-well+plate+auto+injector&doi=10.2174%2F138620709787581693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Simultaneous determination of LogD, LogP, and pKa of drugs by using a reverse phase HPLC coupled with a 96-well plate auto injector</span></div><div class="casAuthors">Chiang, Po-Chang; Hu, Yiding</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">250-257</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  For years, the physicochem. properties of drug candidates were used to predict their in vivo pharmacokinetic behaviors.  Several theories and empirical correlations have been established by various researchers with the overall goal of expediting the drug candidate selection process, with greater confidence and faster turnaround.  This study describes a 96-well reverse phase HPLC method, simultaneously detg. LogD, LogP, and pKa values of drugs in a throughput mode.  The LogD and LogP values of each compd. were detd., based on the octanol-aq. partitioning behavior of the charged and non-charged species under different pH values.  The pKa value was detd. by the Polynomial fit between LogP and LogD and the equation LogD (pKa) ≈ LogP - 0.301.  The advantages of this method are: low sample consumption, suitability for low soly. compds., less restriction on compd. purity, potential for higher throughput, precise data, and multiple detns. in one assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3h7viwTwxUrVg90H21EOLACvtfcHk0ljoNknBizsq-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1CgtL8%253D&md5=de5cf4ce8d5273e341f3c8a4b07f3a1d</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.2174%2F138620709787581693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138620709787581693%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DP.%2BC.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DSimultaneous%2520determination%2520of%2520LogD%252C%2520LogP%252C%2520and%2520pK%2528a%2529%2520of%2520drugs%2520by%2520using%2520a%2520reverse%2520phase%2520HPLC%2520coupled%2520with%2520a%252096-well%2520plate%2520auto%2520injector%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2009%26volume%3D12%26spage%3D250%26epage%3D257%26doi%3D10.2174%2F138620709787581693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i40"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01971">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_72047"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01971?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01971</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Schemes for the synthesis of the title compounds, purity data, effects of the title compounds, adamantane, and PEITC on breast cancer cell lines, colony formation assay, Ad-ITC <b>6</b>- and PEITC-induced apoptosis on breast cancer cell lines, effects of Ad-ITC <b>6</b> on MDM2 and TP53 expression in mutant p53 and WT p53 cells  and siRNA transfected MDA-MB-468 cell proliferation, synthesis of Ad-ISeC <b>14</b> and its effect on breast cancer cell proliferation, apoptosis, and MDM2 and TP53 regulation, effects of Ad-ITC <b>6</b> and Ad-ISeC <b>14</b> on normal mammary epithelial and normal colon cell proliferation, and log <i>P</i> values (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_001.pdf">jm0c01971_si_001.pdf (1.43 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01971/suppl_file/jm0c01971_si_002.csv">jm0c01971_si_002.csv (0.7 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01971&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-10%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01971%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01971" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a07687c9f3d6c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
